1	Genetic	genetic	JJ	_	2	NMOD
2	background	background	NN	_	3	SBJ
3	determines	determine	VBZ	_	0	ROOT
4	response	response	NN	_	3	OBJ
5	to	to	IN	_	4	NMOD
6	hemostasis	hemostasis	NN	_	5	PMOD
7	and	and	CC	_	6	COORD
8	thrombosis	thrombosis	NN	_	7	CONJ

1	Abstract	abstract	NN	_	0	ROOT

1	Background	background	NN	_	0	ROOT

1	Thrombosis	thrombosis	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	the	the	DT	_	7	NMOD
4	fatal	fatal	JJ	_	7	NMOD
5	and	and	CC	_	4	COORD
6	disabling	disable	VBG	_	5	CONJ
7	consequence	consequence	NN	_	2	PRD
8	of	of	IN	_	7	NMOD
9	cardiovascular	cardiovascular	JJ	_	10	NMOD
10	diseases	disease	NNS	_	8	PMOD
11	,	,	,	_	10	P
12	the	the	DT	_	14	NMOD
13	leading	lead	VBG	_	14	NMOD
14	cause	cause	NN	_	10	APPO
15	of	of	IN	_	14	NMOD
16	mortality	mortality	NN	_	15	PMOD
17	and	and	CC	_	16	COORD
18	morbidity	morbidity	NN	_	17	CONJ
19	in	in	IN	_	14	LOC
20	Western	western	JJ	_	21	NMOD
21	countries	country	NNS	_	19	PMOD
22	.	.	.	_	2	P

1	Two	two	CD	_	4	NMOD
2	inbred	inbred	JJ	_	4	NMOD
3	mouse	mouse	NN	_	4	NMOD
4	strains	strain	NNS	_	14	SBJ
5	,	,	,	_	4	P
6	C57BL	c0bl	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	6J	0j	NN	_	4	APPO
9	and	and	CC	_	8	COORD
10	A	a	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	J	j	NN	_	9	CONJ
13	,	,	,	_	14	P
14	have	have	VBP	_	0	ROOT
15	marked	marked	JJ	_	16	NMOD
16	differences	difference	NNS	_	14	OBJ
17	in	in	IN	_	16	NMOD
18	susceptibility	susceptibility	NN	_	17	PMOD
19	to	to	IN	_	18	NMOD
20	obesity	obesity	NN	_	19	PMOD
21	,	,	,	_	20	P
22	atherosclerosis	atherosclerosis	NN	_	20	CONJ
23	,	,	,	_	22	P
24	and	and	CC	_	22	COORD
25	vessel	vessel	NN	_	26	NMOD
26	remodeling	remodeling	NN	_	24	CONJ
27	.	.	.	_	14	P

1	However	however	RB	_	4	ADV
2	,	,	,	_	4	P
3	it	it	PRP	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	unclear	unclear	JJ	_	4	PRD
6	how	how	WRB	_	11	MNR
7	these	these	DT	_	10	NMOD
8	diverse	diverse	JJ	_	10	NMOD
9	genetic	genetic	JJ	_	10	NMOD
10	backgrounds	background	NNS	_	11	SBJ
11	influence	influence	VBP	_	4	OBJ
12	pathways	pathway	NNS	_	11	OBJ
13	known	know	VBN	_	12	NMOD
14	to	to	TO	_	13	OPRD
15	regulate	regulate	VB	_	14	IM
16	thrombosis	thrombosis	NN	_	15	OBJ
17	and	and	CC	_	16	COORD
18	hemostasis	hemostasis	NN	_	17	CONJ
19	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	objective	objective	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	5	NMOD
5	study	study	NN	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	to	to	TO	_	6	PRD
8	evaluate	evaluate	VB	_	7	IM
9	thrombosis	thrombosis	NN	_	8	OBJ
10	and	and	CC	_	9	COORD
11	hemostasis	hemostasis	NN	_	10	CONJ
12	in	in	IN	_	8	LOC
13	these	these	DT	_	16	NMOD
14	two	two	CD	_	16	NMOD
15	inbred	inbred	JJ	_	16	NMOD
16	strains	strain	NNS	_	12	PMOD
17	and	and	CC	_	8	COORD
18	determine	determine	VB	_	17	CONJ
19	the	the	DT	_	21	NMOD
20	phenotypic	phenotypic	JJ	_	21	NMOD
21	response	response	NN	_	18	OBJ
22	of	of	IN	_	21	NMOD
23	A	a	NN	_	25	NMOD
24	/	/	HYPH	_	23	P
25	J	j	NN	_	26	NMOD
26	chromosomes	chromosome	NNS	_	22	PMOD
27	in	in	IN	_	18	LOC
28	the	the	DT	_	32	NMOD
29	C57BL	c0bl	NN	_	31	NMOD
30	/	/	HYPH	_	29	P
31	6J	0j	NN	_	32	NMOD
32	background	background	NN	_	27	PMOD
33	.	.	.	_	6	P

1	Methods	method	NNS	_	0	ROOT

1	A	a	NN	_	3	NMOD
2	/	/	HYPH	_	1	P
3	J	j	NN	_	8	NMOD
4	and	and	CC	_	3	COORD
5	C57Bl	c0bl	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	6J	0j	NN	_	4	CONJ
8	mice	mouse	NNS	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	evaluated	evaluate	VBN	_	9	VC
11	for	for	IN	_	10	PRP
12	differences	difference	NNS	_	11	PMOD
13	in	in	IN	_	12	NMOD
14	thrombosis	thrombosis	NN	_	13	PMOD
15	and	and	CC	_	14	COORD
16	hemostasis	hemostasis	NN	_	15	CONJ
17	.	.	.	_	9	P

1	A	a	DT	_	2	NMOD
2	thrombus	thrombus	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	induced	induce	VBN	_	3	VC
5	in	in	IN	_	4	LOC
6	the	the	DT	_	8	NMOD
7	carotid	carotid	JJ	_	8	NMOD
8	artery	artery	NN	_	5	PMOD
9	by	by	IN	_	4	MNR
10	application	application	NN	_	9	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	exposed	expose	VBN	_	14	NMOD
14	carotid	carotid	NN	_	11	PMOD
15	to	to	IN	_	10	NMOD
16	ferric	ferric	JJ	_	17	NMOD
17	chloride	chloride	NN	_	15	PMOD
18	and	and	CC	_	3	COORD
19	blood	blood	NN	_	20	NMOD
20	flow	flow	NN	_	21	SBJ
21	measured	measure	VBN	_	18	GAP
22	until	until	IN	_	21	TMP
23	the	the	DT	_	24	NMOD
24	vessel	vessel	NN	_	25	SBJ
25	occluded	occlude	VBD	_	22	SUB
26	.	.	.	_	3	P

1	Bleeding	bleeding	NN	_	4	NMOD
2	and	and	CC	_	1	COORD
3	rebleeding	rebleeding	NN	_	2	CONJ
4	times	time	NNS	_	14	SBJ
5	,	,	,	_	4	P
6	as	as	IN	_	4	NMOD
7	surrogate	surrogate	JJ	_	8	NMOD
8	markers	marker	NNS	_	6	PMOD
9	for	for	IN	_	8	NMOD
10	thrombosis	thrombosis	NN	_	9	PMOD
11	and	and	CC	_	10	COORD
12	hemostasis	hemostasis	NN	_	11	CONJ
13	,	,	,	_	14	P
14	were	be	VBD	_	0	ROOT
15	determined	determine	VBN	_	14	VC
16	after	after	IN	_	15	TMP
17	clipping	clip	VBG	_	16	PMOD
18	the	the	DT	_	19	NMOD
19	tail	tail	NN	_	17	OBJ
20	and	and	CC	_	17	COORD
21	placing	place	VBG	_	20	CONJ
22	in	in	IN	_	21	LOC
23	warm	warm	JJ	_	24	NMOD
24	saline	saline	NN	_	22	PMOD
25	.	.	.	_	14	P

1	Twenty	twenty	CD	_	6	NMOD
2	-	-	HYPH	_	1	P
3	one	one	CD	_	1	QMOD
4	chromosome	chromosome	NN	_	6	NMOD
5	substitution	substitution	NN	_	6	NMOD
6	strains	strain	NNS	_	19	SBJ
7	,	,	,	_	6	P
8	A	a	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	J	j	NN	_	11	NMOD
11	chromosomes	chromosome	NNS	_	6	APPO
12	in	in	IN	_	11	LOC
13	a	a	DT	_	17	NMOD
14	C57BL	c0bl	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	6J	0j	NN	_	17	NMOD
17	background	background	NN	_	12	PMOD
18	,	,	,	_	19	P
19	were	be	VBD	_	0	ROOT
20	screened	screen	VBN	_	19	VC
21	for	for	IN	_	20	PRP
22	response	response	NN	_	21	PMOD
23	to	to	IN	_	22	NMOD
24	the	the	DT	_	27	NMOD
25	tail	tail	NN	_	26	NMOD
26	bleeding	bleeding	NN	_	27	NMOD
27	assay	assay	NN	_	23	PMOD
28	.	.	.	_	19	P

1	Results	result	NNS	_	0	ROOT

1	Thrombus	thrombus	NN	_	2	NMOD
2	occlusion	occlusion	NN	_	3	NMOD
3	time	time	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	markedly	markedly	RB	_	4	ADV
6	decreased	decrease	VBN	_	4	VC
7	in	in	IN	_	6	LOC
8	the	the	DT	_	12	NMOD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	12	NMOD
12	mice	mouse	NNS	_	7	PMOD
13	compared	compare	VBN	_	6	ADV
14	to	to	IN	_	13	PMOD
15	C57BL	c0bl	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	6J	0j	NN	_	18	NMOD
18	mice	mouse	NNS	_	14	PMOD
19	.	.	.	_	4	P

1	Tail	tail	NN	_	2	NMOD
2	bleeding	bleeding	NN	_	3	NMOD
3	time	time	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	similar	similar	JJ	_	4	PRD
6	in	in	IN	_	4	LOC
7	the	the	DT	_	9	NMOD
8	two	two	CD	_	9	NMOD
9	strains	strain	NNS	_	6	PMOD
10	,	,	,	_	4	P
11	but	but	CC	_	4	COORD
12	rebleeding	rebleeding	NN	_	13	NMOD
13	time	time	NN	_	14	SBJ
14	was	be	VBD	_	11	CONJ
15	markedly	markedly	RB	_	14	ADV
16	increased	increase	VBN	_	14	VC
17	in	in	IN	_	16	LOC
18	the	the	DT	_	22	NMOD
19	A	a	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	J	j	NN	_	22	NMOD
22	mice	mouse	NNS	_	17	PMOD
23	compared	compare	VBN	_	16	ADV
24	to	to	IN	_	23	PMOD
25	C57BL	c0bl	NN	_	27	NMOD
26	/	/	HYPH	_	25	P
27	6J	0j	NN	_	28	NMOD
28	mice	mouse	NNS	_	24	PMOD
29	.	.	.	_	4	P

1	Coagulation	coagulation	NN	_	2	NMOD
2	times	time	NNS	_	6	SBJ
3	and	and	CC	_	2	COORD
4	tail	tail	NN	_	5	NMOD
5	morphology	morphology	NN	_	3	CONJ
6	were	be	VBD	_	0	ROOT
7	similar	similar	JJ	_	6	PRD
8	,	,	,	_	6	P
9	but	but	CC	_	6	COORD
10	tail	tail	NN	_	11	NMOD
11	collagen	collagen	NN	_	12	NMOD
12	content	content	NN	_	13	SBJ
13	was	be	VBD	_	9	CONJ
14	higher	high	JJR	_	13	PRD
15	in	in	IN	_	13	LOC
16	A	a	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	J	j	NN	_	15	PMOD
19	than	than	IN	_	14	AMOD
20	C57BL	c0bl	NN	_	22	NMOD
21	/	/	HYPH	_	20	P
22	6J	0j	NN	_	19	PMOD
23	mice	mouse	NNS	_	22	NMOD
24	.	.	.	_	6	P

1	Three	three	CD	_	4	NMOD
2	chromosome	chromosome	NN	_	4	NMOD
3	substitution	substitution	NN	_	4	NMOD
4	strains	strain	NNS	_	25	SBJ
5	,	,	,	_	4	P
6	B6	b0	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	Chr5A	chr0a	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	J	j	NN	_	4	APPO
11	,	,	,	_	10	P
12	B6	b0	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	Chr11A	chr0a	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	J	j	NN	_	10	CONJ
17	,	,	,	_	16	P
18	and	and	CC	_	16	COORD
19	B6	b0	NN	_	21	NMOD
20	-	-	HYPH	_	19	P
21	Chr17A	chr0a	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	J	j	NN	_	18	CONJ
24	,	,	,	_	25	P
25	were	be	VBD	_	0	ROOT
26	identified	identify	VBN	_	25	VC
27	with	with	IN	_	26	ADV
28	increased	increase	VBN	_	30	NMOD
29	rebleeding	rebleeding	NN	_	30	NMOD
30	time	time	NN	_	27	PMOD
31	,	,	,	_	30	P
32	a	a	DT	_	33	NMOD
33	phenotype	phenotype	NN	_	30	APPO
34	similar	similar	JJ	_	33	NMOD
35	to	to	IN	_	34	AMOD
36	A	a	NN	_	38	NMOD
37	/	/	HYPH	_	36	P
38	J	j	NN	_	39	NMOD
39	mice	mouse	NNS	_	35	PMOD
40	.	.	.	_	25	P

1	Mice	mouse	NNS	_	8	SBJ
2	heterosomic	heterosomic	JJ	_	1	NMOD
3	for	for	IN	_	2	AMOD
4	chromosomes	chromosome	NNS	_	5	NMOD
5	5	0	CD	_	3	PMOD
6	or	or	CC	_	5	COORD
7	17	0	CD	_	6	CONJ
8	had	have	VBD	_	0	ROOT
9	rebleeding	rebleeding	NN	_	10	NMOD
10	times	time	NNS	_	8	OBJ
11	similar	similar	JJ	_	10	NMOD
12	to	to	IN	_	11	AMOD
13	C57BL	c0bl	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	6J	0j	NN	_	16	NMOD
16	mice	mouse	NNS	_	12	PMOD
17	,	,	,	_	8	P
18	but	but	CC	_	8	COORD
19	when	when	IN	_	39	TMP
20	these	these	DT	_	24	NMOD
21	two	two	CD	_	24	NMOD
22	chromosome	chromosome	NN	_	24	NMOD
23	substitution	substitution	NN	_	24	NMOD
24	strains	strain	NNS	_	38	SBJ
25	,	,	,	_	24	P
26	B6	b0	NN	_	28	NMOD
27	-	-	HYPH	_	26	P
28	Chr5A	chr0a	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	J	j	NN	_	24	APPO
31	and	and	CC	_	30	COORD
32	B6	b0	NN	_	34	NMOD
33	-	-	HYPH	_	32	P
34	Chr17A	chr0a	NN	_	36	NMOD
35	/	/	HYPH	_	34	P
36	J	j	NN	_	31	CONJ
37	,	,	,	_	38	P
38	were	be	VBD	_	46	TMP
39	crossed	cross	VBN	_	38	VC
40	,	,	,	_	46	P
41	the	the	DT	_	45	NMOD
42	A	a	NN	_	44	NMOD
43	/	/	HYPH	_	42	P
44	J	j	NN	_	45	NMOD
45	phenotype	phenotype	NN	_	46	SBJ
46	was	be	VBD	_	18	CONJ
47	restored	restore	VBN	_	46	VC
48	in	in	IN	_	47	LOC
49	these	these	DT	_	52	NMOD
50	doubly	doubly	RB	_	51	AMOD
51	heterosomic	heterosomic	JJ	_	52	NMOD
52	progeny	progeny	NN	_	48	PMOD
53	.	.	.	_	8	P

1	Conclusion	conclusion	NN	_	0	ROOT

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	susceptibility	susceptibility	NN	_	11	SBJ
6	to	to	IN	_	5	NMOD
7	arterial	arterial	JJ	_	8	NMOD
8	thrombosis	thrombosis	NN	_	6	PMOD
9	and	and	CC	_	8	COORD
10	haemostasis	haemostasis	NN	_	9	CONJ
11	is	be	VBZ	_	4	SUB
12	remarkably	remarkably	RB	_	13	AMOD
13	different	different	JJ	_	11	PRD
14	in	in	IN	_	11	LOC
15	C57BL	c0bl	NN	_	20	NMOD
16	/	/	HYPH	_	15	P
17	and	and	CC	_	15	COORD
18	A	a	NN	_	17	CONJ
19	/	/	HYPH	_	18	P
20	J	j	NN	_	21	NMOD
21	mice	mouse	NNS	_	14	PMOD
22	.	.	.	_	3	P

1	Three	three	CD	_	7	NMOD
2	A	a	NN	_	4	NMOD
3	/	/	HYPH	_	2	P
4	J	j	NN	_	7	NMOD
5	chromosome	chromosome	NN	_	7	NMOD
6	substitution	substitution	NN	_	7	NMOD
7	strains	strain	NNS	_	8	SBJ
8	were	be	VBD	_	0	ROOT
9	identified	identify	VBN	_	8	VC
10	that	that	WDT	_	11	SBJ
11	expressed	express	VBD	_	7	NMOD
12	a	a	DT	_	13	NMOD
13	phenotype	phenotype	NN	_	11	OBJ
14	similar	similar	JJ	_	13	NMOD
15	to	to	IN	_	14	AMOD
16	A	a	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	J	j	NN	_	15	PMOD
19	for	for	IN	_	9	PRP
20	rebleeding	rebleeding	VBG	_	19	PMOD
21	,	,	,	_	8	P
22	the	the	DT	_	26	NMOD
23	C57Bl	c0bl	NN	_	25	NMOD
24	/	/	HYPH	_	23	P
25	6J	0j	NN	_	26	NMOD
26	background	background	NN	_	27	SBJ
27	could	could	MD	_	8	CONJ
28	modify	modify	VB	_	27	VC
29	the	the	DT	_	33	NMOD
30	A	a	NN	_	32	NMOD
31	/	/	HYPH	_	30	P
32	J	j	NN	_	33	NMOD
33	phenotype	phenotype	NN	_	28	OBJ
34	,	,	,	_	27	P
35	and	and	CC	_	27	COORD
36	the	the	DT	_	37	NMOD
37	combination	combination	NN	_	44	SBJ
38	of	of	IN	_	37	NMOD
39	two	two	CD	_	43	NMOD
40	A	a	NN	_	42	NMOD
41	/	/	HYPH	_	40	P
42	J	j	NN	_	43	NMOD
43	QTL	qtl	NN	_	38	PMOD
44	could	could	MD	_	35	CONJ
45	restore	restore	VB	_	44	VC
46	the	the	DT	_	47	NMOD
47	phenotype	phenotype	NN	_	45	OBJ
48	.	.	.	_	8	P

1	The	the	DT	_	4	NMOD
2	diverse	diverse	JJ	_	4	NMOD
3	genetic	genetic	JJ	_	4	NMOD
4	backgrounds	background	NNS	_	20	SBJ
5	and	and	CC	_	4	COORD
6	differences	difference	NNS	_	5	CONJ
7	in	in	IN	_	6	NMOD
8	response	response	NN	_	7	PMOD
9	to	to	IN	_	8	NMOD
10	vascular	vascular	JJ	_	11	NMOD
11	injury	injury	NN	_	12	AMOD
12	induced	induce	VBN	_	13	NMOD
13	thrombosis	thrombosis	NN	_	9	PMOD
14	and	and	CC	_	13	COORD
15	the	the	DT	_	18	NMOD
16	tail	tail	NN	_	17	NMOD
17	bleeding	bleeding	NN	_	18	NMOD
18	assay	assay	NN	_	14	CONJ
19	,	,	,	_	20	P
20	suggest	suggest	VBP	_	0	ROOT
21	the	the	DT	_	22	NMOD
22	potential	potential	NN	_	20	OBJ
23	for	for	IN	_	22	NMOD
24	identifying	identify	VBG	_	23	PMOD
25	novel	novel	JJ	_	27	NMOD
26	genetic	genetic	JJ	_	27	NMOD
27	determinants	determinant	NNS	_	24	OBJ
28	of	of	IN	_	27	NMOD
29	thrombotic	thrombotic	JJ	_	30	NMOD
30	risk	risk	NN	_	28	PMOD
31	.	.	.	_	20	P

1	Background	background	NN	_	0	ROOT

1	Family	family	NN	_	2	NMOD
2	history	history	NN	_	6	SBJ
3	[	[	-LRB-	_	4	P
4	1	0	CD	_	2	PRN
5	]	]	-RRB-	_	4	P
6	is	be	VBZ	_	0	ROOT
7	the	the	DT	_	10	NMOD
8	strongest	strong	JJS	_	10	NMOD
9	risk	risk	NN	_	10	NMOD
10	factor	factor	NN	_	6	PRD
11	for	for	IN	_	10	NMOD
12	cardiovascular	cardiovascular	JJ	_	13	NMOD
13	diseases	disease	NNS	_	15	NMOD
14	(	(	-LRB-	_	15	P
15	CVD	cvd	NNS	_	11	PMOD
16	)	)	-RRB-	_	6	P
17	.	.	.	_	6	P

1	While	while	IN	_	12	ADV
2	a	a	DT	_	3	NMOD
3	number	number	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	genetic	genetic	JJ	_	6	NMOD
6	mutations	mutation	NNS	_	4	PMOD
7	have	have	VBP	_	1	SUB
8	been	be	VBN	_	7	VC
9	identified	identify	VBN	_	8	VC
10	,	,	,	_	12	P
11	these	these	DT	_	12	SBJ
12	account	account	VBP	_	0	ROOT
13	for	for	IN	_	12	ADV
14	only	only	RB	_	17	NMOD
15	a	a	DT	_	17	NMOD
16	small	small	JJ	_	17	NMOD
17	percentage	percentage	NN	_	13	PMOD
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	20	NMOD
20	CVD	cvd	NNS	_	18	PMOD
21	in	in	IN	_	20	LOC
22	human	human	JJ	_	23	NMOD
23	populations	population	NNS	_	21	PMOD
24	.	.	.	_	12	P

1	Thrombus	thrombus	NN	_	2	NMOD
2	formation	formation	NN	_	7	SBJ
3	on	on	IN	_	2	NMOD
4	fissured	fissure	VBN	_	6	NMOD
5	atherosclerotic	atherosclerotic	JJ	_	6	NMOD
6	plaques	plaque	NNS	_	3	PMOD
7	is	be	VBZ	_	0	ROOT
8	the	the	DT	_	10	NMOD
9	precipitating	precipitate	VBG	_	10	NMOD
10	event	event	NN	_	7	PRD
11	in	in	IN	_	10	NMOD
12	the	the	DT	_	13	NMOD
13	transition	transition	NN	_	11	PMOD
14	from	from	IN	_	13	NMOD
15	a	a	DT	_	20	NMOD
16	stable	stable	JJ	_	20	NMOD
17	or	or	CC	_	16	COORD
18	subclinical	subclinical	JJ	_	17	CONJ
19	atherosclerotic	atherosclerotic	JJ	_	20	NMOD
20	disease	disease	NN	_	14	PMOD
21	and	and	CC	_	7	COORD
22	leads	lead	VBZ	_	21	CONJ
23	to	to	IN	_	22	ADV
24	acute	acute	JJ	_	26	NMOD
25	myocardial	myocardial	JJ	_	26	NMOD
26	infarction	infarction	NN	_	23	PMOD
27	,	,	,	_	26	P
28	ischemic	ischemic	JJ	_	29	NMOD
29	stroke	stroke	NN	_	26	CONJ
30	or	or	CC	_	29	COORD
31	peripheral	peripheral	JJ	_	32	AMOD
32	arterial	arterial	JJ	_	33	NMOD
33	occlusion	occlusion	NN	_	30	CONJ
34	.	.	.	_	7	P

1	Arterial	arterial	JJ	_	4	NMOD
2	and	and	CC	_	1	COORD
3	venous	venous	JJ	_	2	CONJ
4	thrombosis	thrombosis	NN	_	5	SBJ
5	are	be	VBP	_	0	ROOT
6	complex	complex	JJ	_	7	NMOD
7	responses	response	NNS	_	5	PRD
8	and	and	CC	_	5	COORD
9	are	be	VBP	_	8	CONJ
10	influenced	influence	VBN	_	9	VC
11	by	by	IN	_	10	LGS
12	multiple	multiple	JJ	_	16	NMOD
13	genetic	genetic	JJ	_	16	NMOD
14	and	and	CC	_	13	COORD
15	environmental	environmental	JJ	_	14	CONJ
16	factors	factor	NNS	_	11	PMOD
17	[	[	-LRB-	_	18	P
18	2	0	CD	_	10	PRN
19	-	-	SYM	_	20	P
20	5	0	CD	_	18	NMOD
21	]	]	-RRB-	_	18	P
22	.	.	.	_	5	P

1	Polymorphisms	polymorphism	NNS	_	26	SBJ
2	and	and	CC	_	1	COORD
3	mutations	mutation	NNS	_	2	CONJ
4	in	in	IN	_	1	NMOD
5	coagulation	coagulation	NN	_	6	NMOD
6	factors	factor	NNS	_	4	PMOD
7	,	,	,	_	6	P
8	fibrinolytic	fibrinolytic	JJ	_	9	NMOD
9	factors	factor	NNS	_	6	CONJ
10	,	,	,	_	9	P
11	platelet	platelet	NN	_	12	NMOD
12	surface	surface	NN	_	13	NMOD
13	receptors	receptor	NNS	_	9	CONJ
14	,	,	,	_	13	P
15	methylenetetrahydrofalate	methylenetetrahydrofalate	NN	_	16	NMOD
16	reductase	reductase	NN	_	13	CONJ
17	,	,	,	_	16	P
18	endothelial	endothelial	JJ	_	21	NMOD
19	nitric	nitric	JJ	_	20	NMOD
20	oxide	oxide	NN	_	21	NMOD
21	synthase	synthase	NN	_	16	CONJ
22	,	,	,	_	21	P
23	and	and	CC	_	21	COORD
24	antioxidant	antioxidant	JJ	_	25	NMOD
25	enzymes	enzyme	NNS	_	23	CONJ
26	have	have	VBP	_	0	ROOT
27	been	be	VBN	_	26	VC
28	implicated	implicate	VBN	_	27	VC
29	as	as	IN	_	28	ADV
30	genetic	genetic	JJ	_	31	NMOD
31	determinants	determinant	NNS	_	29	PMOD
32	of	of	IN	_	31	NMOD
33	susceptibility	susceptibility	NN	_	32	PMOD
34	to	to	IN	_	33	NMOD
35	thrombosis	thrombosis	NN	_	34	PMOD
36	[	[	-LRB-	_	39	P
37	6	0	CD	_	39	NMOD
38	,	,	,	_	39	P
39	7	0	CD	_	28	PRN
40	]	]	-RRB-	_	39	P
41	.	.	.	_	26	P

1	Great	great	JJ	_	2	NMOD
2	strides	stride	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	been	be	VBN	_	3	VC
5	made	make	VBN	_	4	VC
6	in	in	IN	_	5	ADV
7	the	the	DT	_	8	NMOD
8	diagnosis	diagnosis	NN	_	6	PMOD
9	and	and	CC	_	8	COORD
10	treatment	treatment	NN	_	9	CONJ
11	of	of	IN	_	8	NMOD
12	thrombosis	thrombosis	NN	_	11	PMOD
13	in	in	IN	_	5	TMP
14	the	the	DT	_	16	NMOD
15	last	last	JJ	_	16	NMOD
16	decade	decade	NN	_	13	PMOD
17	.	.	.	_	3	P

1	However	however	RB	_	7	ADV
2	,	,	,	_	7	P
3	strategies	strategy	NNS	_	7	SBJ
4	to	to	TO	_	3	NMOD
5	prevent	prevent	VB	_	4	IM
6	thrombosis	thrombosis	NN	_	5	OBJ
7	have	have	VBP	_	0	ROOT
8	lagged	lag	VBN	_	7	VC
9	far	far	RB	_	10	AMOD
10	behind	behind	RB	_	8	ADV
11	due	due	IN	_	8	PRP
12	,	,	,	_	11	P
13	in	in	IN	_	11	PMOD
14	part	part	JJ	_	13	PMOD
15	,	,	,	_	11	P
16	to	to	IN	_	11	PMOD
17	the	the	DT	_	18	NMOD
18	contribution	contribution	NN	_	11	PMOD
19	of	of	IN	_	18	NMOD
20	multiple	multiple	JJ	_	28	NMOD
21	,	,	,	_	20	P
22	and	and	CC	_	20	COORD
23	as	as	RB	_	24	AMOD
24	yet	yet	RB	_	25	AMOD
25	undefined	undefined	JJ	_	22	CONJ
26	,	,	,	_	28	P
27	genetic	genetic	JJ	_	28	NMOD
28	factors	factor	NNS	_	19	PMOD
29	that	that	WDT	_	30	SBJ
30	lead	lead	VBP	_	28	NMOD
31	to	to	IN	_	30	ADV
32	thrombotic	thrombotic	JJ	_	33	NMOD
33	risk	risk	NN	_	31	PMOD
34	.	.	.	_	7	P

1	Moreover	moreover	RB	_	4	ADV
2	,	,	,	_	4	P
3	it	it	PRP	_	4	SBJ
4	remains	remain	VBZ	_	0	ROOT
5	unclear	unclear	JJ	_	4	OPRD
6	how	how	WRB	_	9	MNR
7	genetic	genetic	JJ	_	8	NMOD
8	background	background	NN	_	9	SBJ
9	influences	influence	VBZ	_	4	OBJ
10	the	the	DT	_	11	NMOD
11	function	function	NN	_	9	OBJ
12	of	of	IN	_	11	NMOD
13	molecules	molecule	NNS	_	12	PMOD
14	and	and	CC	_	13	COORD
15	pathways	pathway	NNS	_	14	CONJ
16	known	know	VBN	_	13	NMOD
17	to	to	TO	_	16	OPRD
18	regulate	regulate	VB	_	17	IM
19	thrombus	thrombus	NN	_	20	NMOD
20	formation	formation	NN	_	18	OBJ
21	and	and	CC	_	20	COORD
22	lysis	lysis	NN	_	21	CONJ
23	and	and	CC	_	9	COORD
24	,	,	,	_	23	P
25	thereby	thereby	RB	_	27	ADV
26	,	,	,	_	27	P
27	contributes	contribute	VBZ	_	23	CONJ
28	to	to	IN	_	27	ADV
29	the	the	DT	_	30	NMOD
30	risk	risk	NN	_	28	PMOD
31	of	of	IN	_	30	NMOD
32	thrombotic	thrombotic	JJ	_	33	NMOD
33	disease	disease	NN	_	31	PMOD
34	.	.	.	_	4	P

1	Many	many	JJ	_	22	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	7	NMOD
4	available	available	JJ	_	7	NMOD
5	inbred	inbred	JJ	_	6	NMOD
6	mouse	mouse	NN	_	7	NMOD
7	strains	strain	NNS	_	2	PMOD
8	,	,	,	_	7	P
9	such	such	JJ	_	10	PMOD
10	as	as	IN	_	7	NMOD
11	C57BL	c0bl	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	6J	0j	NN	_	15	NMOD
14	(	(	-LRB-	_	15	P
15	B6	b0	NN	_	10	PMOD
16	)	)	-RRB-	_	15	P
17	and	and	CC	_	15	COORD
18	A	a	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	J	j	NN	_	17	CONJ
21	,	,	,	_	22	P
22	have	have	VBP	_	0	ROOT
23	been	be	VBN	_	22	VC
24	classified	classify	VBN	_	23	VC
25	as	as	IN	_	24	ADV
26	resistant	resistant	JJ	_	25	PMOD
27	or	or	CC	_	26	COORD
28	susceptible	susceptible	JJ	_	27	CONJ
29	to	to	IN	_	26	AMOD
30	particular	particular	JJ	_	32	NMOD
31	complex	complex	JJ	_	32	NMOD
32	diseases	disease	NNS	_	29	PMOD
33	(	(	-LRB-	_	34	P
34	Table	table	NN	_	24	PRN
35	1	0	CD	_	34	NMOD
36	)	)	-RRB-	_	34	P
37	.	.	.	_	22	P

1	These	these	DT	_	3	NMOD
2	two	two	CD	_	3	NMOD
3	strains	strain	NNS	_	4	SBJ
4	have	have	VBP	_	0	ROOT
5	diverse	diverse	JJ	_	6	NMOD
6	responses	response	NNS	_	4	OBJ
7	to	to	IN	_	6	NMOD
8	diet	diet	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	induced	induce	VBN	_	11	NMOD
11	obesity	obesity	NN	_	7	PMOD
12	[	[	-LRB-	_	13	P
13	8	0	CD	_	11	PRN
14	]	]	-RRB-	_	13	P
15	(	(	-LRB-	_	21	P
16	B6	b0	NN	_	21	DEP
17	susceptible	susceptible	JJ	_	16	OPRD
18	;	;	:	_	21	P
19	A	a	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	J	j	NN	_	11	PRN
22	resistant	resistant	JJ	_	21	OPRD
23	)	)	-RRB-	_	21	P
24	,	,	,	_	11	P
25	diet	diet	NN	_	27	AMOD
26	-	-	HYPH	_	25	P
27	induced	induce	VBN	_	28	NMOD
28	atherosclerosis	atherosclerosis	NN	_	11	CONJ
29	(	(	-LRB-	_	35	P
30	B6	b0	NN	_	35	DEP
31	susceptible	susceptible	JJ	_	30	OPRD
32	;	;	:	_	35	P
33	A	a	NN	_	35	NMOD
34	/	/	HYPH	_	33	P
35	J	j	NN	_	28	PRN
36	resistant	resistant	JJ	_	35	OPRD
37	)	)	-RRB-	_	35	P
38	[	[	-LRB-	_	39	P
39	9	0	CD	_	28	PRN
40	]	]	-RRB-	_	39	P
41	,	,	,	_	28	P
42	arterial	arterial	JJ	_	43	NMOD
43	ligation	ligation	NN	_	45	AMOD
44	-	-	HYPH	_	43	P
45	induced	induce	VBN	_	47	NMOD
46	neointimal	neointimal	JJ	_	47	NMOD
47	hyperplasia	hyperplasia	NN	_	28	CONJ
48	(	(	-LRB-	_	54	P
49	B6	b0	NN	_	54	DEP
50	resistant	resistant	JJ	_	49	OPRD
51	;	;	:	_	54	P
52	A	a	NN	_	54	NMOD
53	/	/	HYPH	_	52	P
54	J	j	NN	_	47	PRN
55	resistant	resistant	JJ	_	54	OPRD
56	)	)	-RRB-	_	54	P
57	,	,	,	_	47	P
58	and	and	CC	_	47	COORD
59	ligation	ligation	NN	_	60	AMOD
60	induced	induce	VBN	_	62	NMOD
61	vessel	vessel	NN	_	62	NMOD
62	remodeling	remodeling	NN	_	58	CONJ
63	(	(	-LRB-	_	73	P
64	B6	b0	NN	_	73	DEP
65	resistant	resistant	JJ	_	64	OPRD
66	;	;	:	_	73	P
67	A	a	NN	_	69	NMOD
68	/	/	HYPH	_	67	P
69	J	j	NN	_	73	DEP
70	susceptible	susceptible	JJ	_	69	OPRD
71	)	)	-RRB-	_	73	P
72	[	[	-LRB-	_	73	P
73	10	0	CD	_	62	PRN
74	]	]	-RRB-	_	73	P
75	.	.	.	_	4	P

1	These	these	DT	_	2	NMOD
2	conditions	condition	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	predisposing	predispose	VBG	_	3	PRD
5	to	to	IN	_	4	AMOD
6	thrombosis	thrombosis	NN	_	5	PMOD
7	per	per	FW	_	8	AMOD
8	se	se	FW	_	3	MNR
9	,	,	,	_	3	P
10	but	but	CC	_	3	COORD
11	these	these	DT	_	12	NMOD
12	mice	mouse	NNS	_	13	SBJ
13	have	have	VBP	_	10	CONJ
14	not	not	RB	_	13	ADV
15	been	be	VBN	_	13	VC
16	systematically	systematically	RB	_	15	MNR
17	evaluated	evaluate	VBN	_	15	VC
18	for	for	IN	_	17	ADV
19	thrombosis	thrombosis	NN	_	18	PMOD
20	.	.	.	_	3	P

1	Clot	clot	NN	_	2	NMOD
2	formation	formation	NN	_	11	SBJ
3	and	and	CC	_	2	COORD
4	lysis	lysis	NN	_	3	CONJ
5	,	,	,	_	2	P
6	which	which	WDT	_	8	SBJ
7	ultimately	ultimately	RB	_	8	ADV
8	determine	determine	VBP	_	2	NMOD
9	thrombosis	thrombosis	NN	_	8	OBJ
10	,	,	,	_	11	P
11	requires	require	VBZ	_	0	ROOT
12	platelet	platelet	NN	_	13	NMOD
13	aggregation	aggregation	NN	_	11	OBJ
14	,	,	,	_	13	P
15	coagulation	coagulation	NN	_	13	CONJ
16	,	,	,	_	15	P
17	and	and	CC	_	15	COORD
18	fibrinolytic	fibrinolytic	JJ	_	19	NMOD
19	functions	function	NNS	_	17	CONJ
20	.	.	.	_	11	P

1	Interactions	interaction	NNS	_	5	SBJ
2	among	among	IN	_	1	NMOD
3	these	these	DT	_	4	NMOD
4	pathways	pathway	NNS	_	2	PMOD
5	may	may	MD	_	0	ROOT
6	occur	occur	VB	_	5	VC
7	and	and	CC	_	5	COORD
8	additional	additional	JJ	_	9	NMOD
9	factors	factor	NNS	_	10	SBJ
10	may	may	MD	_	7	CONJ
11	modulate	modulate	VB	_	10	VC
12	these	these	DT	_	13	NMOD
13	processes	process	NNS	_	11	OBJ
14	.	.	.	_	5	P

1	Identification	identification	NN	_	10	SBJ
2	of	of	IN	_	1	NMOD
3	novel	novel	JJ	_	4	NMOD
4	modulators	modulators	NNS	_	2	PMOD
5	and	and	CC	_	4	COORD
6	factors	factor	NNS	_	5	CONJ
7	of	of	IN	_	4	NMOD
8	these	these	DT	_	9	NMOD
9	pathways	pathway	NNS	_	7	PMOD
10	can	can	MD	_	0	ROOT
11	be	be	VB	_	10	VC
12	identified	identify	VBN	_	11	VC
13	by	by	IN	_	12	MNR
14	associating	associate	VBG	_	13	PMOD
15	the	the	DT	_	16	NMOD
16	phenotype	phenotype	NN	_	14	OBJ
17	with	with	IN	_	14	ADV
18	a	a	DT	_	19	NMOD
19	location	location	NN	_	17	PMOD
20	(	(	-LRB-	_	19	P
21	s	s	AFX	_	19	NMOD
22	)	)	-RRB-	_	19	P
23	on	on	IN	_	19	LOC
24	a	a	DT	_	26	NMOD
25	specific	specific	JJ	_	26	NMOD
26	chromosome	chromosome	NN	_	23	PMOD
27	,	,	,	_	19	P
28	a	a	DT	_	33	NMOD
29	quantitative	quantitative	JJ	_	31	NMOD
30	trait	trait	NN	_	31	NMOD
31	locus	locus	NN	_	33	NMOD
32	(	(	-LRB-	_	33	P
33	QTL	qtl	NN	_	19	APPO
34	)	)	-RRB-	_	10	P
35	.	.	.	_	10	P

1	Table	table	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Identification	identification	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	mice	mouse	NNS	_	2	PMOD
4	susceptible	susceptible	JJ	_	3	NMOD
5	or	or	CC	_	4	COORD
6	resistant	resistant	JJ	_	5	CONJ
7	to	to	IN	_	4	AMOD
8	obesity	obesity	NN	_	7	PMOD
9	,	,	,	_	8	P
10	atherosclerosis	atherosclerosis	NN	_	8	CONJ
11	,	,	,	_	10	P
12	and	and	CC	_	10	COORD
13	vascular	vascular	JJ	_	14	NMOD
14	injury	injury	NN	_	12	CONJ

1	R	r	NN	_	5	NMOD
2	:	:	:	_	1	P
3	resistant	resistant	JJ	_	1	NMOD
4	;	;	:	_	5	P
5	S	s	NN	_	0	ROOT
6	:	:	:	_	5	P
7	susceptible	susceptible	JJ	_	5	NMOD
8	.	.	.	_	5	P

1	Reference	reference	NN	_	2	SBJ
2	provided	provide	VBN	_	0	ROOT
3	by	by	IN	_	2	LGS
4	number	number	NN	_	3	PMOD
5	in	in	IN	_	4	NMOD
6	parenthesis	parenthesis	NN	_	5	PMOD
7	.	.	.	_	2	P

1	Lepob	lepob	NN	_	15	NMOD
2	,	,	,	_	1	P
3	Plg	plg	NN	_	1	CONJ
4	-	-	SYM	_	3	P
5	/	/	HYPH	_	3	P
6	-	-	SYM	_	3	P
7	,	,	,	_	3	P
8	and	and	CC	_	3	COORD
9	PAI	pai	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	F1	f0	NN	_	8	CONJ
12	-	-	SYM	_	11	P
13	/	/	HYPH	_	11	P
14	-	-	SYM	_	11	P
15	mice	mouse	NNS	_	16	SBJ
16	were	be	VBD	_	0	ROOT
17	in	in	IN	_	16	PRD
18	a	a	DT	_	20	NMOD
19	B6	b0	NN	_	20	NMOD
20	background	background	NN	_	17	PMOD
21	.	.	.	_	16	P

1	A	a	DT	_	2	NMOD
2	panel	panel	NN	_	10	SBJ
3	of	of	IN	_	2	NMOD
4	chromosome	chromosome	NN	_	6	NMOD
5	substitution	substitution	NN	_	6	NMOD
6	strains	strain	NNS	_	8	NMOD
7	(	(	-LRB-	_	8	P
8	CSS	cs	NNS	_	3	PMOD
9	)	)	-RRB-	_	10	P
10	was	be	VBD	_	0	ROOT
11	generated	generate	VBN	_	10	VC
12	[	[	-LRB-	_	13	P
13	11	0	CD	_	11	PRN
14	]	]	-RRB-	_	13	P
15	by	by	IN	_	11	LGS
16	a	a	DT	_	23	NMOD
17	``	``	``	_	23	P
18	marker	marker	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	assisted	assist	VBN	_	23	NMOD
21	''	''	''	_	23	P
22	breeding	breeding	NN	_	23	NMOD
23	program	program	NN	_	15	PMOD
24	where	where	WRB	_	37	LOC
25	the	the	DT	_	26	NMOD
26	progeny	progeny	NN	_	35	SBJ
27	of	of	IN	_	26	NMOD
28	a	a	DT	_	34	NMOD
29	B6	b0	NN	_	33	NMOD
30	×	×	SYM	_	33	P
31	A	a	NN	_	33	NMOD
32	/	/	HYPH	_	31	P
33	J	j	NN	_	34	NMOD
34	cross	cross	NN	_	27	PMOD
35	were	be	VBD	_	23	NMOD
36	successively	successively	RB	_	35	ADV
37	backcrossed	backcross	VBN	_	35	VC
38	to	to	IN	_	37	ADV
39	the	the	DT	_	41	NMOD
40	B6	b0	NN	_	41	NMOD
41	mice	mouse	NNS	_	38	PMOD
42	.	.	.	_	10	P

1	Genetic	genetic	JJ	_	2	NMOD
2	markers	marker	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	used	use	VBN	_	3	VC
5	to	to	TO	_	4	PRP
6	identify	identify	VB	_	5	IM
7	homozygosity	homozygosity	NN	_	6	OBJ
8	in	in	IN	_	7	LOC
9	the	the	DT	_	12	NMOD
10	background	background	NN	_	12	NMOD
11	(	(	-LRB-	_	12	P
12	B6	b0	NN	_	8	PMOD
13	)	)	-RRB-	_	12	P
14	and	and	CC	_	12	COORD
15	the	the	DT	_	19	NMOD
16	individual	individual	JJ	_	19	NMOD
17	A	a	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	J	j	NN	_	14	CONJ
20	chromosome	chromosome	NN	_	19	NMOD
21	.	.	.	_	3	P

1	These	these	DT	_	2	NMOD
2	strains	strain	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	one	one	CD	_	5	NMOD
5	chromosome	chromosome	NN	_	3	OBJ
6	from	from	IN	_	5	NMOD
7	A	a	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	J	j	NN	_	10	NMOD
10	mice	mouse	NNS	_	6	PMOD
11	in	in	IN	_	3	LOC
12	a	a	DT	_	14	NMOD
13	B6	b0	NN	_	14	NMOD
14	background	background	NN	_	11	PMOD
15	.	.	.	_	3	P

1	This	this	DT	_	2	SBJ
2	allows	allow	VBZ	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	identification	identification	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	a	a	DT	_	7	NMOD
7	trait	trait	NN	_	5	PMOD
8	in	in	IN	_	7	NMOD
9	one	one	CD	_	12	NMOD
10	or	or	CC	_	9	COORD
11	more	more	JJR	_	10	CONJ
12	CSS	cs	NN	_	8	PMOD
13	and	and	CC	_	2	COORD
14	implies	imply	VBZ	_	13	CONJ
15	that	that	IN	_	14	OBJ
16	at	at	RB	_	17	QMOD
17	least	least	RBS	_	19	NMOD
18	one	one	CD	_	17	QMOD
19	QTL	qtl	NN	_	20	SBJ
20	resides	reside	VBZ	_	15	SUB
21	on	on	IN	_	20	LOC
22	this	this	DT	_	23	NMOD
23	chromosome	chromosome	NN	_	21	PMOD
24	.	.	.	_	2	P

1	Use	use	NN	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	this	this	DT	_	4	NMOD
4	panel	panel	NN	_	2	PMOD
5	requires	require	VBZ	_	0	ROOT
6	fewer	few	JJR	_	7	NMOD
7	mice	mouse	NNS	_	5	OBJ
8	to	to	TO	_	5	PRP
9	determine	determine	VB	_	8	IM
10	the	the	DT	_	11	NMOD
11	QTL	qtl	NN	_	9	OBJ
12	than	than	IN	_	7	NMOD
13	does	do	VBZ	_	12	SUB
14	a	a	DT	_	18	NMOD
15	genome	genome	NN	_	17	AMOD
16	-	-	HYPH	_	15	P
17	wide	wide	JJ	_	18	NMOD
18	scan	scan	NN	_	13	SBJ
19	.	.	.	_	5	P

1	Another	another	DT	_	2	NMOD
2	advantage	advantage	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	the	the	DT	_	5	NMOD
5	ability	ability	NN	_	3	PRD
6	for	for	IN	_	5	NMOD
7	detection	detection	NN	_	6	PMOD
8	of	of	IN	_	7	NMOD
9	QTL	qtl	NNS	_	8	PMOD
10	in	in	IN	_	7	NMOD
11	the	the	DT	_	12	NMOD
12	presence	presence	NN	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	other	other	JJ	_	15	NMOD
15	QTL	qtl	NN	_	13	PMOD
16	.	.	.	_	3	P

1	In	in	IN	_	9	ADV
2	addition	addition	NN	_	1	PMOD
3	,	,	,	_	9	P
4	initial	initial	JJ	_	5	NMOD
5	screens	screen	NNS	_	9	SBJ
6	with	with	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	CSS	cs	NN	_	6	PMOD
9	simplify	simplify	VBP	_	0	ROOT
10	the	the	DT	_	13	NMOD
11	fine	fine	RB	_	13	NMOD
12	-	-	HYPH	_	11	P
13	mapping	map	VBG	_	9	OPRD
14	of	of	IN	_	13	NMOD
15	QTL	qtl	NN	_	14	PMOD
16	.	.	.	_	9	P

1	Several	several	JJ	_	2	NMOD
2	studies	study	NNS	_	19	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	6	NMOD
5	CSS	cs	NN	_	6	NMOD
6	panel	panel	NN	_	3	PMOD
7	,	,	,	_	6	P
8	B6	b0	NN	_	11	NMOD
9	Chr1	chr0	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	19	0	NN	_	6	APPO
12	,	,	,	_	11	P
13	X	x	NN	_	11	APPO
14	,	,	,	_	13	P
15	YA	ya	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	J	j	NN	_	13	APPO
18	,	,	,	_	19	P
19	have	have	VBP	_	0	ROOT
20	been	be	VBN	_	19	VC
21	reported	report	VBN	_	20	VC
22	for	for	IN	_	21	ADV
23	behavior	behavior	NN	_	22	PMOD
24	[	[	-LRB-	_	25	P
25	12	0	CD	_	23	PRN
26	]	]	-RRB-	_	25	P
27	,	,	,	_	23	P
28	weight	weight	NN	_	29	NMOD
29	gain	gain	NN	_	23	CONJ
30	[	[	-LRB-	_	31	P
31	13	0	CD	_	29	PRN
32	]	]	-RRB-	_	31	P
33	,	,	,	_	29	P
34	sterols	sterol	NNS	_	29	CONJ
35	[	[	-LRB-	_	36	P
36	13	0	CD	_	34	PRN
37	]	]	-RRB-	_	36	P
38	,	,	,	_	34	P
39	and	and	CC	_	34	COORD
40	plasma	plasma	NN	_	43	NMOD
41	amino	amino	NN	_	42	NMOD
42	acids	acid	NNS	_	43	NMOD
43	levels	level	NNS	_	39	CONJ
44	[	[	-LRB-	_	47	P
45	13	0	CD	_	47	NMOD
46	,	,	,	_	47	P
47	14	0	CD	_	43	PRN
48	]	]	-RRB-	_	47	P
49	,	,	,	_	19	P
50	and	and	CC	_	19	COORD
51	have	have	VBP	_	50	CONJ
52	identified	identify	VBN	_	51	VC
53	many	many	JJ	_	54	AMOD
54	more	more	JJR	_	55	NMOD
55	QTL	qtl	NN	_	52	OBJ
56	than	than	IN	_	55	NMOD
57	studies	study	NNS	_	56	PMOD
58	of	of	IN	_	57	NMOD
59	the	the	DT	_	61	NMOD
60	same	same	JJ	_	61	NMOD
61	traits	trait	NNS	_	58	PMOD
62	using	use	VBG	_	57	NMOD
63	a	a	DT	_	67	NMOD
64	genome	genome	NN	_	66	AMOD
65	-	-	HYPH	_	64	P
66	wide	wide	JJ	_	67	NMOD
67	scan	scan	NN	_	62	OBJ
68	.	.	.	_	19	P

1	The	the	DT	_	2	NMOD
2	purpose	purpose	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	5	NMOD
5	study	study	NN	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	to	to	TO	_	6	PRD
8	evaluate	evaluate	VB	_	7	IM
9	the	the	DT	_	12	NMOD
10	two	two	CD	_	12	NMOD
11	inbred	inbred	JJ	_	12	NMOD
12	strains	strain	NNS	_	8	OBJ
13	of	of	IN	_	12	NMOD
14	mice	mouse	NNS	_	13	PMOD
15	for	for	IN	_	8	PRP
16	prothrombotic	prothrombotic	JJ	_	17	NMOD
17	risk	risk	NN	_	15	PMOD
18	,	,	,	_	8	P
19	utilizing	utilize	VBG	_	8	MNR
20	a	a	DT	_	25	NMOD
21	ferric	ferric	JJ	_	22	NMOD
22	chloride	chloride	NN	_	25	NMOD
23	vascular	vascular	JJ	_	24	NMOD
24	injury	injury	NN	_	25	NMOD
25	model	model	NN	_	19	OBJ
26	,	,	,	_	25	P
27	tail	tail	NN	_	28	NMOD
28	bleeding	bleeding	NN	_	29	NMOD
29	assay	assay	NN	_	25	CONJ
30	,	,	,	_	29	P
31	and	and	CC	_	29	COORD
32	measures	measure	NNS	_	31	CONJ
33	of	of	IN	_	32	NMOD
34	coagulation	coagulation	NN	_	33	PMOD
35	and	and	CC	_	34	COORD
36	fibrinolysis	fibrinolysis	NN	_	35	CONJ
37	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	results	result	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	5	NMOD
5	study	study	NN	_	3	PMOD
6	indicate	indicate	VBP	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	the	the	DT	_	11	NMOD
9	two	two	CD	_	11	NMOD
10	inbred	inbred	JJ	_	11	NMOD
11	strains	strain	NNS	_	20	SBJ
12	,	,	,	_	11	P
13	B6	b0	NN	_	18	NMOD
14	and	and	CC	_	13	COORD
15	A	a	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	J	j	NN	_	14	CONJ
18	mice	mouse	NNS	_	11	APPO
19	,	,	,	_	20	P
20	have	have	VBP	_	7	SUB
21	diverse	diverse	JJ	_	23	NMOD
22	prothrombotic	prothrombotic	JJ	_	23	NMOD
23	phenotypes	phenotype	NNS	_	20	OBJ
24	,	,	,	_	23	P
25	unrelated	unrelated	JJ	_	23	NMOD
26	to	to	IN	_	25	AMOD
27	coagulation	coagulation	NN	_	26	PMOD
28	or	or	CC	_	27	COORD
29	platelet	platelet	NN	_	30	NMOD
30	aggregation	aggregation	NN	_	28	CONJ
31	.	.	.	_	6	P

1	In	in	IN	_	22	ADV
2	addition	addition	NN	_	1	PMOD
3	,	,	,	_	22	P
4	in	in	IN	_	22	LOC
5	the	the	DT	_	6	NMOD
6	CSS	cs	NN	_	4	PMOD
7	,	,	,	_	22	P
8	expression	expression	NN	_	22	SBJ
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	14	NMOD
11	A	a	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	J	j	NN	_	14	NMOD
14	phenotypes	phenotype	NNS	_	9	PMOD
15	,	,	,	_	14	P
16	rebleeding	rebleeding	NN	_	17	NMOD
17	time	time	NN	_	14	CONJ
18	and	and	CC	_	17	COORD
19	arterial	arterial	JJ	_	20	NMOD
20	occlusion	occlusion	NN	_	18	CONJ
21	,	,	,	_	22	P
22	was	be	VBD	_	0	ROOT
23	modified	modify	VBN	_	22	VC
24	in	in	IN	_	23	LOC
25	the	the	DT	_	27	NMOD
26	B6	b0	NN	_	27	NMOD
27	background	background	NN	_	24	PMOD
28	,	,	,	_	22	P
29	and	and	CC	_	22	COORD
30	suggested	suggest	VBD	_	29	CONJ
31	that	that	IN	_	30	OBJ
32	interactions	interaction	NNS	_	33	SBJ
33	occurred	occur	VBD	_	31	SUB
34	among	among	IN	_	33	LOC
35	the	the	DT	_	39	NMOD
36	A	a	NN	_	38	NMOD
37	/	/	HYPH	_	36	P
38	J	j	NN	_	39	NMOD
39	QTL	qtl	NN	_	34	PMOD
40	.	.	.	_	22	P

1	Thus	thus	RB	_	4	ADV
2	,	,	,	_	4	P
3	it	it	PRP	_	4	SBJ
4	should	should	MD	_	0	ROOT
5	be	be	VB	_	4	VC
6	possible	possible	JJ	_	5	PRD
7	to	to	TO	_	5	OPRD
8	identify	identify	VB	_	7	IM
9	independent	independent	JJ	_	11	NMOD
10	genetic	genetic	JJ	_	11	NMOD
11	determinants	determinant	NNS	_	8	OBJ
12	of	of	IN	_	11	NMOD
13	susceptibility	susceptibility	NN	_	12	PMOD
14	to	to	IN	_	13	NMOD
15	pathological	pathological	JJ	_	16	NMOD
16	haemostasis	haemostasis	NN	_	14	PMOD
17	and	and	CC	_	16	COORD
18	thrombosis	thrombosis	NN	_	17	CONJ
19	.	.	.	_	4	P

1	Methods	method	NNS	_	0	ROOT

1	Mice	mouse	NNS	_	0	ROOT

1	The	the	DT	_	3	NMOD
2	inbred	inbred	JJ	_	3	NMOD
3	strains	strain	NNS	_	56	SBJ
4	,	,	,	_	3	P
5	B6	b0	NN	_	3	CONJ
6	(	(	-LRB-	_	7	P
7	#	#	NN	_	5	PRN
8	000664	0	CD	_	7	NMOD
9	)	)	-RRB-	_	7	P
10	,	,	,	_	5	P
11	Lepob	lepob	NN	_	5	CONJ
12	(	(	-LRB-	_	13	P
13	#	#	NN	_	11	PRN
14	000632	0	CD	_	13	NMOD
15	)	)	-RRB-	_	13	P
16	,	,	,	_	11	P
17	A	a	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	J	j	NN	_	11	CONJ
20	(	(	-LRB-	_	21	P
21	#	#	NN	_	19	PRN
22	000646	0	CD	_	21	NMOD
23	)	)	-RRB-	_	21	P
24	and	and	CC	_	19	COORD
25	gene	gene	NN	_	27	AMOD
26	-	-	HYPH	_	25	P
27	targeted	target	VBN	_	51	NMOD
28	plasminogen	plasminogen	NN	_	30	NMOD
29	(	(	-LRB-	_	30	P
30	Plg	plg	NN	_	33	NMOD
31	)	)	-RRB-	_	33	P
32	activator	activator	NN	_	33	NMOD
33	inhibitor	inhibitor	NN	_	34	AMOD
34	deficient	deficient	JJ	_	35	NMOD
35	mice	mouse	NNS	_	51	NMOD
36	(	(	-LRB-	_	51	P
37	PAI	pai	NN	_	51	NMOD
38	-	-	HYPH	_	37	P
39	1	0	CD	_	37	NMOD
40	-	-	SYM	_	37	P
41	/	/	HYPH	_	37	P
42	-	-	SYM	_	37	P
43	)	)	-RRB-	_	37	P
44	(	(	-LRB-	_	45	P
45	#	#	NN	_	37	PRN
46	002507	0	CD	_	45	NMOD
47	)	)	-RRB-	_	45	P
48	[	[	-LRB-	_	49	P
49	15	0	CD	_	37	PRN
50	]	]	-RRB-	_	49	P
51	mice	mouse	NNS	_	24	CONJ
52	in	in	IN	_	51	LOC
53	a	a	DT	_	55	NMOD
54	B6	b0	NN	_	55	NMOD
55	background	background	NN	_	52	PMOD
56	were	be	VBD	_	0	ROOT
57	obtained	obtain	VBN	_	56	VC
58	from	from	IN	_	57	ADV
59	Jackson	jackson	NNP	_	60	NMOD
60	Laboratory	laboratory	NNP	_	58	PMOD
61	(	(	-LRB-	_	60	P
62	Bar	bar	NNP	_	63	NMOD
63	Harbor	harbor	NNP	_	60	LOC
64	,	,	,	_	63	P
65	Maine	maine	NNP	_	63	APPO
66	)	)	-RRB-	_	57	P
67	at	at	IN	_	57	TMP
68	6	0	CD	_	69	NMOD
69	wks	wks	NNS	_	67	PMOD
70	-	-	HYPH	_	69	P
71	of	of	IN	_	69	NMOD
72	-	-	HYPH	_	71	P
73	age	age	NN	_	71	PMOD
74	.	.	.	_	56	P

1	The	the	DT	_	6	NMOD
2	Plg	plg	NN	_	6	NMOD
3	-	-	SYM	_	2	P
4	/	/	HYPH	_	2	P
5	-	-	SYM	_	2	P
6	mice	mouse	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	generated	generate	VBN	_	7	VC
9	as	as	IN	_	8	ADV
10	previously	previously	RB	_	11	TMP
11	described	describe	VBN	_	9	SUB
12	[	[	-LRB-	_	13	P
13	16	0	CD	_	11	PRN
14	]	]	-RRB-	_	13	P
15	and	and	CC	_	8	COORD
16	maintained	maintain	VBN	_	15	CONJ
17	in	in	IN	_	16	LOC
18	the	the	DT	_	20	NMOD
19	B6	b0	NN	_	20	NMOD
20	background	background	NN	_	17	PMOD
21	,	,	,	_	16	P
22	generated	generate	VBN	_	16	CONJ
23	by	by	IN	_	22	MNR
24	crossing	cross	VBG	_	23	PMOD
25	mice	mouse	NNS	_	24	OBJ
26	from	from	IN	_	25	NMOD
27	the	the	DT	_	35	NMOD
28	original	original	JJ	_	35	NMOD
29	mixed	mixed	JJ	_	35	NMOD
30	(	(	-LRB-	_	35	P
31	B6	b0	NN	_	35	NMOD
32	:	:	HYPH	_	31	P
33	129	0	CD	_	31	NMOD
34	)	)	-RRB-	_	35	P
35	background	background	NN	_	26	PMOD
36	for	for	IN	_	24	TMP
37	eight	eight	CD	_	38	NMOD
38	generations	generation	NNS	_	36	PMOD
39	with	with	IN	_	24	ADV
40	B6	b0	NN	_	41	NMOD
41	mice	mouse	NNS	_	39	PMOD
42	.	.	.	_	7	P

1	The	the	DT	_	6	NMOD
2	Plg	plg	NN	_	6	NMOD
3	-	-	SYM	_	2	P
4	/	/	HYPH	_	2	P
5	-	-	SYM	_	2	P
6	mice	mouse	NNS	_	7	SBJ
7	do	do	VBP	_	0	ROOT
8	not	not	RB	_	7	ADV
9	reproduce	reproduce	VB	_	7	VC
10	well	well	RB	_	9	MNR
11	and	and	CC	_	7	COORD
12	Plg	plg	NN	_	14	NMOD
13	heterozygous	heterozygous	JJ	_	14	NMOD
14	pairs	pair	NNS	_	15	SBJ
15	were	be	VBD	_	11	CONJ
16	used	use	VBN	_	15	VC
17	for	for	IN	_	16	PRP
18	breeding	breeding	NN	_	17	PMOD
19	.	.	.	_	7	P

1	Genotypes	genotype	NNS	_	3	NMOD
2	(	(	-LRB-	_	3	P
3	Plg	plg	NN	_	21	SBJ
4	+	+	SYM	_	3	P
5	/	/	HYPH	_	3	P
6	+	+	SYM	_	3	P
7	,	,	,	_	3	P
8	Plg	plg	NN	_	3	APPO
9	+	+	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	-	-	SYM	_	8	P
12	,	,	,	_	8	P
13	Plg	plg	NN	_	8	APPO
14	-	-	SYM	_	13	P
15	/	/	HYPH	_	13	P
16	-	-	SYM	_	13	P
17	)	)	-RRB-	_	3	P
18	of	of	IN	_	3	NMOD
19	the	the	DT	_	20	NMOD
20	offspring	offspring	NN	_	18	PMOD
21	were	be	VBD	_	0	ROOT
22	determined	determine	VBN	_	21	VC
23	by	by	IN	_	22	MNR
24	a	a	DT	_	26	NMOD
25	PCR	pcr	NN	_	26	NMOD
26	assay	assay	NN	_	23	PMOD
27	at	at	IN	_	26	TMP
28	3	0	CD	_	31	NMOD
29	–	–	SYM	_	28	P
30	4	0	CD	_	28	QMOD
31	weeks	week	NNS	_	27	PMOD
32	-	-	HYPH	_	31	P
33	of	of	IN	_	31	NMOD
34	-	-	HYPH	_	33	P
35	age	age	NN	_	33	PMOD
36	from	from	IN	_	26	NMOD
37	an	an	DT	_	39	NMOD
38	ear	ear	NN	_	39	NMOD
39	punch	punch	NN	_	36	PMOD
40	[	[	-LRB-	_	41	P
41	17	0	CD	_	22	PRN
42	]	]	-RRB-	_	41	P
43	.	.	.	_	21	P

1	Breeding	breeding	NN	_	2	NMOD
2	pairs	pair	NNS	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	CSS	cs	NN	_	6	NMOD
6	mice	mouse	NNS	_	3	PMOD
7	were	be	VBD	_	0	ROOT
8	transferred	transfer	VBN	_	7	VC
9	from	from	IN	_	8	ADV
10	Dr.	dr.	NNP	_	11	NMOD
11	Nadeau	nadeau	NNP	_	13	NMOD
12	's	's	POS	_	11	NMOD
13	laboratory	laboratory	NN	_	9	PMOD
14	.	.	.	_	7	P

1	All	all	DT	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	housed	house	VBN	_	3	VC
5	and	and	CC	_	4	COORD
6	bred	breed	VBN	_	5	CONJ
7	in	in	IN	_	4	LOC
8	the	the	DT	_	11	NMOD
9	Biological	biological	NNP	_	11	NMOD
10	Resource	resource	NNP	_	11	NMOD
11	Unit	unit	NNP	_	7	PMOD
12	at	at	IN	_	11	LOC
13	the	the	DT	_	16	NMOD
14	Cleveland	cleveland	NNP	_	16	NMOD
15	Clinic	clinic	NNP	_	16	NMOD
16	Foundation	foundation	NNP	_	18	NMOD
17	(	(	-LRB-	_	18	P
18	CCF	ccf	NN	_	12	PMOD
19	)	)	-RRB-	_	3	P
20	.	.	.	_	3	P

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	housed	house	VBN	_	2	VC
4	in	in	IN	_	3	LOC
5	sterilized	sterilize	VBN	_	7	NMOD
6	isolator	isolator	NN	_	7	NMOD
7	cages	cage	NNS	_	4	PMOD
8	,	,	,	_	3	P
9	maintained	maintain	VBN	_	3	VC
10	on	on	IN	_	9	ADV
11	a	a	DT	_	19	NMOD
12	14	0	CD	_	13	NMOD
13	hr	hr	NN	_	14	NMOD
14	light	light	NN	_	18	NMOD
15	/	/	HYPH	_	14	P
16	10	0	CD	_	17	NMOD
17	hr	hr	NN	_	18	NMOD
18	dark	dark	NN	_	19	NMOD
19	cycle	cycle	NN	_	10	PMOD
20	,	,	,	_	2	P
21	and	and	CC	_	2	COORD
22	were	be	VBD	_	21	CONJ
23	provided	provide	VBN	_	22	VC
24	sterilized	sterilize	VBN	_	25	NMOD
25	food	food	NN	_	23	OBJ
26	and	and	CC	_	25	COORD
27	water	water	NN	_	26	CONJ
28	ad	ad	FW	_	29	AMOD
29	libitum	libitum	FW	_	23	MNR
30	.	.	.	_	2	P

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	fed	feed	VBN	_	2	VC
4	a	a	DT	_	8	NMOD
5	standard	standard	JJ	_	8	NMOD
6	autoclavable	autoclavable	JJ	_	8	NMOD
7	laboratory	laboratory	NN	_	8	NMOD
8	diet	diet	NN	_	3	OBJ
9	consisting	consist	VBG	_	8	NMOD
10	of	of	IN	_	9	ADV
11	:	:	:	_	10	P
12	23	0	CD	_	13	NMOD
13	%	%	NN	_	14	NMOD
14	protein	protein	NN	_	10	PMOD
15	,	,	,	_	14	P
16	4.5	0	CD	_	17	NMOD
17	%	%	NN	_	18	NMOD
18	fat	fat	NN	_	14	APPO
19	,	,	,	_	18	P
20	6	0	CD	_	21	NMOD
21	%	%	NN	_	22	NMOD
22	fiber	fiber	NN	_	18	APPO
23	,	,	,	_	14	P
24	(	(	-LRB-	_	25	P
25	Purina	purina	NNP	_	14	PRN
26	,	,	,	_	25	P
27	St.	st.	NNP	_	28	NMOD
28	Louis	louis	NNP	_	25	APPO
29	,	,	,	_	28	P
30	MO	mo	NNP	_	28	APPO
31	)	)	-RRB-	_	25	P
32	,	,	,	_	3	P
33	and	and	CC	_	3	COORD
34	tested	test	VBN	_	33	CONJ
35	between	between	IN	_	34	TMP
36	7	0	CD	_	39	NMOD
37	and	and	CC	_	36	COORD
38	9	0	CD	_	37	CONJ
39	wks	wks	NNS	_	35	PMOD
40	-	-	HYPH	_	39	P
41	of	of	IN	_	39	NMOD
42	-	-	HYPH	_	41	P
43	age	age	NN	_	41	PMOD
44	.	.	.	_	2	P

1	All	all	DT	_	3	NMOD
2	animal	animal	NN	_	3	NMOD
3	experiments	experiment	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	performed	perform	VBN	_	4	VC
6	in	in	IN	_	5	ADV
7	accordance	accordance	NN	_	6	PMOD
8	with	with	IN	_	7	NMOD
9	a	a	DT	_	10	NMOD
10	protocol	protocol	NN	_	8	PMOD
11	approved	approve	VBN	_	10	NMOD
12	by	by	IN	_	11	LGS
13	the	the	DT	_	20	NMOD
14	Institutional	institutional	NNP	_	20	NMOD
15	Animal	animal	NNP	_	16	NMOD
16	Care	care	NNP	_	20	NMOD
17	and	and	CC	_	16	COORD
18	Research	research	NNP	_	19	NMOD
19	Advisory	advisory	NNP	_	17	CONJ
20	Committee	committee	NNP	_	12	PMOD
21	at	at	IN	_	20	LOC
22	CCF	ccf	NNP	_	21	PMOD
23	.	.	.	_	4	P

1	Vascular	vascular	JJ	_	2	NMOD
2	injury	injury	NN	_	0	ROOT

1	To	to	TO	_	25	PRP
2	induce	induce	VB	_	1	IM
3	thrombosis	thrombosis	NN	_	4	NMOD
4	formation	formation	NN	_	2	OBJ
5	in	in	IN	_	2	LOC
6	the	the	DT	_	8	NMOD
7	carotid	carotid	NN	_	8	NMOD
8	artery	artery	NN	_	5	PMOD
9	,	,	,	_	25	P
10	a	a	DT	_	16	NMOD
11	ferric	ferric	JJ	_	12	NMOD
12	chloride	chloride	NN	_	14	NMOD
13	(	(	-LRB-	_	14	P
14	FeCl3	fecl0	NN	_	16	NMOD
15	)	)	-RRB-	_	16	P
16	model	model	NN	_	25	SBJ
17	of	of	IN	_	16	NMOD
18	vessel	vessel	NN	_	19	NMOD
19	injury	injury	NN	_	17	PMOD
20	[	[	-LRB-	_	23	P
21	18	0	CD	_	23	NMOD
22	,	,	,	_	23	P
23	19	0	CD	_	16	PRN
24	]	]	-RRB-	_	23	P
25	was	be	VBD	_	0	ROOT
26	employed	employ	VBN	_	25	VC
27	.	.	.	_	25	P

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	anesthetized	anesthetize	VBN	_	2	VC
4	with	with	IN	_	3	MNR
5	ketamine	ketamine	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	xylazine	xylazine	NN	_	4	PMOD
8	(	(	-LRB-	_	15	P
9	80	0	CD	_	10	NMOD
10	mg	mg	NNS	_	15	DEP
11	/	/	SYM	_	12	P
12	kg	kg	NN	_	10	NMOD
13	,	,	,	_	15	P
14	5	0	CD	_	15	NMOD
15	mg	mg	NNS	_	7	PRN
16	/	/	SYM	_	17	P
17	kg	kg	NN	_	15	NMOD
18	)	)	-RRB-	_	15	P
19	,	,	,	_	2	P
20	a	a	DT	_	23	NMOD
21	midline	midline	NN	_	23	NMOD
22	cervical	cervical	JJ	_	23	NMOD
23	incision	incision	NN	_	24	SBJ
24	was	be	VBD	_	2	CONJ
25	made	make	VBN	_	24	VC
26	and	and	CC	_	24	COORD
27	the	the	DT	_	31	NMOD
28	left	left	JJ	_	31	NMOD
29	common	common	JJ	_	31	NMOD
30	carotid	carotid	JJ	_	31	NMOD
31	artery	artery	NN	_	32	SBJ
32	isolated	isolate	VBN	_	26	GAP
33	by	by	IN	_	32	MNR
34	blunt	blunt	JJ	_	35	NMOD
35	dissection	dissection	NN	_	33	PMOD
36	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	flow	flow	NN	_	3	NMOD
3	probe	probe	NN	_	11	SBJ
4	(	(	-LRB-	_	9	P
5	Transonic	transonic	NNP	_	6	NMOD
6	Systems	system	NNP	_	9	DEP
7	,	,	,	_	9	P
8	model	model	NN	_	9	NMOD
9	0.5PSB	0psb	NN	_	3	PRN
10	)	)	-RRB-	_	9	P
11	was	be	VBD	_	0	ROOT
12	placed	place	VBN	_	11	VC
13	under	under	IN	_	12	LOC
14	the	the	DT	_	15	NMOD
15	artery	artery	NN	_	13	PMOD
16	and	and	CC	_	11	COORD
17	when	when	WRB	_	22	TMP
18	a	a	DT	_	20	NMOD
19	stable	stable	JJ	_	20	NMOD
20	baseline	baseline	NN	_	21	SBJ
21	was	be	VBD	_	39	TMP
22	reached	reach	VBN	_	21	VC
23	,	,	,	_	39	P
24	a	a	DT	_	29	NMOD
25	0.5	0	CD	_	27	NMOD
26	×	×	SYM	_	27	P
27	2	0	CD	_	28	NMOD
28	mm	mm	NN	_	29	NMOD
29	strip	strip	NN	_	39	SBJ
30	of	of	IN	_	29	NMOD
31	filter	filter	NN	_	32	NMOD
32	paper	paper	NN	_	30	PMOD
33	saturated	saturate	VBN	_	29	NMOD
34	with	with	IN	_	33	MNR
35	10	0	CD	_	36	NMOD
36	%	%	NN	_	37	NMOD
37	FeCl3	fecl0	NN	_	38	NMOD
38	solution	solution	NN	_	34	PMOD
39	was	be	VBD	_	16	CONJ
40	applied	apply	VBN	_	39	VC
41	to	to	IN	_	40	ADV
42	the	the	DT	_	43	NMOD
43	surface	surface	NN	_	41	PMOD
44	of	of	IN	_	43	NMOD
45	the	the	DT	_	47	NMOD
46	carotid	carotid	JJ	_	47	NMOD
47	artery	artery	NN	_	44	PMOD
48	for	for	IN	_	40	TMP
49	3	0	CD	_	50	NMOD
50	min	min	NNS	_	48	PMOD
51	.	.	.	_	11	P

1	Occlusion	occlusion	NN	_	2	NMOD
2	time	time	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	determined	determine	VBN	_	3	VC
5	from	from	IN	_	4	TMP
6	the	the	DT	_	7	NMOD
7	addition	addition	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	FeCl3	fecl0	NN	_	11	NMOD
11	solution	solution	NN	_	8	PMOD
12	to	to	IN	_	5	PMOD
13	the	the	DT	_	14	NMOD
14	occlusion	occlusion	NN	_	21	NMOD
15	of	of	IN	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	artery	artery	NN	_	15	PMOD
18	(	(	-LRB-	_	21	P
19	minimum	minimum	NN	_	21	NMOD
20	blood	blood	NN	_	21	NMOD
21	flow	flow	NN	_	12	PMOD
22	)	)	-RRB-	_	3	P
23	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	flow	flow	NN	_	3	NMOD
3	probe	probe	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	in	in	IN	_	4	PRD
6	place	place	NN	_	5	PMOD
7	from	from	IN	_	4	TMP
8	the	the	DT	_	9	NMOD
9	establishment	establishment	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	12	NMOD
12	baseline	baseline	NN	_	10	PMOD
13	until	until	IN	_	7	TMP
14	several	several	JJ	_	15	NMOD
15	min	min	NNS	_	16	ADV
16	after	after	IN	_	13	PMOD
17	the	the	DT	_	19	NMOD
18	stable	stable	JJ	_	19	NMOD
19	occlusion	occlusion	NN	_	20	SBJ
20	had	have	VBD	_	16	SUB
21	been	be	VBN	_	20	VC
22	reached	reach	VBN	_	21	VC
23	or	or	CC	_	4	COORD
24	stopped	stop	VBD	_	23	CONJ
25	at	at	IN	_	24	TMP
26	30	0	CD	_	27	NMOD
27	min	min	NNS	_	25	PMOD
28	if	if	IN	_	24	ADV
29	it	it	PRP	_	30	SBJ
30	had	have	VBD	_	28	SUB
31	not	not	RB	_	30	ADV
32	occluded	occlude	VBN	_	30	VC
33	.	.	.	_	4	P

1	Blood	blood	NN	_	2	NMOD
2	flow	flow	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	recorded	record	VBN	_	3	VC
5	every	every	DT	_	7	NMOD
6	10	0	CD	_	7	NMOD
7	sec	sec	NN	_	4	TMP
8	(	(	-LRB-	_	13	P
9	Transonic	transonic	NNP	_	10	NMOD
10	Systems	system	NNP	_	13	DEP
11	,	,	,	_	13	P
12	model	model	NN	_	13	NMOD
13	TS420	ts0	NN	_	4	PRN
14	)	)	-RRB-	_	13	P
15	.	.	.	_	3	P

1	There	there	EX	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	no	no	DT	_	4	NMOD
4	difference	difference	NN	_	2	PRD
5	in	in	IN	_	4	NMOD
6	body	body	NN	_	7	NMOD
7	weight	weight	NN	_	5	PMOD
8	among	among	IN	_	2	LOC
9	the	the	DT	_	10	NMOD
10	mice	mouse	NNS	_	8	PMOD
11	that	that	WDT	_	12	SBJ
12	were	be	VBD	_	10	NMOD
13	tested	test	VBN	_	12	VC
14	in	in	IN	_	13	ADV
15	the	the	DT	_	18	NMOD
16	vascular	vascular	JJ	_	17	NMOD
17	injury	injury	NN	_	18	NMOD
18	model	model	NN	_	14	PMOD
19	.	.	.	_	2	P

1	Bleeding	bleeding	NN	_	4	NMOD
2	and	and	CC	_	1	COORD
3	rebleeding	rebleeding	NN	_	2	CONJ
4	assay	assay	NN	_	0	ROOT

1	For	for	IN	_	8	PRP
2	the	the	DT	_	5	NMOD
3	tail	tail	NN	_	4	NMOD
4	bleeding	bleeding	NN	_	5	NMOD
5	assay	assay	NN	_	1	PMOD
6	,	,	,	_	8	P
7	mice	mouse	NNS	_	8	SBJ
8	were	be	VBD	_	0	ROOT
9	anesthetized	anesthetize	VBN	_	8	VC
10	with	with	IN	_	9	MNR
11	ketamine	ketamine	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	xylazine	xylazine	NN	_	10	PMOD
14	(	(	-LRB-	_	21	P
15	80	0	CD	_	16	NMOD
16	mg	mg	NNS	_	21	DEP
17	/	/	SYM	_	18	P
18	kg	kg	NN	_	16	NMOD
19	,	,	,	_	21	P
20	5	0	CD	_	21	NMOD
21	mg	mg	NNS	_	13	PRN
22	/	/	SYM	_	23	P
23	kg	kg	NN	_	21	NMOD
24	)	)	-RRB-	_	21	P
25	,	,	,	_	8	P
26	the	the	DT	_	27	NMOD
27	tail	tail	NN	_	28	SBJ
28	prewarmed	prewarmed	VBN	_	8	GAP
29	for	for	IN	_	28	TMP
30	5	0	CD	_	31	NMOD
31	min	min	NNS	_	29	PMOD
32	in	in	IN	_	28	LOC
33	10	0	CD	_	34	NMOD
34	mL	ml	NNS	_	32	PMOD
35	of	of	IN	_	34	NMOD
36	saline	saline	NN	_	35	PMOD
37	at	at	IN	_	36	NMOD
38	37°	0°	NNS	_	39	NMOD
39	C	c	NNP	_	37	PMOD
40	in	in	IN	_	28	LOC
41	a	a	DT	_	43	NMOD
42	water	water	NN	_	43	NMOD
43	bath	bath	NN	_	40	PMOD
44	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	tail	tail	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	lifted	lift	VBN	_	3	VC
5	from	from	IN	_	4	ADV
6	the	the	DT	_	7	NMOD
7	saline	saline	NN	_	5	PMOD
8	and	and	CC	_	3	COORD
9	a	a	DT	_	13	NMOD
10	5	0	CD	_	11	NMOD
11	mm	mm	NN	_	13	NMOD
12	tail	tail	NN	_	13	NMOD
13	segment	segment	NN	_	14	SBJ
14	amputated	amputate	VBN	_	8	GAP
15	and	and	CC	_	14	COORD
16	immediately	immediately	RB	_	17	TMP
17	returned	return	VBD	_	15	CONJ
18	to	to	IN	_	17	LOC
19	the	the	DT	_	20	NMOD
20	saline	saline	NN	_	18	PMOD
21	.	.	.	_	3	P

1	Bleeding	bleeding	NN	_	2	NMOD
2	time	time	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	measured	measure	VBN	_	3	VC
5	as	as	IN	_	4	ADV
6	the	the	DT	_	7	NMOD
7	time	time	NN	_	5	PMOD
8	between	between	IN	_	7	TMP
9	the	the	DT	_	10	NMOD
10	start	start	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	bleeding	bleed	VBG	_	11	PMOD
13	to	to	IN	_	8	PMOD
14	cessation	cessation	NN	_	13	PMOD
15	of	of	IN	_	14	NMOD
16	bleeding	bleeding	NN	_	15	PMOD
17	.	.	.	_	3	P

1	With	with	IN	_	14	MNR
2	the	the	DT	_	3	NMOD
3	tail	tail	NN	_	4	SBJ
4	remaining	remain	VBG	_	1	PMOD
5	in	in	IN	_	4	LOC
6	the	the	DT	_	9	NMOD
7	same	same	JJ	_	9	NMOD
8	saline	saline	NN	_	9	NMOD
9	solution	solution	NN	_	5	PMOD
10	,	,	,	_	14	P
11	the	the	DT	_	13	NMOD
12	rebleeding	rebleeding	NN	_	13	NMOD
13	time	time	NN	_	14	SBJ
14	was	be	VBD	_	0	ROOT
15	measured	measure	VBN	_	14	VC
16	from	from	IN	_	15	ADV
17	the	the	DT	_	18	NMOD
18	time	time	NN	_	16	PMOD
19	between	between	IN	_	18	TMP
20	bleeding	bleeding	NN	_	21	NMOD
21	cessation	cessation	NN	_	19	PMOD
22	and	and	CC	_	21	COORD
23	the	the	DT	_	24	NMOD
24	start	start	NN	_	22	CONJ
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	28	NMOD
27	second	$#ORD#$	JJ	_	28	NMOD
28	bleeding	bleeding	NN	_	25	PMOD
29	.	.	.	_	14	P

1	Coagulation	coagulation	NN	_	16	NMOD
2	,	,	,	_	1	P
3	Plg	plg	NN	_	1	CONJ
4	,	,	,	_	3	P
5	α2	α0	NN	_	7	NMOD
6	-	-	HYPH	_	5	P
7	antiplasmin	antiplasmin	NN	_	3	CONJ
8	,	,	,	_	7	P
9	fibrinogen	fibrinogen	NN	_	7	CONJ
10	,	,	,	_	9	P
11	fibrinolytic	fibrinolytic	JJ	_	9	CONJ
12	and	and	CC	_	11	COORD
13	PAI	pai	NN	_	12	CONJ
14	-	-	HYPH	_	13	P
15	1	0	CD	_	13	NMOD
16	assays	assay	NNS	_	0	ROOT

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	anesthetized	anesthetize	VBN	_	2	VC
4	with	with	IN	_	3	MNR
5	Isoflurane	isoflurane	NN	_	4	PMOD
6	(	(	-LRB-	_	7	P
7	Abbott	abbott	NNP	_	5	PRN
8	)	)	-RRB-	_	7	P
9	,	,	,	_	3	P
10	bled	bleed	VBN	_	3	VC
11	from	from	IN	_	10	ADV
12	the	the	DT	_	14	NMOD
13	orbital	orbital	JJ	_	14	NMOD
14	sinus	sinus	NN	_	11	PMOD
15	into	into	IN	_	10	ADV
16	uncoated	uncoated	JJ	_	18	NMOD
17	capillary	capillary	JJ	_	18	NMOD
18	tubes	tube	NNS	_	15	PMOD
19	,	,	,	_	2	P
20	and	and	CC	_	2	COORD
21	a	a	DT	_	22	NMOD
22	drop	drop	NN	_	26	SBJ
23	of	of	IN	_	22	NMOD
24	blood	blood	NN	_	23	PMOD
25	immediately	immediately	RB	_	26	TMP
26	placed	place	VBN	_	20	GAP
27	on	on	IN	_	26	LOC
28	a	a	DT	_	30	NMOD
29	reagent	reagent	NN	_	30	NMOD
30	strip	strip	NN	_	27	PMOD
31	(	(	-LRB-	_	32	P
32	Synbiotics	synbiotics	NNP	_	30	PRN
33	)	)	-RRB-	_	32	P
34	for	for	IN	_	26	PRP
35	prothrombin	prothrombin	NN	_	36	NMOD
36	time	time	NN	_	38	NMOD
37	(	(	-LRB-	_	38	P
38	PT	pt	NN	_	48	NMOD
39	)	)	-RRB-	_	38	P
40	or	or	CC	_	38	COORD
41	activated	activate	VBN	_	44	NMOD
42	partial	partial	JJ	_	44	NMOD
43	thromboplastin	thromboplastin	NN	_	44	NMOD
44	time	time	NN	_	46	NMOD
45	(	(	-LRB-	_	46	P
46	aPTT	aptt	NN	_	40	CONJ
47	)	)	-RRB-	_	48	P
48	determinations	determination	NNS	_	34	PMOD
49	and	and	CC	_	26	COORD
50	inserted	insert	VBN	_	49	CONJ
51	into	into	IN	_	50	DIR
52	the	the	DT	_	55	NMOD
53	precalibrated	precalibrated	VBN	_	55	NMOD
54	Coagulation	coagulation	NNP	_	55	NMOD
55	Analyzer	analyzer	NNP	_	51	PMOD
56	(	(	-LRB-	_	59	P
57	SCA2000	sca0	NNP	_	59	DEP
58	,	,	,	_	59	P
59	Synbiotics	synbiotics	NNP	_	55	PRN
60	)	)	-RRB-	_	59	P
61	.	.	.	_	2	P

1	PAI	pai	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	1	0	CD	_	1	NMOD
4	activity	activity	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	determined	determine	VBN	_	5	VC
7	according	accord	VBG	_	6	MNR
8	to	to	IN	_	7	PMOD
9	the	the	DT	_	10	NMOD
10	method	method	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	Chandler	chandler	NNP	_	11	PMOD
13	et	et	FW	_	14	AMOD
14	al	al	FW	_	12	NMOD
15	[	[	-LRB-	_	16	P
16	20	0	CD	_	12	PRN
17	]	]	-RRB-	_	16	P
18	.	.	.	_	5	P

1	PAI	pai	NN	_	5	NMOD
2	-	-	HYPH	_	1	P
3	1	0	CD	_	1	NMOD
4	antigen	antigen	NN	_	5	NMOD
5	concentration	concentration	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	determined	determine	VBN	_	6	VC
8	by	by	IN	_	7	MNR
9	ELISA	elisa	NNP	_	8	PMOD
10	[	[	-LRB-	_	11	P
11	21	0	CD	_	9	PRN
12	]	]	-RRB-	_	11	P
13	using	use	VBG	_	7	MNR
14	sheep	sheep	NN	_	18	NMOD
15	-	-	HYPH	_	14	P
16	anti	anti	AFX	_	17	AMOD
17	mouse	mouse	NN	_	18	NMOD
18	PAI	pai	NN	_	13	OBJ
19	-	-	HYPH	_	18	P
20	1	0	CD	_	18	NMOD
21	(	(	-LRB-	_	23	P
22	American	american	NNP	_	23	NMOD
23	Diagnostica	diagnostica	NNP	_	18	PRN
24	)	)	-RRB-	_	23	P
25	as	as	IN	_	13	ADV
26	the	the	DT	_	28	NMOD
27	capture	capture	NN	_	28	NMOD
28	antibody	antibody	NN	_	25	PMOD
29	and	and	CC	_	13	COORD
30	mouse	mouse	NN	_	31	NMOD
31	PAI	pai	NN	_	29	GAP
32	-	-	HYPH	_	31	P
33	1	0	CD	_	31	NMOD
34	(	(	-LRB-	_	36	P
35	American	american	NNP	_	36	NMOD
36	Diagnostica	diagnostica	NNP	_	31	PRN
37	)	)	-RRB-	_	36	P
38	as	as	IN	_	31	ADV
39	the	the	DT	_	40	NMOD
40	standard	standard	JJ	_	38	PMOD
41	(	(	-LRB-	_	45	P
42	0	0	CD	_	45	NMOD
43	–	–	SYM	_	42	P
44	3.5	0	CD	_	42	QMOD
45	ng	ng	NNS	_	40	PRN
46	/	/	SYM	_	47	P
47	mL	ml	NN	_	45	NMOD
48	)	)	-RRB-	_	45	P
49	.	.	.	_	6	P

1	Plg	plg	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	determined	determine	VBN	_	2	VC
4	with	with	IN	_	3	MNR
5	a	a	DT	_	7	NMOD
6	chromogenic	chromogenic	JJ	_	7	NMOD
7	assay	assay	NN	_	4	PMOD
8	[	[	-LRB-	_	9	P
9	22	0	CD	_	3	PRN
10	]	]	-RRB-	_	9	P
11	and	and	CC	_	2	COORD
12	the	the	DT	_	14	NMOD
13	fibrinolytic	fibrinolytic	JJ	_	14	NMOD
14	activity	activity	NN	_	15	SBJ
15	determined	determine	VBN	_	11	GAP
16	by	by	IN	_	15	MNR
17	fibrin	fibrin	NN	_	18	NMOD
18	degradation	degradation	NN	_	16	PMOD
19	[	[	-LRB-	_	20	P
20	23	0	CD	_	15	PRN
21	]	]	-RRB-	_	20	P
22	.	.	.	_	2	P

1	For	for	IN	_	18	PRP
2	the	the	DT	_	4	NMOD
3	negative	negative	JJ	_	4	NMOD
4	controls	control	NNS	_	1	PMOD
5	in	in	IN	_	4	NMOD
6	these	these	DT	_	7	NMOD
7	assays	assay	NNS	_	5	PMOD
8	,	,	,	_	18	P
9	plasma	plasma	NN	_	18	SBJ
10	from	from	IN	_	9	NMOD
11	PAI	pai	NN	_	16	AMOD
12	-	-	HYPH	_	11	P
13	1	0	CD	_	11	NMOD
14	or	or	CC	_	11	COORD
15	Plg	plg	NN	_	14	CONJ
16	deficient	deficient	JJ	_	17	NMOD
17	mice	mouse	NNS	_	10	PMOD
18	was	be	VBD	_	0	ROOT
19	used	use	VBN	_	18	VC
20	.	.	.	_	18	P

1	Functionally	functionally	RB	_	2	AMOD
2	active	active	JJ	_	6	NMOD
3	mouse	mouse	NN	_	6	NMOD
4	α2	α0	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	antiplasmin	antiplasmin	NN	_	7	SBJ
7	was	be	VBD	_	0	ROOT
8	determined	determine	VBN	_	7	VC
9	with	with	IN	_	8	MNR
10	a	a	DT	_	13	NMOD
11	plasmin	plasmin	NN	_	12	NMOD
12	capture	capture	NN	_	13	NMOD
13	assay	assay	NN	_	9	PMOD
14	and	and	CC	_	13	COORD
15	detection	detection	NN	_	14	CONJ
16	with	with	IN	_	15	NMOD
17	a	a	DT	_	19	NMOD
18	mouse	mouse	NN	_	19	NMOD
19	antibody	antibody	NN	_	16	PMOD
20	(	(	-LRB-	_	22	P
21	Molecular	molecular	NNP	_	22	NMOD
22	Innovations	innovation	NNPS	_	19	PRN
23	,	,	,	_	22	P
24	Southfield	southfield	NNP	_	22	APPO
25	,	,	,	_	24	P
26	MI	mi	NNP	_	24	APPO
27	)	)	-RRB-	_	22	P
28	,	,	,	_	8	P
29	and	and	CC	_	8	COORD
30	fibrinogen	fibrinogen	NN	_	29	GAP-SBJ
31	with	with	IN	_	30	MNR
32	an	an	DT	_	34	NMOD
33	ELISA	elisa	NN	_	34	NMOD
34	assay	assay	NN	_	31	PMOD
35	with	with	IN	_	34	NMOD
36	antibodies	antibody	NNS	_	35	PMOD
37	that	that	WDT	_	38	SBJ
38	recognize	recognize	VBP	_	36	NMOD
39	mouse	mouse	NN	_	40	NMOD
40	fibrinogen	fibrinogen	NN	_	38	OBJ
41	(	(	-LRB-	_	43	P
42	Hyphen	hyphen	NNP	_	43	NMOD
43	BioMed	biomed	NNP	_	36	PRN
44	,	,	,	_	43	P
45	France	france	NNP	_	43	APPO
46	)	)	-RRB-	_	43	P
47	.	.	.	_	7	P

1	Histochemical	histochemical	JJ	_	4	NMOD
2	and	and	CC	_	1	COORD
3	immunohistochemistry	immunohistochemistry	NN	_	2	CONJ
4	analysis	analysis	NN	_	0	ROOT

1	The	the	DT	_	3	NMOD
2	frozen	freeze	VBN	_	3	NMOD
3	tails	tail	NNS	_	9	SBJ
4	or	or	CC	_	3	COORD
5	injured	injured	JJ	_	6	NMOD
6	carotids	carotids	NNS	_	4	CONJ
7	in	in	IN	_	3	LOC
8	OCT	oct	NN	_	7	PMOD
9	were	be	VBD	_	0	ROOT
10	sectioned	section	VBN	_	9	VC
11	at	at	IN	_	10	ADV
12	5	0	CD	_	13	NMOD
13	μm	μm	NNS	_	14	NMOD
14	thickness	thickness	NN	_	11	PMOD
15	and	and	CC	_	10	COORD
16	stained	stain	VBD	_	15	CONJ
17	with	with	IN	_	16	MNR
18	Masson	masson	NNP	_	20	NMOD
19	's	's	POS	_	18	NMOD
20	Trichrome	trichrome	NN	_	17	PMOD
21	(	(	-LRB-	_	26	P
22	HT	ht	NN	_	26	DEP
23	15	0	CD	_	22	NMOD
24	,	,	,	_	26	P
25	Sigma	sigma	NNP	_	26	NMOD
26	Diagnostics	diagnostics	NNPS	_	20	PRN
27	)	)	-RRB-	_	26	P
28	.	.	.	_	9	P

1	For	for	IN	_	19	PRP
2	quantitative	quantitative	JJ	_	3	NMOD
3	analysis	analysis	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	collagen	collagen	NN	_	6	NMOD
6	area	area	NN	_	4	PMOD
7	in	in	IN	_	3	LOC
8	the	the	DT	_	10	NMOD
9	tail	tail	NN	_	10	NMOD
10	sections	section	NNS	_	7	PMOD
11	,	,	,	_	19	P
12	four	four	CD	_	13	NMOD
13	sections	section	NNS	_	19	SBJ
14	from	from	IN	_	13	NMOD
15	2	0	CD	_	18	NMOD
16	–	–	SYM	_	15	P
17	3	0	CD	_	15	QMOD
18	sites	site	NNS	_	14	PMOD
19	were	be	VBD	_	0	ROOT
20	measured	measure	VBN	_	19	VC
21	using	use	VBG	_	20	MNR
22	computer	computer	NN	_	23	AMOD
23	assisted	assist	VBN	_	25	NMOD
24	image	image	NN	_	25	NMOD
25	analysis	analysis	NN	_	21	OBJ
26	(	(	-LRB-	_	32	P
27	Image	image	NNP	_	30	NMOD
28	-	-	HYPH	_	27	P
29	Pro	pro	NNP	_	30	NMOD
30	Plus	plus	NNP	_	32	DEP
31	,	,	,	_	32	P
32	Cybernetics	cybernetics	NNPS	_	21	PRN
33	)	)	-RRB-	_	32	P
34	.	.	.	_	19	P

1	For	for	IN	_	22	PRP
2	the	the	DT	_	4	NMOD
3	area	area	NN	_	4	NMOD
4	determination	determination	NN	_	1	PMOD
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	9	NMOD
7	injured	injured	JJ	_	9	NMOD
8	carotid	carotid	NN	_	9	NMOD
9	lumen	lumen	NN	_	5	PMOD
10	,	,	,	_	22	P
11	3	0	CD	_	14	NMOD
12	–	–	SYM	_	11	P
13	4	0	CD	_	11	QMOD
14	sections	section	NNS	_	22	SBJ
15	from	from	IN	_	14	NMOD
16	different	different	JJ	_	17	NMOD
17	sites	site	NNS	_	15	PMOD
18	approximately	approximately	RB	_	19	QMOD
19	100	0	CD	_	20	NMOD
20	μm	μm	NNS	_	21	AMOD
21	apart	apart	RB	_	17	NMOD
22	were	be	VBD	_	0	ROOT
23	analyzed	analyze	VBN	_	22	VC
24	and	and	CC	_	23	COORD
25	averaged	average	VBN	_	24	CONJ
26	for	for	IN	_	23	ADV
27	each	each	DT	_	28	NMOD
28	mouse	mouse	NN	_	26	PMOD
29	.	.	.	_	22	P

1	Statistics	statistic	NN	_	0	ROOT

1	Data	datum	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	presented	present	VBN	_	2	VC
4	as	as	IN	_	3	ADV
5	mean	mean	NN	_	7	NMOD
6	±	±	SYM	_	7	P
7	SEM	sem	NN	_	4	PMOD
8	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	statistical	statistical	JJ	_	3	NMOD
3	analysis	analysis	NN	_	27	SBJ
4	for	for	IN	_	3	NMOD
5	comparisons	comparison	NNS	_	4	PMOD
6	between	between	IN	_	5	NMOD
7	A	a	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	J	j	NN	_	12	NMOD
10	and	and	CC	_	9	COORD
11	B6	b0	NN	_	10	CONJ
12	mice	mouse	NNS	_	6	PMOD
13	and	and	CC	_	6	COORD
14	between	between	IN	_	13	CONJ
15	wild	wild	JJ	_	17	NMOD
16	-	-	HYPH	_	15	P
17	type	type	NN	_	19	NMOD
18	(	(	-LRB-	_	19	P
19	WT	wt	NN	_	26	NMOD
20	)	)	-RRB-	_	19	P
21	and	and	CC	_	19	COORD
22	Plg	plg	NN	_	21	CONJ
23	-	-	SYM	_	22	P
24	/	/	HYPH	_	22	P
25	-	-	SYM	_	22	P
26	littermates	littermates	NNS	_	14	PMOD
27	was	be	VBD	_	0	ROOT
28	compared	compare	VBN	_	27	VC
29	with	with	IN	_	28	MNR
30	a	a	DT	_	36	NMOD
31	two	two	CD	_	33	AMOD
32	-	-	HYPH	_	31	P
33	tailed	tail	VBN	_	36	NMOD
34	t	t	NN	_	36	NMOD
35	-	-	HYPH	_	34	P
36	test	test	NN	_	29	PMOD
37	.	.	.	_	27	P

1	Differences	difference	NNS	_	14	SBJ
2	among	among	IN	_	1	NMOD
3	B6	b0	NN	_	7	NMOD
4	,	,	,	_	7	P
5	Lepob	lepob	NN	_	7	NMOD
6	,	,	,	_	7	P
7	PAI	pai	NN	_	13	NMOD
8	-	-	HYPH	_	7	P
9	1	0	CD	_	7	NMOD
10	-	-	SYM	_	7	P
11	/	/	HYPH	_	7	P
12	-	-	SYM	_	7	P
13	mice	mouse	NNS	_	2	PMOD
14	were	be	VBD	_	0	ROOT
15	determined	determine	VBN	_	14	VC
16	by	by	IN	_	15	LGS
17	a	a	DT	_	21	NMOD
18	one	one	CD	_	20	NMOD
19	-	-	HYPH	_	18	P
20	way	way	NN	_	21	NMOD
21	ANOVA	anova	NN	_	16	PMOD
22	and	and	CC	_	21	COORD
23	a	a	DT	_	27	NMOD
24	Newman	newman	NNP	_	26	NMOD
25	-	-	HYPH	_	24	P
26	Keuls	keuls	NNP	_	27	NMOD
27	post-test	post-test	NN	_	22	CONJ
28	.	.	.	_	14	P

1	A	a	DT	_	2	NMOD
2	value	value	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	P	p	NN	_	3	PMOD
5	<	<	SYM	_	6	P
6	0.05	0	CD	_	4	NMOD
7	was	be	VBD	_	0	ROOT
8	considered	consider	VBN	_	7	VC
9	significant	significant	JJ	_	8	OPRD
10	.	.	.	_	7	P

1	The	the	DT	_	3	NMOD
2	statistical	statistical	JJ	_	3	NMOD
3	analysis	analysis	NN	_	11	SBJ
4	for	for	IN	_	3	NMOD
5	comparisons	comparison	NNS	_	4	PMOD
6	between	between	IN	_	5	NMOD
7	B6	b0	NN	_	8	NMOD
8	mice	mouse	NNS	_	6	PMOD
9	and	and	CC	_	8	COORD
10	CSS	cs	NN	_	9	CONJ
11	were	be	VBD	_	0	ROOT
12	determined	determine	VBN	_	11	VC
13	with	with	IN	_	12	MNR
14	two	two	CD	_	16	NMOD
15	-	-	HYPH	_	14	P
16	tail	tail	NN	_	19	NMOD
17	t	t	NN	_	19	NMOD
18	-	-	HYPH	_	17	P
19	tests	test	NNS	_	13	PMOD
20	and	and	CC	_	11	COORD
21	the	the	DT	_	22	NMOD
22	level	level	NN	_	34	SBJ
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	28	NMOD
25	significant	significant	JJ	_	28	NMOD
26	P	p	NN	_	28	NMOD
27	-	-	HYPH	_	26	P
28	values	value	NNS	_	23	PMOD
29	(	(	-LRB-	_	30	P
30	see	see	VB	_	22	PRN
31	figure	figure	NN	_	32	NMOD
32	legends	legend	NNS	_	30	OBJ
33	)	)	-RRB-	_	30	P
34	determined	determine	VBN	_	20	GAP
35	with	with	IN	_	34	MNR
36	a	a	DT	_	38	NMOD
37	Bonferroni	bonferroni	NNP	_	38	NMOD
38	correction	correction	NN	_	35	PMOD
39	to	to	TO	_	38	NMOD
40	account	account	VB	_	39	IM
41	for	for	IN	_	40	ADV
42	multihypothesis	multihypothesis	NN	_	43	NMOD
43	testing	testing	NN	_	41	PMOD
44	[	[	-LRB-	_	45	P
45	13	0	CD	_	34	PRN
46	]	]	-RRB-	_	45	P
47	.	.	.	_	11	P

1	Results	result	NNS	_	0	ROOT

1	Marked	marked	JJ	_	2	NMOD
2	differences	difference	NNS	_	0	ROOT
3	in	in	IN	_	2	NMOD
4	arterial	arterial	JJ	_	5	NMOD
5	thrombus	thrombus	NN	_	6	NMOD
6	formation	formation	NN	_	3	PMOD
7	in	in	IN	_	2	LOC
8	B6	b0	NN	_	13	NMOD
9	and	and	CC	_	8	COORD
10	A	a	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	J	j	NN	_	9	CONJ
13	mice	mouse	NNS	_	7	PMOD

1	The	the	DT	_	6	NMOD
2	FeCl3	fecl0	NN	_	6	NMOD
3	cartoid	cartoid	JJ	_	4	NMOD
4	artery	artery	NN	_	6	NMOD
5	injury	injury	NN	_	6	NMOD
6	model	model	NN	_	19	SBJ
7	[	[	-LRB-	_	8	P
8	24	0	CD	_	6	PRN
9	]	]	-RRB-	_	8	P
10	,	,	,	_	6	P
11	a	a	DT	_	17	NMOD
12	well	good	JJ	_	14	AMOD
13	-	-	HYPH	_	12	P
14	characterized	characterize	VBN	_	17	NMOD
15	arterial	arterial	JJ	_	16	NMOD
16	thrombosis	thrombosis	NN	_	17	NMOD
17	model	model	NN	_	6	APPO
18	,	,	,	_	19	P
19	was	be	VBD	_	0	ROOT
20	used	use	VBN	_	19	VC
21	to	to	TO	_	20	PRP
22	induce	induce	VB	_	21	IM
23	an	an	DT	_	25	NMOD
24	occlusive	occlusive	JJ	_	25	NMOD
25	thrombus	thrombus	NN	_	22	OBJ
26	in	in	IN	_	22	LOC
27	the	the	DT	_	34	NMOD
28	B6	b0	NN	_	34	NMOD
29	and	and	CC	_	28	COORD
30	A	a	NN	_	32	NMOD
31	/	/	HYPH	_	30	P
32	J	j	NN	_	29	CONJ
33	mouse	mouse	NN	_	34	NMOD
34	strains	strain	NNS	_	26	PMOD
35	under	under	IN	_	34	NMOD
36	investigation	investigation	NN	_	35	PMOD
37	.	.	.	_	19	P

1	A	a	DT	_	3	NMOD
2	marked	marked	JJ	_	3	NMOD
3	difference	difference	NN	_	9	SBJ
4	in	in	IN	_	3	NMOD
5	arterial	arterial	JJ	_	6	NMOD
6	thrombus	thrombus	NN	_	7	NMOD
7	occlusion	occlusion	NN	_	8	NMOD
8	time	time	NN	_	4	PMOD
9	was	be	VBD	_	0	ROOT
10	found	find	VBN	_	9	VC
11	between	between	IN	_	10	ADV
12	the	the	DT	_	13	NMOD
13	B6	b0	NN	_	11	PMOD
14	and	and	CC	_	13	COORD
15	the	the	DT	_	18	NMOD
16	A	a	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	J	j	NN	_	14	CONJ
19	mice	mouse	NNS	_	18	NMOD
20	(	(	-LRB-	_	22	P
21	Figure	figure	NN	_	22	NMOD
22	1A	0a	NN	_	10	PRN
23	)	)	-RRB-	_	22	P
24	.	.	.	_	9	P

1	The	the	DT	_	3	NMOD
2	occlusion	occlusion	NN	_	3	NMOD
3	time	time	NN	_	10	SBJ
4	in	in	IN	_	3	LOC
5	the	the	DT	_	9	NMOD
6	A	a	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	J	j	NN	_	9	NMOD
9	mice	mouse	NNS	_	4	PMOD
10	was	be	VBD	_	0	ROOT
11	2-fold	0-fold	RB	_	12	AMOD
12	less	less	JJR	_	10	PRD
13	than	than	IN	_	12	AMOD
14	for	for	IN	_	13	PMOD
15	the	the	DT	_	17	NMOD
16	B6	b0	NN	_	17	NMOD
17	mice	mouse	NNS	_	14	PMOD
18	.	.	.	_	10	P

1	A	a	DT	_	4	NMOD
2	5	0	CD	_	3	NMOD
3	%	%	NN	_	4	NMOD
4	dose	dose	NN	_	7	SBJ
5	of	of	IN	_	4	NMOD
6	FeCl3	fecl0	NN	_	5	PMOD
7	was	be	VBD	_	0	ROOT
8	tested	test	VBN	_	7	VC
9	in	in	IN	_	8	LOC
10	the	the	DT	_	16	NMOD
11	A	a	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	J	j	NN	_	16	NMOD
14	and	and	CC	_	13	COORD
15	B6	b0	NN	_	14	CONJ
16	mice	mouse	NNS	_	9	PMOD
17	and	and	CC	_	7	COORD
18	the	the	DT	_	20	NMOD
19	occlusion	occlusion	NN	_	20	NMOD
20	time	time	NN	_	21	SBJ
21	was	be	VBD	_	17	CONJ
22	lower	low	JJR	_	21	PRD
23	in	in	IN	_	22	LOC
24	the	the	DT	_	27	NMOD
25	A	a	NN	_	27	NMOD
26	/	/	HYPH	_	25	P
27	J	j	NN	_	23	PMOD
28	than	than	IN	_	22	AMOD
29	the	the	DT	_	30	NMOD
30	B6	b0	NN	_	28	PMOD
31	mice	mouse	NNS	_	30	NMOD
32	,	,	,	_	21	P
33	the	the	DT	_	35	NMOD
34	same	same	JJ	_	35	NMOD
35	results	result	NNS	_	21	ADV
36	as	as	IN	_	35	NMOD
37	with	with	IN	_	36	PMOD
38	the	the	DT	_	41	NMOD
39	10	0	CD	_	40	NMOD
40	%	%	NN	_	41	NMOD
41	dose	dose	NN	_	37	PMOD
42	.	.	.	_	7	P

1	The	the	DT	_	3	NMOD
2	occlusion	occlusion	NN	_	3	NMOD
3	time	time	NN	_	34	SBJ
4	(	(	-LRB-	_	5	P
5	min	min	NNS	_	3	PRN
6	for	for	IN	_	5	NMOD
7	both	both	CC	_	8	COORD
8	B6	b0	NN	_	6	PMOD
9	(	(	-LRB-	_	16	P
10	15	0	CD	_	16	DEP
11	±	±	SYM	_	10	P
12	3	0	CD	_	10	QMOD
13	,	,	,	_	16	P
14	n	n	NN	_	16	SBJ
15	=	=	SYM	_	16	P
16	3	0	CD	_	8	PRN
17	)	)	-RRB-	_	16	P
18	and	and	CC	_	8	COORD
19	A	a	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	J	j	NN	_	18	CONJ
22	(	(	-LRB-	_	29	P
23	8	0	CD	_	29	DEP
24	±	±	SYM	_	23	P
25	1	0	CD	_	23	QMOD
26	,	,	,	_	29	P
27	n	n	NN	_	29	SBJ
28	=	=	SYM	_	29	P
29	3	0	CD	_	21	PRN
30	)	)	-RRB-	_	29	P
31	at	at	IN	_	3	NMOD
32	5	0	CD	_	33	NMOD
33	%	%	NN	_	31	PMOD
34	were	be	VBD	_	0	ROOT
35	longer	long	JJR	_	34	PRD
36	than	than	IN	_	35	AMOD
37	at	at	IN	_	36	PMOD
38	10	0	CD	_	39	NMOD
39	%	%	NN	_	37	PMOD
40	for	for	IN	_	34	ADV
41	B6	b0	NN	_	40	PMOD
42	(	(	-LRB-	_	49	P
43	10	0	CD	_	49	DEP
44	±	±	SYM	_	43	P
45	1	0	CD	_	43	QMOD
46	,	,	,	_	49	P
47	n	n	NN	_	49	SBJ
48	=	=	SYM	_	49	P
49	17	0	CD	_	41	PRN
50	and	and	CC	_	41	COORD
51	A	a	NN	_	53	NMOD
52	/	/	HYPH	_	51	P
53	J	j	NN	_	50	CONJ
54	(	(	-LRB-	_	61	P
55	5	0	CD	_	61	DEP
56	±	±	SYM	_	55	P
57	2	0	CD	_	55	QMOD
58	,	,	,	_	61	P
59	n	n	NN	_	61	SBJ
60	=	=	SYM	_	61	P
61	14	0	CD	_	53	PRN
62	)	)	-RRB-	_	61	P
63	.	.	.	_	34	P

1	The	the	DT	_	2	NMOD
2	curves	curve	NNS	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	blood	blood	NN	_	5	NMOD
5	flow	flow	NN	_	3	PMOD
6	after	after	IN	_	2	TMP
7	FeCl3	fecl0	NN	_	8	NMOD
8	application	application	NN	_	6	PMOD
9	indicated	indicate	VBD	_	0	ROOT
10	a	a	DT	_	11	NMOD
11	pattern	pattern	NN	_	9	OBJ
12	with	with	IN	_	9	ADV
13	a	a	DT	_	15	NMOD
14	gradual	gradual	JJ	_	15	NMOD
15	decrease	decrease	NN	_	12	PMOD
16	before	before	IN	_	15	TMP
17	occlusion	occlusion	NN	_	16	PMOD
18	for	for	IN	_	15	NMOD
19	the	the	DT	_	21	NMOD
20	B6	b0	NN	_	21	NMOD
21	mice	mouse	NNS	_	18	PMOD
22	(	(	-LRB-	_	24	P
23	Figure	figure	NN	_	24	NMOD
24	1B	0b	NN	_	9	PRN
25	)	)	-RRB-	_	24	P
26	,	,	,	_	9	P
27	but	but	CC	_	9	COORD
28	for	for	IN	_	37	PRP
29	the	the	DT	_	33	NMOD
30	A	a	NN	_	32	NMOD
31	/	/	HYPH	_	30	P
32	J	j	NN	_	33	NMOD
33	mice	mouse	NNS	_	28	PMOD
34	the	the	DT	_	36	NMOD
35	blood	blood	NN	_	36	NMOD
36	flow	flow	NN	_	37	SBJ
37	decreased	decrease	VBD	_	27	CONJ
38	abruptly	abruptly	RB	_	37	TMP
39	to	to	IN	_	37	ADV
40	zero	zero	CD	_	39	PMOD
41	(	(	-LRB-	_	43	P
42	Figure	figure	NN	_	43	NMOD
43	1C	0c	NN	_	37	PRN
44	)	)	-RRB-	_	43	P
45	,	,	,	_	37	P
46	demonstrating	demonstrate	VBG	_	37	ADV
47	a	a	DT	_	49	NMOD
48	marked	marked	JJ	_	49	NMOD
49	difference	difference	NN	_	46	OBJ
50	from	from	IN	_	49	NMOD
51	the	the	DT	_	53	NMOD
52	B6	b0	NN	_	53	NMOD
53	strain	strain	NN	_	50	PMOD
54	.	.	.	_	9	P

1	The	the	DT	_	4	NMOD
2	mean	mean	JJ	_	4	NMOD
3	occlusion	occlusion	NN	_	4	NMOD
4	times	time	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	significantly	significantly	RB	_	7	AMOD
7	different	different	JJ	_	5	PRD
8	between	between	IN	_	5	ADV
9	the	the	DT	_	11	NMOD
10	two	two	CD	_	11	NMOD
11	strains	strain	NNS	_	8	PMOD
12	(	(	-LRB-	_	14	P
13	Figure	figure	NN	_	14	NMOD
14	1A	0a	NN	_	5	PRN
15	)	)	-RRB-	_	14	P
16	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	size	size	NN	_	10	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	carotids	carotids	NNS	_	3	PMOD
6	in	in	IN	_	2	LOC
7	the	the	DT	_	9	NMOD
8	two	two	CD	_	9	NMOD
9	strains	strain	NNS	_	6	PMOD
10	was	be	VBD	_	0	ROOT
11	noticeably	noticeably	RB	_	12	AMOD
12	different	different	JJ	_	10	PRD
13	.	.	.	_	10	P

1	The	the	DT	_	2	NMOD
2	area	area	NN	_	18	SBJ
3	(	(	-LRB-	_	4	P
4	mm2	mm0	NN	_	2	PRN
5	)	)	-RRB-	_	4	P
6	of	of	IN	_	2	NMOD
7	the	the	DT	_	8	NMOD
8	lumen	lumen	NN	_	6	PMOD
9	(	(	-LRB-	_	16	P
10	0.066	0	CD	_	16	DEP
11	±	±	SYM	_	10	P
12	0.007	0	CD	_	10	QMOD
13	,	,	,	_	16	P
14	n	n	NN	_	16	SBJ
15	=	=	SYM	_	16	P
16	6	0	CD	_	8	PRN
17	)	)	-RRB-	_	16	P
18	was	be	VBD	_	0	ROOT
19	significantly	significantly	RB	_	20	AMOD
20	less	less	JJR	_	18	PRD
21	in	in	IN	_	18	LOC
22	the	the	DT	_	26	NMOD
23	A	a	NN	_	25	NMOD
24	/	/	SYM	_	25	P
25	J	j	NN	_	26	NMOD
26	mice	mouse	NNS	_	21	PMOD
27	than	than	IN	_	20	AMOD
28	for	for	IN	_	27	PMOD
29	B6	b0	NN	_	30	NMOD
30	mice	mouse	NNS	_	28	PMOD
31	(	(	-LRB-	_	38	P
32	0.128	0	CD	_	38	DEP
33	±	±	SYM	_	32	P
34	0.007	0	CD	_	32	QMOD
35	,	,	,	_	38	P
36	n	n	NN	_	38	SBJ
37	=	=	SYM	_	38	P
38	6	0	CD	_	18	PRN
39	)	)	-RRB-	_	38	P
40	.	.	.	_	18	P

1	However	however	RB	_	10	ADV
2	,	,	,	_	10	P
3	the	the	DT	_	4	NMOD
4	ratio	ratio	NN	_	10	SBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	thrombus	thrombus	NN	_	5	PMOD
8	to	to	IN	_	4	NMOD
9	lumen	lumen	NN	_	8	PMOD
10	was	be	VBD	_	0	ROOT
11	similar	similar	JJ	_	10	PRD
12	for	for	IN	_	10	ADV
13	A	a	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	J	j	NN	_	12	PMOD
16	(	(	-LRB-	_	17	P
17	0.63	0	CD	_	15	PRN
18	±	±	SYM	_	17	P
19	0.03	0	CD	_	17	QMOD
20	)	)	-RRB-	_	17	P
21	compared	compare	VBN	_	15	NMOD
22	to	to	IN	_	21	PMOD
23	B6	b0	NN	_	24	NMOD
24	mice	mouse	NNS	_	22	PMOD
25	(	(	-LRB-	_	26	P
26	0.67	0	CD	_	24	PRN
27	±	±	SYM	_	26	P
28	0.09	0	CD	_	26	QMOD
29	)	)	-RRB-	_	26	P
30	.	.	.	_	10	P

1	Calculated	calculate	VBN	_	4	NMOD
2	sheer	sheer	NN	_	4	NMOD
3	stress	stress	NN	_	4	NMOD
4	rates	rate	NNS	_	8	SBJ
5	[	[	-LRB-	_	6	P
6	25	0	CD	_	4	PRN
7	]	]	-RRB-	_	6	P
8	were	be	VBD	_	0	ROOT
9	14	0	CD	_	10	NMOD
10	%	%	NN	_	11	AMOD
11	less	less	JJR	_	8	PRD
12	in	in	IN	_	8	LOC
13	the	the	DT	_	17	NMOD
14	A	a	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	J	j	NN	_	17	NMOD
17	mice	mouse	NNS	_	12	PMOD
18	when	when	WRB	_	19	TMP
19	compared	compare	VBN	_	8	TMP
20	to	to	IN	_	19	ADV
21	B6	b0	NN	_	22	NMOD
22	mice	mouse	NNS	_	20	PMOD
23	.	.	.	_	8	P

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Arterial	arterial	JJ	_	2	NMOD
2	occlusion	occlusion	NN	_	3	NMOD
3	time	time	NN	_	0	ROOT
4	in	in	IN	_	3	LOC
5	B6	b0	NN	_	10	NMOD
6	and	and	CC	_	5	COORD
7	A	a	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	J	j	NN	_	6	CONJ
10	mice	mouse	NNS	_	4	PMOD
11	.	.	.	_	3	P

1	Panels	panel	NNS	_	2	NMOD
2	A	a	NN	_	5	SBJ
3	and	and	CC	_	2	COORD
4	B	b	NN	_	3	CONJ
5	are	be	VBP	_	0	ROOT
6	representative	representative	JJ	_	8	NMOD
7	occlusion	occlusion	NN	_	8	NMOD
8	curves	curve	NNS	_	5	PRD
9	from	from	IN	_	8	NMOD
10	each	each	DT	_	11	NMOD
11	genotype	genotype	NN	_	9	PMOD
12	.	.	.	_	5	P

1	Red	red	JJ	_	2	NMOD
2	arrows	arrow	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	duration	duration	NN	_	3	OBJ
5	of	of	IN	_	4	NMOD
6	ferric	ferric	JJ	_	7	NMOD
7	chloride	chloride	NN	_	8	NMOD
8	application	application	NN	_	5	PMOD
9	to	to	IN	_	8	NMOD
10	the	the	DT	_	11	NMOD
11	carotid	carotid	NN	_	9	PMOD
12	.	.	.	_	3	P

1	Panel	panel	NN	_	2	NMOD
2	A	a	NN	_	5	NMOD
3	:	:	:	_	5	P
4	B6	b0	NN	_	5	NMOD
5	mice	mouse	NNS	_	0	ROOT
6	,	,	,	_	5	P
7	Panel	panel	NN	_	8	NMOD
8	B	b	NN	_	13	NMOD
9	:	:	:	_	13	P
10	A	a	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	J	j	NN	_	13	NMOD
13	mice	mouse	NNS	_	5	APPO
14	.	.	.	_	5	P

1	Panel	panel	NN	_	2	NMOD
2	C	c	NN	_	6	NMOD
3	:	:	:	_	6	P
4	Arterial	arterial	JJ	_	5	NMOD
5	occlusion	occlusion	NN	_	6	NMOD
6	time	time	NN	_	0	ROOT
7	,	,	,	_	6	P
8	mean	mean	NN	_	10	NMOD
9	±	±	SYM	_	10	P
10	SEM	sem	NN	_	6	APPO
11	of	of	IN	_	10	NMOD
12	14	0	CD	_	15	NMOD
13	–	–	HYPH	_	12	P
14	17	0	CD	_	12	QMOD
15	mice	mouse	NNS	_	11	PMOD
16	per	per	IN	_	15	NMOD
17	genotype	genotype	NN	_	16	PMOD
18	.	.	.	_	6	P

1	Symbol	symbol	NN	_	2	SBJ
2	indicates	indicate	VBZ	_	0	ROOT
3	a	a	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	2	OBJ
6	(	(	-LRB-	_	10	P
7	**	**	SYM	_	8	P
8	P	p	NN	_	10	SBJ
9	<	<	SYM	_	10	P
10	0.01	0	CD	_	5	PRN
11	)	)	-RRB-	_	10	P
12	between	between	IN	_	5	NMOD
13	B6	b0	NN	_	14	NMOD
14	mice	mouse	NNS	_	12	PMOD
15	determined	determine	VBN	_	5	NMOD
16	with	with	IN	_	15	MNR
17	a	a	DT	_	20	NMOD
18	t	t	NN	_	20	NMOD
19	-	-	HYPH	_	18	P
20	test	test	NN	_	16	PMOD
21	.	.	.	_	2	P

1	Marked	marked	JJ	_	2	NMOD
2	differences	difference	NNS	_	0	ROOT
3	in	in	IN	_	2	NMOD
4	rebleeding	rebleeding	NN	_	5	NMOD
5	time	time	NN	_	3	PMOD
6	in	in	IN	_	2	LOC
7	B6	b0	NN	_	12	NMOD
8	and	and	CC	_	7	COORD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	8	CONJ
12	mice	mouse	NNS	_	6	PMOD

1	The	the	DT	_	3	NMOD
2	bleeding	bleeding	NN	_	3	NMOD
3	time	time	NN	_	11	SBJ
4	,	,	,	_	3	P
5	an	an	DT	_	6	NMOD
6	indicator	indicator	NN	_	3	APPO
7	of	of	IN	_	6	NMOD
8	hemostatic	hemostatic	JJ	_	9	NMOD
9	activity	activity	NN	_	7	PMOD
10	,	,	,	_	11	P
11	was	be	VBD	_	0	ROOT
12	determined	determine	VBN	_	11	VC
13	after	after	IN	_	12	TMP
14	prewarming	prewarming	VBG	_	13	PMOD
15	the	the	DT	_	16	NMOD
16	tail	tail	NN	_	14	OBJ
17	,	,	,	_	14	P
18	clipping	clip	VBG	_	14	CONJ
19	a	a	DT	_	22	NMOD
20	5	0	CD	_	21	NMOD
21	mm	mm	NN	_	22	NMOD
22	segment	segment	NN	_	18	OBJ
23	,	,	,	_	18	P
24	placing	place	VBG	_	18	CONJ
25	the	the	DT	_	26	NMOD
26	tail	tail	NN	_	24	OBJ
27	in	in	IN	_	24	LOC
28	warm	warm	JJ	_	29	NMOD
29	saline	saline	NN	_	27	PMOD
30	and	and	CC	_	24	COORD
31	measuring	measure	VBG	_	30	CONJ
32	the	the	DT	_	33	NMOD
33	time	time	NN	_	31	OBJ
34	for	for	IN	_	33	NMOD
35	the	the	DT	_	36	NMOD
36	bleeding	bleeding	NN	_	37	SBJ
37	to	to	TO	_	34	SUB
38	stop	stop	VB	_	37	IM
39	.	.	.	_	11	P

1	We	we	PRP	_	2	SBJ
2	found	find	VBD	_	0	ROOT
3	this	this	DT	_	4	NMOD
4	procedure	procedure	NN	_	5	SBJ
5	was	be	VBD	_	2	OBJ
6	consistent	consistent	JJ	_	5	PRD
7	and	and	CC	_	6	COORD
8	reproducible	reproducible	JJ	_	7	CONJ
9	in	in	IN	_	5	LOC
10	different	different	JJ	_	12	NMOD
11	mouse	mouse	NN	_	12	NMOD
12	strains	strain	NNS	_	9	PMOD
13	and	and	CC	_	5	COORD
14	was	be	VBD	_	13	CONJ
15	not	not	RB	_	14	ADV
16	gender	gender	NN	_	17	AMOD
17	dependent	dependent	JJ	_	14	PRD
18	.	.	.	_	2	P

1	Bleeding	bleeding	NN	_	2	NMOD
2	time	time	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	not	not	RB	_	3	ADV
5	different	different	JJ	_	3	PRD
6	in	in	IN	_	3	LOC
7	A	a	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	J	j	NN	_	10	NMOD
10	mice	mouse	NNS	_	6	PMOD
11	compared	compare	VBN	_	3	ADV
12	to	to	IN	_	11	PMOD
13	B6	b0	NN	_	14	NMOD
14	mice	mouse	NNS	_	12	PMOD
15	(	(	-LRB-	_	17	P
16	Figure	figure	NN	_	17	NMOD
17	2A	0a	NN	_	3	PRN
18	)	)	-RRB-	_	17	P
19	.	.	.	_	3	P

1	In	in	IN	_	43	PRP
2	order	order	NN	_	1	PMOD
3	to	to	TO	_	2	NMOD
4	determine	determine	VB	_	3	IM
5	if	if	IN	_	4	OBJ
6	specific	specific	JJ	_	7	NMOD
7	pathways	pathway	NNS	_	8	SBJ
8	were	be	VBD	_	5	SUB
9	altered	alter	VBN	_	8	VC
10	in	in	IN	_	9	LOC
11	the	the	DT	_	17	NMOD
12	B6	b0	NN	_	17	NMOD
13	and	and	CC	_	12	COORD
14	A	a	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	J	j	NN	_	13	CONJ
17	strains	strain	NNS	_	10	PMOD
18	,	,	,	_	43	P
19	mice	mouse	NNS	_	43	SBJ
20	with	with	IN	_	19	NMOD
21	known	known	JJ	_	22	NMOD
22	alterations	alteration	NNS	_	20	PMOD
23	in	in	IN	_	22	LOC
24	hemostasis	hemostasis	NN	_	23	PMOD
25	,	,	,	_	19	P
26	Lepob	lepob	NN	_	27	NMOD
27	mice	mouse	NNS	_	19	APPO
28	,	,	,	_	19	P
29	or	or	CC	_	19	COORD
30	thrombosis	thrombosis	NN	_	41	NMOD
31	,	,	,	_	41	P
32	Plg	plg	NN	_	41	NMOD
33	-	-	SYM	_	32	P
34	/	/	HYPH	_	32	P
35	-	-	SYM	_	32	P
36	and	and	CC	_	32	COORD
37	PAI	pai	NN	_	36	CONJ
38	-	-	SYM	_	37	P
39	/	/	HYPH	_	37	P
40	-	-	SYM	_	37	P
41	mice	mouse	NNS	_	29	GAP
42	,	,	,	_	43	P
43	were	be	VBD	_	0	ROOT
44	also	also	RB	_	43	ADV
45	tested	test	VBN	_	43	VC
46	.	.	.	_	43	P

1	The	the	DT	_	3	NMOD
2	Lepob	lepob	NN	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	have	have	VBP	_	0	ROOT
5	impaired	impair	VBN	_	7	NMOD
6	platelet	platelet	NN	_	7	NMOD
7	aggregation	aggregation	NN	_	4	OBJ
8	[	[	-LRB-	_	9	P
9	26	0	CD	_	4	PRN
10	]	]	-RRB-	_	9	P
11	and	and	CC	_	4	COORD
12	were	be	VBD	_	11	CONJ
13	evaluated	evaluate	VBN	_	12	VC
14	as	as	IN	_	13	ADV
15	a	a	DT	_	16	NMOD
16	reference	reference	NN	_	14	PMOD
17	for	for	IN	_	16	NMOD
18	platelet	platelet	NN	_	19	NMOD
19	function	function	NN	_	17	PMOD
20	.	.	.	_	4	P

1	In	in	IN	_	10	LOC
2	the	the	DT	_	4	NMOD
3	Lepob	lepob	NN	_	4	NMOD
4	mice	mouse	NNS	_	1	PMOD
5	(	(	-LRB-	_	7	P
6	Figure	figure	NN	_	7	NMOD
7	2A	0a	NN	_	4	PRN
8	)	)	-RRB-	_	7	P
9	there	there	EX	_	10	SBJ
10	was	be	VBD	_	0	ROOT
11	nearly	nearly	RB	_	14	NMOD
12	a	a	DT	_	14	NMOD
13	10-fold	0-fold	RB	_	14	NMOD
14	increase	increase	NN	_	10	PRD
15	in	in	IN	_	14	NMOD
16	bleeding	bleeding	NN	_	17	NMOD
17	time	time	NN	_	15	PMOD
18	compared	compare	VBN	_	14	NMOD
19	to	to	IN	_	18	PMOD
20	B6	b0	NN	_	21	NMOD
21	mice	mouse	NNS	_	19	PMOD
22	.	.	.	_	10	P

1	Bleeding	bleeding	NN	_	2	NMOD
2	time	time	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	also	also	RB	_	3	ADV
5	significantly	significantly	RB	_	3	ADV
6	(	(	-LRB-	_	9	P
7	P	p	NN	_	9	SBJ
8	=	=	SYM	_	9	P
9	0.0001	0	CD	_	5	PRN
10	)	)	-RRB-	_	9	P
11	increased	increase	VBN	_	3	VC
12	by	by	IN	_	11	EXT
13	66	0	CD	_	14	NMOD
14	%	%	NN	_	12	PMOD
15	in	in	IN	_	11	LOC
16	the	the	DT	_	21	NMOD
17	Plg	plg	NN	_	21	NMOD
18	-	-	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	-	-	SYM	_	17	P
21	mice	mouse	NNS	_	15	PMOD
22	compared	compare	VBN	_	11	ADV
23	to	to	IN	_	22	PMOD
24	WT	wt	NN	_	26	NMOD
25	mice	mouse	NNS	_	26	NMOD
26	littermates	littermates	NNS	_	23	PMOD
27	.	.	.	_	3	P

1	Bleeding	bleeding	NN	_	2	NMOD
2	time	time	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	not	not	RB	_	3	ADV
5	different	different	JJ	_	3	PRD
6	in	in	IN	_	3	LOC
7	PAI	pai	NN	_	13	NMOD
8	-	-	HYPH	_	7	P
9	1	0	CD	_	7	NMOD
10	-	-	SYM	_	7	P
11	/	/	HYPH	_	7	P
12	-	-	SYM	_	7	P
13	mice	mouse	NNS	_	6	PMOD
14	compared	compare	VBN	_	3	ADV
15	to	to	IN	_	14	PMOD
16	B6	b0	NN	_	17	NMOD
17	mice	mouse	NNS	_	15	PMOD
18	.	.	.	_	3	P

1	In	in	IN	_	19	ADV
2	contrast	contrast	NN	_	1	PMOD
3	to	to	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	Lepob	lepob	NN	_	6	NMOD
6	mice	mouse	NNS	_	3	PMOD
7	with	with	IN	_	6	NMOD
8	a	a	DT	_	10	NMOD
9	platelet	platelet	NN	_	10	NMOD
10	defect	defect	NN	_	7	PMOD
11	and	and	CC	_	10	COORD
12	10-fold	0-fold	RB	_	13	NMOD
13	increase	increase	NN	_	11	CONJ
14	in	in	IN	_	13	NMOD
15	bleeding	bleeding	NN	_	16	NMOD
16	time	time	NN	_	14	PMOD
17	,	,	,	_	19	P
18	there	there	EX	_	19	SBJ
19	was	be	VBD	_	0	ROOT
20	no	no	DT	_	21	NMOD
21	difference	difference	NN	_	19	PRD
22	in	in	IN	_	21	NMOD
23	the	the	DT	_	25	NMOD
24	bleeding	bleeding	NN	_	25	NMOD
25	time	time	NN	_	22	PMOD
26	between	between	IN	_	25	NMOD
27	B6	b0	NN	_	32	NMOD
28	and	and	CC	_	27	COORD
29	A	a	NN	_	31	NMOD
30	/	/	HYPH	_	29	P
31	J	j	NN	_	28	CONJ
32	mice	mouse	NNS	_	26	PMOD
33	and	and	CC	_	19	COORD
34	suggested	suggest	VBD	_	33	CONJ
35	platelet	platelet	NN	_	36	NMOD
36	aggregation	aggregation	NN	_	37	SBJ
37	is	be	VBZ	_	34	OBJ
38	not	not	RB	_	37	ADV
39	altered	alter	VBN	_	37	VC
40	in	in	IN	_	39	LOC
41	these	these	DT	_	43	NMOD
42	two	two	CD	_	43	NMOD
43	strains	strain	NNS	_	40	PMOD
44	.	.	.	_	19	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Bleeding	bleeding	NN	_	4	NMOD
2	and	and	CC	_	1	COORD
3	rebleeding	rebleeding	NN	_	2	CONJ
4	time	time	NN	_	0	ROOT
5	in	in	IN	_	4	LOC
6	B6	b0	NN	_	25	NMOD
7	,	,	,	_	6	P
8	A	a	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	J	j	NN	_	6	CONJ
11	,	,	,	_	10	P
12	Lepob	lepob	NNP	_	10	CONJ
13	,	,	,	_	12	P
14	Plg	plg	NN	_	12	CONJ
15	-	-	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	-	-	SYM	_	14	P
18	and	and	CC	_	14	COORD
19	PAI	pai	NN	_	18	CONJ
20	-	-	HYPH	_	19	P
21	1	0	CD	_	19	NMOD
22	-	-	SYM	_	19	P
23	/	/	HYPH	_	19	P
24	-	-	SYM	_	19	P
25	mice	mouse	NNS	_	5	PMOD
26	.	.	.	_	4	P

1	Panel	panel	NN	_	4	NMOD
2	A	a	NN	_	4	NMOD
3	,	,	,	_	4	P
4	B	b	NN	_	0	ROOT
5	:	:	:	_	4	P
6	Bleeding	bleeding	NN	_	7	NMOD
7	time	time	NN	_	4	DEP
8	(	(	-LRB-	_	9	P
9	seconds	second	NNS	_	7	PRN
10	)	)	-RRB-	_	9	P
11	and	and	CC	_	4	COORD
12	Panel	panel	NN	_	15	NMOD
13	C	c	NN	_	15	NMOD
14	,	,	,	_	15	P
15	D	d	NN	_	11	CONJ
16	:	:	:	_	15	P
17	Rebleeding	rebleeding	NN	_	18	NMOD
18	time	time	NN	_	15	DEP
19	(	(	-LRB-	_	20	P
20	seconds	second	NNS	_	18	PRN
21	)	)	-RRB-	_	20	P
22	.	.	.	_	4	P

1	To	to	TO	_	22	PRP
2	determine	determine	VB	_	1	IM
3	statistical	statistical	JJ	_	4	NMOD
4	differences	difference	NNS	_	2	OBJ
5	,	,	,	_	22	P
6	values	value	NNS	_	22	SBJ
7	from	from	IN	_	6	NMOD
8	B6	b0	NN	_	7	PMOD
9	and	and	CC	_	8	COORD
10	A	a	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	J	j	NN	_	9	CONJ
13	and	and	CC	_	7	COORD
14	from	from	IN	_	13	CONJ
15	WT	wt	NN	_	14	PMOD
16	and	and	CC	_	15	COORD
17	Plg	plg	NN	_	16	CONJ
18	-	-	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	-	-	SYM	_	17	P
21	littermates	littermates	NNS	_	15	NMOD
22	were	be	VBD	_	0	ROOT
23	compared	compare	VBN	_	22	VC
24	with	with	IN	_	23	MNR
25	a	a	DT	_	28	NMOD
26	t	t	NN	_	28	NMOD
27	-	-	HYPH	_	26	P
28	test	test	NN	_	24	PMOD
29	,	,	,	_	22	P
30	and	and	CC	_	22	COORD
31	values	value	NNS	_	43	SBJ
32	from	from	IN	_	31	NMOD
33	B6	b0	NN	_	32	PMOD
34	,	,	,	_	33	P
35	PAI	pai	NN	_	33	CONJ
36	-	-	HYPH	_	35	P
37	1	0	CD	_	35	NMOD
38	-	-	SYM	_	35	P
39	/	/	HYPH	_	35	P
40	-	-	SYM	_	35	P
41	and	and	CC	_	35	COORD
42	Lepob	lepob	NN	_	41	CONJ
43	were	be	VBD	_	30	CONJ
44	compared	compare	VBN	_	43	VC
45	by	by	IN	_	44	MNR
46	a	a	DT	_	50	NMOD
47	one	one	CD	_	49	NMOD
48	-	-	HYPH	_	47	P
49	way	way	NN	_	50	NMOD
50	ANOVA	anova	NN	_	45	PMOD
51	and	and	CC	_	50	COORD
52	a	a	DT	_	56	NMOD
53	Newman	newman	NNP	_	55	NMOD
54	-	-	HYPH	_	53	P
55	Keuls	keuls	NNP	_	56	NMOD
56	post-test	post-test	NN	_	51	CONJ
57	.	.	.	_	22	P

1	Symbols	symbol	NNS	_	2	SBJ
2	indicate	indicate	VBP	_	0	ROOT
3	a	a	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	2	OBJ
6	(	(	-LRB-	_	20	P
7	*	*	SYM	_	8	P
8	P	p	NN	_	10	SBJ
9	<	<	SYM	_	10	P
10	0.05	0	CD	_	20	DEP
11	,	,	,	_	20	P
12	**	**	SYM	_	13	P
13	P	p	NN	_	15	SBJ
14	<	<	SYM	_	15	P
15	0.01	0	CD	_	20	DEP
16	,	,	,	_	20	P
17	***	***	SYM	_	18	P
18	P	p	NN	_	20	SBJ
19	<	<	SYM	_	20	P
20	0.001	0	CD	_	5	PRN
21	)	)	-RRB-	_	20	P
22	between	between	IN	_	5	NMOD
23	B6	b0	NN	_	26	NMOD
24	or	or	CC	_	23	COORD
25	WT	wt	NN	_	24	CONJ
26	mice	mouse	NNS	_	22	PMOD
27	.	.	.	_	2	P

1	Values	value	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	the	the	DT	_	6	NMOD
4	mean	mean	NN	_	6	NMOD
5	±	±	SYM	_	6	P
6	SEM	sem	NN	_	2	PRD
7	of	of	IN	_	6	NMOD
8	10	0	CD	_	11	NMOD
9	–	–	SYM	_	8	P
10	34	0	CD	_	8	QMOD
11	mice	mouse	NNS	_	7	PMOD
12	per	per	IN	_	11	NMOD
13	genotype	genotype	NN	_	12	PMOD
14	.	.	.	_	2	P

1	Rebleeding	rebleeding	NN	_	2	NMOD
2	time	time	NN	_	10	SBJ
3	,	,	,	_	2	P
4	an	an	DT	_	5	NMOD
5	indicator	indicator	NN	_	2	APPO
6	of	of	IN	_	5	NMOD
7	thrombus	thrombus	NN	_	8	NMOD
8	stability	stability	NN	_	6	PMOD
9	,	,	,	_	10	P
10	was	be	VBD	_	0	ROOT
11	measured	measure	VBN	_	10	VC
12	as	as	IN	_	11	ADV
13	the	the	DT	_	14	NMOD
14	time	time	NN	_	12	PMOD
15	between	between	IN	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	cessation	cessation	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	bleeding	bleeding	NN	_	18	PMOD
20	and	and	CC	_	17	COORD
21	the	the	DT	_	22	NMOD
22	start	start	NN	_	20	CONJ
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	26	NMOD
25	second	$#ORD#$	JJ	_	26	NMOD
26	bleeding	bleeding	NN	_	23	PMOD
27	(	(	-LRB-	_	29	P
28	Figure	figure	NN	_	29	NMOD
29	2B	0b	NN	_	11	PRN
30	)	)	-RRB-	_	29	P
31	.	.	.	_	10	P

1	Rebleeding	rebleeding	NN	_	2	NMOD
2	times	time	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	significantly	significantly	RB	_	5	AMOD
5	higher	high	JJR	_	3	PRD
6	in	in	IN	_	3	LOC
7	A	a	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	J	j	NN	_	17	NMOD
10	(	(	-LRB-	_	15	P
11	2.6-fold	0-fold	RB	_	15	ADV
12	,	,	,	_	15	P
13	P	p	NN	_	15	SBJ
14	<	<	SYM	_	15	P
15	0.001	0	CD	_	9	PRN
16	)	)	-RRB-	_	15	P
17	mice	mouse	NNS	_	6	PMOD
18	than	than	IN	_	5	AMOD
19	the	the	DT	_	21	NMOD
20	B6	b0	NN	_	21	NMOD
21	mice	mouse	NNS	_	18	PMOD
22	.	.	.	_	3	P

1	In	in	IN	_	7	ADV
2	contrast	contrast	NN	_	1	PMOD
3	,	,	,	_	7	P
4	the	the	DT	_	6	NMOD
5	rebleeding	rebleeding	NN	_	6	NMOD
6	time	time	NN	_	7	SBJ
7	was	be	VBD	_	0	ROOT
8	nearly	nearly	RB	_	10	AMOD
9	8.5-fold	0-fold	RB	_	8	QMOD
10	less	less	JJR	_	7	PRD
11	in	in	IN	_	7	LOC
12	the	the	DT	_	14	NMOD
13	Lepob	lepob	NN	_	14	NMOD
14	mice	mouse	NNS	_	11	PMOD
15	than	than	IN	_	10	AMOD
16	the	the	DT	_	18	NMOD
17	B6	b0	NN	_	18	NMOD
18	mice	mouse	NNS	_	15	PMOD
19	.	.	.	_	7	P

1	To	to	TO	_	26	PRP
2	determine	determine	VB	_	1	IM
3	how	how	WRB	_	10	MNR
4	alterations	alteration	NNS	_	9	SBJ
5	in	in	IN	_	4	NMOD
6	the	the	DT	_	8	NMOD
7	fibrinolytic	fibrinolytic	JJ	_	8	NMOD
8	system	system	NN	_	5	PMOD
9	may	may	MD	_	2	OBJ
10	affect	affect	VB	_	9	VC
11	rebleeding	rebleeding	NN	_	12	NMOD
12	time	time	NN	_	10	OBJ
13	,	,	,	_	26	P
14	Plg	plg	NN	_	25	NMOD
15	-	-	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	-	-	SYM	_	14	P
18	and	and	CC	_	14	COORD
19	PAI	pai	NN	_	18	CONJ
20	-	-	HYPH	_	19	P
21	1	0	CD	_	19	NMOD
22	-	-	SYM	_	19	P
23	/	/	HYPH	_	19	P
24	-	-	SYM	_	19	P
25	mice	mouse	NNS	_	26	SBJ
26	were	be	VBD	_	0	ROOT
27	also	also	RB	_	26	ADV
28	tested	test	VBN	_	26	VC
29	(	(	-LRB-	_	31	P
30	Figure	figure	NN	_	31	NMOD
31	2B	0b	NN	_	28	PRN
32	)	)	-RRB-	_	31	P
33	.	.	.	_	26	P

1	Rebleeding	rebleeding	VBG	_	2	NMOD
2	time	time	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	not	not	RB	_	3	ADV
5	different	different	JJ	_	3	PRD
6	in	in	IN	_	3	LOC
7	Plg	plg	NN	_	11	NMOD
8	-	-	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	-	-	SYM	_	7	P
11	mice	mouse	NNS	_	6	PMOD
12	compared	compare	VBN	_	3	ADV
13	to	to	IN	_	12	PMOD
14	WT	wt	NN	_	15	NMOD
15	littermates	littermates	NNS	_	13	PMOD
16	,	,	,	_	3	P
17	but	but	CC	_	3	COORD
18	PAI	pai	NN	_	24	NMOD
19	-	-	HYPH	_	18	P
20	1	0	CD	_	18	NMOD
21	-	-	SYM	_	18	P
22	/	/	HYPH	_	18	P
23	-	-	SYM	_	18	P
24	mice	mouse	NNS	_	25	SBJ
25	had	have	VBD	_	17	CONJ
26	a	a	DT	_	35	NMOD
27	significantly	significantly	RB	_	33	AMOD
28	(	(	-LRB-	_	31	P
29	P	p	NN	_	31	SBJ
30	<	<	SYM	_	31	P
31	0.05	0	CD	_	27	PRN
32	)	)	-RRB-	_	31	P
33	reduced	reduce	VBN	_	35	NMOD
34	rebleeding	rebleeding	NN	_	35	NMOD
35	time	time	NN	_	25	OBJ
36	,	,	,	_	35	P
37	which	which	WDT	_	38	SBJ
38	was	be	VBD	_	35	NMOD
39	1.8-fold	0-fold	RB	_	40	AMOD
40	lower	low	JJR	_	38	PRD
41	than	than	IN	_	40	AMOD
42	for	for	IN	_	41	PMOD
43	the	the	DT	_	45	NMOD
44	B6	b0	NN	_	45	NMOD
45	mice	mouse	NNS	_	42	PMOD
46	.	.	.	_	3	P

1	Although	although	IN	_	21	ADV
2	a	a	DT	_	4	NMOD
3	Plg	plg	NN	_	4	NMOD
4	deficiency	deficiency	NN	_	5	SBJ
5	did	do	VBD	_	1	SUB
6	not	not	RB	_	5	ADV
7	result	result	VB	_	5	VC
8	in	in	IN	_	7	ADV
9	a	a	DT	_	12	NMOD
10	prolonged	prolonged	JJ	_	12	NMOD
11	rebleeding	rebleeding	NN	_	12	NMOD
12	time	time	NN	_	8	PMOD
13	as	as	IN	_	7	ADV
14	anticipated	anticipate	VBN	_	13	SUB
15	,	,	,	_	21	P
16	a	a	DT	_	20	NMOD
17	PAI	pai	NN	_	20	NMOD
18	-	-	HYPH	_	17	P
19	1	0	CD	_	17	NMOD
20	deficiency	deficiency	NN	_	21	SBJ
21	resulted	result	VBD	_	0	ROOT
22	in	in	IN	_	21	ADV
23	a	a	DT	_	25	NMOD
24	shortened	shorten	VBN	_	25	NMOD
25	time	time	NN	_	22	PMOD
26	.	.	.	_	21	P

1	The	the	DT	_	5	NMOD
2	markedly	markedly	RB	_	3	AMOD
3	increased	increase	VBN	_	5	NMOD
4	rebleeding	rebleeding	NN	_	5	NMOD
5	time	time	NN	_	11	SBJ
6	in	in	IN	_	5	LOC
7	the	the	DT	_	10	NMOD
8	A	a	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	J	j	NN	_	6	PMOD
11	may	may	MD	_	0	ROOT
12	suggest	suggest	VB	_	11	VC
13	differences	difference	NNS	_	12	OBJ
14	in	in	IN	_	13	NMOD
15	the	the	DT	_	16	NMOD
16	regulation	regulation	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	20	NMOD
19	Plg	plg	NN	_	20	NMOD
20	network	network	NN	_	17	PMOD
21	.	.	.	_	11	P

1	No	no	DT	_	2	NMOD
2	difference	difference	NN	_	0	ROOT
3	in	in	IN	_	2	NMOD
4	blood	blood	NN	_	5	NMOD
5	coagulation	coagulation	NN	_	3	PMOD
6	between	between	IN	_	2	NMOD
7	B6	b0	NN	_	12	NMOD
8	and	and	CC	_	7	COORD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	8	CONJ
12	mice	mouse	NNS	_	6	PMOD

1	To	to	TO	_	30	PRP
2	determine	determine	VB	_	1	IM
3	if	if	IN	_	2	OBJ
4	differences	difference	NNS	_	7	SBJ
5	in	in	IN	_	4	NMOD
6	coagulation	coagulation	NN	_	5	PMOD
7	were	be	VBD	_	3	SUB
8	contributing	contribute	VBG	_	9	NMOD
9	factors	factor	NNS	_	7	PRD
10	to	to	IN	_	9	NMOD
11	the	the	DT	_	15	NMOD
12	bleeding	bleeding	NN	_	15	NMOD
13	and	and	CC	_	12	COORD
14	rebleeding	rebleeding	NN	_	13	CONJ
15	results	result	NNS	_	10	PMOD
16	,	,	,	_	30	P
17	prothrombin	prothrombin	NN	_	18	NMOD
18	time	time	NN	_	20	NMOD
19	(	(	-LRB-	_	20	P
20	PT	pt	NN	_	30	SBJ
21	)	)	-RRB-	_	20	P
22	and	and	CC	_	20	COORD
23	activated	activate	VBN	_	26	NMOD
24	partial	partial	JJ	_	26	NMOD
25	thromboplastin	thromboplastin	NN	_	26	NMOD
26	time	time	NN	_	28	NMOD
27	(	(	-LRB-	_	28	P
28	aPTT	aptt	NN	_	22	CONJ
29	)	)	-RRB-	_	30	P
30	were	be	VBD	_	0	ROOT
31	measured	measure	VBN	_	30	VC
32	.	.	.	_	30	P

1	PT	pt	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	a	a	DT	_	4	NMOD
4	measurement	measurement	NN	_	2	PRD
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	9	NMOD
7	extrinsic	extrinsic	JJ	_	9	NMOD
8	coagulation	coagulation	NN	_	9	NMOD
9	pathway	pathway	NN	_	11	NMOD
10	(	(	-LRB-	_	11	P
11	activation	activation	NN	_	5	PMOD
12	of	of	IN	_	11	NMOD
13	Factor	factor	NN	_	12	PMOD
14	VII	vii	CD	_	13	NMOD
15	by	by	IN	_	11	NMOD
16	tissue	tissue	NN	_	17	NMOD
17	factor	factor	NN	_	15	PMOD
18	)	)	-RRB-	_	2	P
19	while	while	IN	_	2	ADV
20	aPTT	aptt	NN	_	21	SBJ
21	is	be	VBZ	_	19	SUB
22	a	a	DT	_	23	NMOD
23	measurement	measurement	NN	_	21	PRD
24	of	of	IN	_	23	NMOD
25	the	the	DT	_	27	NMOD
26	intrinsic	intrinsic	JJ	_	27	NMOD
27	pathway	pathway	NN	_	29	NMOD
28	(	(	-LRB-	_	29	P
29	activation	activation	NN	_	24	PMOD
30	of	of	IN	_	29	NMOD
31	Factors	factor	NN	_	32	NMOD
32	XII	xii	CD	_	30	PMOD
33	,	,	,	_	32	P
34	XI	xi	CD	_	32	CONJ
35	,	,	,	_	34	P
36	IX	ix	CD	_	34	CONJ
37	and	and	CC	_	36	COORD
38	VIII	viii	CD	_	37	CONJ
39	)	)	-RRB-	_	2	P
40	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	products	product	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	both	both	DT	_	5	NMOD
5	pathways	pathway	NNS	_	3	PMOD
6	activate	activate	VBP	_	0	ROOT
7	Factor	factor	NN	_	6	OBJ
8	X	x	CD	_	7	NMOD
9	,	,	,	_	7	P
10	which	which	WDT	_	11	SBJ
11	initiates	initiate	VBZ	_	7	NMOD
12	the	the	DT	_	14	NMOD
13	common	common	JJ	_	14	NMOD
14	pathway	pathway	NN	_	11	OBJ
15	leading	lead	VBG	_	14	NMOD
16	to	to	IN	_	15	ADV
17	thrombin	thrombin	NN	_	18	NMOD
18	generation	generation	NN	_	16	PMOD
19	and	and	CC	_	18	COORD
20	fibrin	fibrin	NN	_	21	NMOD
21	clot	clot	NN	_	22	NMOD
22	formation	formation	NN	_	19	CONJ
23	.	.	.	_	6	P

1	PT	pt	NN	_	4	SBJ
2	and	and	CC	_	1	COORD
3	aPTT	aptt	NN	_	2	CONJ
4	were	be	VBD	_	0	ROOT
5	measured	measure	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	the	the	DT	_	13	NMOD
8	B6	b0	NN	_	13	NMOD
9	and	and	CC	_	8	COORD
10	A	a	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	J	j	NN	_	9	CONJ
13	mice	mouse	NNS	_	6	PMOD
14	and	and	CC	_	4	COORD
15	values	value	NNS	_	16	SBJ
16	were	be	VBD	_	14	CONJ
17	not	not	RB	_	16	ADV
18	different	different	JJ	_	16	PRD
19	between	between	IN	_	18	AMOD
20	the	the	DT	_	23	NMOD
21	two	two	CD	_	23	NMOD
22	mouse	mouse	NN	_	23	NMOD
23	strains	strain	NNS	_	19	PMOD
24	(	(	-LRB-	_	25	P
25	Table	table	NN	_	16	PRN
26	2	0	CD	_	25	NMOD
27	)	)	-RRB-	_	25	P
28	.	.	.	_	4	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	the	the	DT	_	7	NMOD
6	coagulation	coagulation	NN	_	7	NMOD
7	pathway	pathway	NN	_	8	SBJ
8	is	be	VBZ	_	4	SUB
9	not	not	RB	_	8	ADV
10	different	different	JJ	_	8	PRD
11	in	in	IN	_	8	LOC
12	the	the	DT	_	15	NMOD
13	two	two	CD	_	15	NMOD
14	inbred	inbred	JJ	_	15	NMOD
15	strains	strain	NNS	_	11	PMOD
16	.	.	.	_	3	P

1	Table	table	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Coagulation	coagulation	NN	_	5	NMOD
2	and	and	CC	_	1	COORD
3	Plasminogen	plasminogen	NN	_	2	CONJ
4	System	system	NN	_	5	NMOD
5	Parameters	parameter	NNS	_	0	ROOT
6	in	in	IN	_	5	LOC
7	B6	b0	NN	_	14	NMOD
8	and	and	CC	_	7	COORD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	8	CONJ
12	inbred	inbred	JJ	_	14	NMOD
13	mouse	mouse	NN	_	14	NMOD
14	strains	strain	NNS	_	6	PMOD

1	Values	value	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	the	the	DT	_	6	NMOD
4	mean	mean	NN	_	6	NMOD
5	±	±	SYM	_	6	P
6	SEM	sem	NN	_	2	PRD
7	.	.	.	_	2	P

1	*	*	SYM	_	2	P
2	P	p	NN	_	4	SBJ
3	<	<	SYM	_	4	P
4	0.05	0	CD	_	9	DEP
5	,	,	,	_	9	P
6	**	**	SYM	_	7	P
7	P	p	NN	_	9	SBJ
8	<	<	SYM	_	9	P
9	0.01	0	CD	_	0	ROOT
10	.	.	.	_	9	P

1	n	n	NN	_	3	SBJ
2	=	=	SYM	_	3	P
3	5	0	CD	_	0	ROOT
4	–	–	SYM	_	3	P
5	8	0	CD	_	3	QMOD
6	.	.	.	_	3	P

1	Plg	plg	NN	_	0	ROOT
2	and	and	CC	_	1	COORD
3	PAI	pai	NN	_	2	CONJ
4	-	-	HYPH	_	3	P
5	1	0	CD	_	3	NMOD
6	higher	high	JJR	_	1	OPRD
7	in	in	IN	_	1	LOC
8	A	a	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	J	j	NN	_	7	PMOD
11	than	than	IN	_	6	AMOD
12	B6	b0	NN	_	13	NMOD
13	mice	mouse	NNS	_	11	PMOD

1	Plg	plg	NN	_	2	NMOD
2	concentration	concentration	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	34	0	CD	_	5	NMOD
5	%	%	NN	_	6	AMOD
6	higher	high	JJR	_	3	PRD
7	in	in	IN	_	3	LOC
8	the	the	DT	_	12	NMOD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	12	NMOD
12	mice	mouse	NNS	_	7	PMOD
13	than	than	IN	_	6	AMOD
14	in	in	IN	_	13	LOC
15	B6	b0	NN	_	16	NMOD
16	mice	mouse	NNS	_	14	PMOD
17	.	.	.	_	3	P

1	In	in	IN	_	16	ADV
2	addition	addition	NN	_	1	PMOD
3	,	,	,	_	16	P
4	fibrinolytic	fibrinolytic	JJ	_	5	NMOD
5	activity	activity	NN	_	16	SBJ
6	,	,	,	_	5	P
7	PAI	pai	NN	_	10	NMOD
8	-	-	HYPH	_	7	P
9	1	0	CD	_	7	NMOD
10	activity	activity	NN	_	5	CONJ
11	,	,	,	_	10	P
12	and	and	CC	_	10	COORD
13	α2	α0	NN	_	15	NMOD
14	-	-	HYPH	_	13	P
15	anitplasmin	anitplasmin	NN	_	12	CONJ
16	were	be	VBD	_	0	ROOT
17	also	also	RB	_	16	ADV
18	increased	increase	VBN	_	16	VC
19	in	in	IN	_	18	LOC
20	the	the	DT	_	24	NMOD
21	A	a	NN	_	23	NMOD
22	/	/	SYM	_	23	P
23	J	j	NN	_	24	NMOD
24	mice	mouse	NNS	_	19	PMOD
25	when	when	WRB	_	26	TMP
26	compared	compare	VBN	_	18	TMP
27	to	to	IN	_	26	ADV
28	the	the	DT	_	30	NMOD
29	B6	b0	NN	_	30	NMOD
30	mice	mouse	NNS	_	27	PMOD
31	(	(	-LRB-	_	32	P
32	Table	table	NN	_	18	PRN
33	2	0	CD	_	32	NMOD
34	)	)	-RRB-	_	32	P
35	.	.	.	_	16	P

1	The	the	DT	_	3	NMOD
2	functional	functional	JJ	_	3	NMOD
3	consequences	consequence	NNS	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	these	these	DT	_	6	NMOD
6	differences	difference	NNS	_	4	PMOD
7	are	be	VBP	_	0	ROOT
8	not	not	RB	_	7	ADV
9	clear	clear	JJ	_	7	PRD
10	,	,	,	_	7	P
11	since	since	IN	_	7	PRP
12	fibrinogen	fibrinogen	NN	_	13	SBJ
13	is	be	VBZ	_	11	SUB
14	also	also	RB	_	13	ADV
15	higher	high	JJR	_	13	PRD
16	in	in	IN	_	13	LOC
17	the	the	DT	_	21	NMOD
18	A	a	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	J	j	NN	_	21	NMOD
21	mice	mouse	NNS	_	16	PMOD
22	.	.	.	_	7	P

1	To	to	TO	_	28	PRP
2	determine	determine	VB	_	1	IM
3	whether	whether	IN	_	2	OBJ
4	there	there	EX	_	5	SBJ
5	were	be	VBD	_	3	SUB
6	protein	protein	NN	_	7	NMOD
7	structure	structure	NN	_	8	NMOD
8	changes	change	NNS	_	5	PRD
9	of	of	IN	_	8	NMOD
10	Plg	plg	NN	_	9	PMOD
11	from	from	IN	_	8	NMOD
12	the	the	DT	_	16	NMOD
13	A	a	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	J	j	NN	_	16	NMOD
16	mice	mouse	NNS	_	11	PMOD
17	,	,	,	_	28	P
18	plasma	plasma	NN	_	28	SBJ
19	from	from	IN	_	18	NMOD
20	the	the	DT	_	21	NMOD
21	B6	b0	NN	_	19	PMOD
22	and	and	CC	_	21	COORD
23	the	the	DT	_	26	NMOD
24	A	a	NN	_	26	NMOD
25	/	/	HYPH	_	24	P
26	J	j	NN	_	22	CONJ
27	mice	mouse	NNS	_	26	NMOD
28	were	be	VBD	_	0	ROOT
29	subjected	subject	VBN	_	28	VC
30	to	to	IN	_	29	ADV
31	electrophoresis	electrophoresis	NN	_	30	PMOD
32	under	under	IN	_	29	MNR
33	reduced	reduce	VBN	_	35	AMOD
34	,	,	,	_	35	P
35	non-reduced	non-reduced	JJ	_	39	NMOD
36	,	,	,	_	35	P
37	and	and	CC	_	35	COORD
38	non-denaturing	non-denaturing	VBG	_	37	CONJ
39	conditions	condition	NNS	_	32	PMOD
40	.	.	.	_	28	P

1	No	no	DT	_	2	NMOD
2	difference	difference	NN	_	11	SBJ
3	in	in	IN	_	2	NMOD
4	migration	migration	NN	_	3	PMOD
5	for	for	IN	_	2	NMOD
6	immunostained	immunostained	VBN	_	7	NMOD
7	Plg	plg	NN	_	5	PMOD
8	under	under	IN	_	2	NMOD
9	these	these	DT	_	10	NMOD
10	conditions	condition	NNS	_	8	PMOD
11	was	be	VBD	_	0	ROOT
12	observed	observe	VBN	_	11	VC
13	(	(	-LRB-	_	16	P
14	data	datum	NNS	_	16	SBJ
15	not	not	RB	_	16	ADV
16	shown	show	VBN	_	12	PRN
17	)	)	-RRB-	_	16	P
18	.	.	.	_	11	P

1	The	the	DT	_	2	NMOD
2	density	density	NN	_	26	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	Western	western	NNP	_	6	NMOD
6	blot	blot	NN	_	3	PMOD
7	from	from	IN	_	6	NMOD
8	SDS	sd	NN	_	10	NMOD
9	-	-	HYPH	_	8	P
10	PAGE	page	NN	_	7	PMOD
11	under	under	IN	_	2	NMOD
12	reducing	reducing	NN	_	13	NMOD
13	conditions	condition	NNS	_	11	PMOD
14	of	of	IN	_	13	NMOD
15	plasma	plasma	NN	_	14	PMOD
16	of	of	IN	_	15	NMOD
17	varying	vary	VBG	_	18	NMOD
18	volumes	volume	NNS	_	16	PMOD
19	from	from	IN	_	15	NMOD
20	B6	b0	NN	_	25	NMOD
21	and	and	CC	_	20	COORD
22	A	a	NN	_	24	NMOD
23	/	/	HYPH	_	22	P
24	J	j	NN	_	21	CONJ
25	mice	mouse	NNS	_	19	PMOD
26	was	be	VBD	_	0	ROOT
27	compared	compare	VBN	_	26	VC
28	and	and	CC	_	26	COORD
29	the	the	DT	_	30	NMOD
30	density	density	NN	_	34	SBJ
31	of	of	IN	_	30	NMOD
32	the	the	DT	_	33	NMOD
33	bands	band	NNS	_	31	PMOD
34	was	be	VBD	_	28	CONJ
35	56	0	CD	_	36	NMOD
36	%	%	NN	_	37	AMOD
37	higher	high	JJR	_	34	PRD
38	in	in	IN	_	34	LOC
39	the	the	DT	_	42	NMOD
40	A	a	NN	_	42	NMOD
41	/	/	HYPH	_	40	P
42	J	j	NN	_	38	PMOD
43	than	than	IN	_	37	AMOD
44	the	the	DT	_	45	NMOD
45	B6	b0	NN	_	43	PMOD
46	mice	mouse	NNS	_	45	NMOD
47	(	(	-LRB-	_	51	P
48	six	six	CD	_	50	NMOD
49	individual	individual	JJ	_	50	NMOD
50	mice	mouse	NNS	_	51	SBJ
51	were	be	VBD	_	34	PRN
52	tested	test	VBN	_	51	VC
53	on	on	IN	_	52	TMP
54	at	at	RB	_	55	QMOD
55	least	least	RBS	_	57	NMOD
56	two	two	CD	_	55	QMOD
57	occasions	occasion	NNS	_	53	PMOD
58	)	)	-RRB-	_	51	P
59	from	from	IN	_	34	ADV
60	the	the	DT	_	62	NMOD
61	same	same	JJ	_	62	NMOD
62	amount	amount	NN	_	59	PMOD
63	of	of	IN	_	62	NMOD
64	plasma	plasma	NN	_	63	PMOD
65	(	(	-LRB-	_	67	P
66	Fig.	fig.	NN	_	67	NMOD
67	1B	0b	NN	_	34	PRN
68	)	)	-RRB-	_	67	P
69	.	.	.	_	26	P

1	Thus	thus	RB	_	15	ADV
2	,	,	,	_	15	P
3	the	the	DT	_	4	NMOD
4	concentration	concentration	NN	_	15	SBJ
5	of	of	IN	_	4	NMOD
6	Plg	plg	NN	_	5	PMOD
7	in	in	IN	_	4	LOC
8	plasma	plasma	NN	_	7	PMOD
9	from	from	IN	_	8	NMOD
10	the	the	DT	_	14	NMOD
11	A	a	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	J	j	NN	_	14	NMOD
14	mice	mouse	NNS	_	9	PMOD
15	was	be	VBD	_	0	ROOT
16	higher	high	JJR	_	15	PRD
17	than	than	IN	_	16	AMOD
18	plasma	plasma	NN	_	17	PMOD
19	from	from	IN	_	18	NMOD
20	the	the	DT	_	22	NMOD
21	B6	b0	NN	_	22	NMOD
22	mice	mouse	NNS	_	19	PMOD
23	as	as	IN	_	15	ADV
24	determined	determine	VBN	_	23	SUB
25	by	by	IN	_	24	MNR
26	two	two	CD	_	27	NMOD
27	methods	method	NNS	_	25	PMOD
28	and	and	CC	_	15	COORD
29	no	no	DT	_	30	NMOD
30	difference	difference	NN	_	35	SBJ
31	in	in	IN	_	30	NMOD
32	migration	migration	NN	_	31	PMOD
33	after	after	IN	_	30	TMP
34	electrophoresis	electrophoresis	NN	_	33	PMOD
35	was	be	VBD	_	28	CONJ
36	observed	observe	VBN	_	35	VC
37	,	,	,	_	36	P
38	suggesting	suggest	VBG	_	36	ADV
39	no	no	DT	_	41	NMOD
40	marked	marked	JJ	_	41	NMOD
41	changes	change	NNS	_	38	OBJ
42	in	in	IN	_	41	NMOD
43	the	the	DT	_	44	NMOD
44	structure	structure	NN	_	42	PMOD
45	of	of	IN	_	44	NMOD
46	Plg	plg	NN	_	45	PMOD
47	in	in	IN	_	41	LOC
48	the	the	DT	_	51	NMOD
49	two	two	CD	_	51	NMOD
50	mouse	mouse	NN	_	51	NMOD
51	strains	strain	NNS	_	47	PMOD
52	.	.	.	_	15	P

1	Tail	tail	NN	_	2	NMOD
2	morphology	morphology	NN	_	0	ROOT
3	in	in	IN	_	2	LOC
4	B6	b0	NN	_	3	PMOD
5	and	and	CC	_	4	COORD
6	A	a	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	J	j	NN	_	5	CONJ

1	The	the	DT	_	2	NMOD
2	tails	tail	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	mice	mouse	NNS	_	3	PMOD
6	were	be	VBD	_	0	ROOT
7	examined	examine	VBN	_	6	VC
8	for	for	IN	_	7	ADV
9	differences	difference	NNS	_	8	PMOD
10	that	that	WDT	_	11	SBJ
11	might	might	MD	_	9	NMOD
12	account	account	VB	_	11	VC
13	for	for	IN	_	12	ADV
14	the	the	DT	_	15	NMOD
15	variations	variation	NNS	_	13	PMOD
16	in	in	IN	_	15	NMOD
17	the	the	DT	_	21	NMOD
18	bleeding	bleeding	NN	_	21	NMOD
19	and	and	CC	_	18	COORD
20	rebleeding	rebleeding	NN	_	19	CONJ
21	values	value	NNS	_	16	PMOD
22	.	.	.	_	6	P

1	Sections	section	NNS	_	13	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	4	NMOD
4	tail	tail	NN	_	2	PMOD
5	from	from	IN	_	4	NMOD
6	the	the	DT	_	12	NMOD
7	B6	b0	NN	_	12	NMOD
8	and	and	CC	_	7	COORD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	8	CONJ
12	mice	mouse	NNS	_	5	PMOD
13	were	be	VBD	_	0	ROOT
14	stained	stain	VBN	_	13	VC
15	with	with	IN	_	14	MNR
16	Hematoxylin	hematoxylin	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	Eosin	eosin	NN	_	15	PMOD
19	or	or	CC	_	18	COORD
20	Masson	masson	NNP	_	22	NMOD
21	's	's	POS	_	20	NMOD
22	Trichrome	trichrome	NN	_	19	CONJ
23	and	and	CC	_	13	COORD
24	representative	representative	JJ	_	25	NMOD
25	sections	section	NNS	_	26	SBJ
26	are	be	VBP	_	23	CONJ
27	shown	show	VBN	_	26	VC
28	in	in	IN	_	27	ADV
29	Figure	figure	NN	_	28	PMOD
30	3	0	CD	_	29	NMOD
31	.	.	.	_	13	P

1	No	no	DT	_	4	NMOD
2	obvious	obvious	JJ	_	4	NMOD
3	qualitative	qualitative	JJ	_	4	NMOD
4	differences	difference	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	observed	observe	VBN	_	5	VC
7	in	in	IN	_	6	LOC
8	hair	hair	NN	_	9	NMOD
9	follicles	follicle	NNS	_	7	PMOD
10	,	,	,	_	9	P
11	sebaceous	sebaceous	JJ	_	12	NMOD
12	glands	gland	NNS	_	9	CONJ
13	,	,	,	_	12	P
14	or	or	CC	_	12	COORD
15	center	center	NN	_	16	NMOD
16	bone	bone	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	cartilage	cartilage	NN	_	14	CONJ
19	in	in	IN	_	6	LOC
20	Hematoxylin	hematoxylin	NN	_	22	NMOD
21	/	/	HYPH	_	20	P
22	Eosin	eosin	NN	_	27	AMOD
23	(	(	-LRB-	_	25	P
24	Figure	figure	NN	_	25	NMOD
25	3A	0a	NN	_	22	PRN
26	)	)	-RRB-	_	25	P
27	stained	stain	VBN	_	28	NMOD
28	sections	section	NNS	_	19	PMOD
29	.	.	.	_	5	P

1	Sections	section	NNS	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	4	NMOD
4	tails	tail	NNS	_	2	PMOD
5	were	be	VBD	_	0	ROOT
6	stained	stain	VBN	_	5	VC
7	with	with	IN	_	6	MNR
8	Masson	masson	NNP	_	10	NMOD
9	's	's	POS	_	8	NMOD
10	Trichrome	trichrome	NN	_	7	PMOD
11	(	(	-LRB-	_	13	P
12	Figure	figure	NN	_	13	NMOD
13	3B	0b	NN	_	10	PRN
14	)	)	-RRB-	_	13	P
15	that	that	WDT	_	16	SBJ
16	detects	detect	VBZ	_	10	NMOD
17	collagen	collagen	NN	_	16	OBJ
18	,	,	,	_	17	P
19	the	the	DT	_	23	NMOD
20	major	major	JJ	_	23	NMOD
21	platelet	platelet	NN	_	23	NMOD
22	adhesive	adhesive	JJ	_	21	NMOD
23	substratum	substratum	NN	_	17	APPO
24	for	for	IN	_	23	NMOD
25	initiation	initiation	NN	_	24	PMOD
26	of	of	IN	_	25	NMOD
27	thrombus	thrombus	NN	_	28	NMOD
28	formation	formation	NN	_	26	PMOD
29	.	.	.	_	5	P

1	Collagen	collagen	NN	_	2	NMOD
2	content	content	NN	_	8	SBJ
3	(	(	-LRB-	_	6	P
4	%	%	NN	_	6	NMOD
5	tail	tail	NN	_	6	NMOD
6	area	area	NN	_	2	PRN
7	)	)	-RRB-	_	6	P
8	was	be	VBD	_	0	ROOT
9	quantified	quantify	VBN	_	8	VC
10	(	(	-LRB-	_	12	P
11	Figure	figure	NN	_	12	NMOD
12	3C	0c	NN	_	9	PRN
13	)	)	-RRB-	_	12	P
14	from	from	IN	_	9	ADV
15	3	0	CD	_	18	NMOD
16	–	–	SYM	_	15	P
17	4	0	CD	_	15	QMOD
18	sections	section	NNS	_	14	PMOD
19	from	from	IN	_	18	NMOD
20	2	0	CD	_	23	NMOD
21	–	–	SYM	_	20	P
22	3	0	CD	_	20	QMOD
23	areas	area	NNS	_	19	PMOD
24	/	/	SYM	_	25	P
25	mouse	mouse	NN	_	23	NMOD
26	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	amount	amount	NN	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	collagen	collagen	NN	_	3	PMOD
5	was	be	VBD	_	0	ROOT
6	greater	great	JJR	_	5	PRD
7	in	in	IN	_	5	LOC
8	the	the	DT	_	11	NMOD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	7	PMOD
12	than	than	IN	_	6	AMOD
13	the	the	DT	_	15	NMOD
14	B6	b0	NN	_	15	NMOD
15	mice	mouse	NNS	_	12	PMOD
16	(	(	-LRB-	_	19	P
17	P	p	NN	_	19	SBJ
18	<	<	SYM	_	19	P
19	0.05	0	CD	_	5	PRN
20	)	)	-RRB-	_	19	P
21	.	.	.	_	5	P

1	Collagen	collagen	NN	_	13	SBJ
2	in	in	IN	_	1	LOC
3	vessels	vessel	NNS	_	2	PMOD
4	in	in	IN	_	3	LOC
5	adipose	adipose	NN	_	6	NMOD
6	tissue	tissue	NN	_	4	PMOD
7	in	in	IN	_	6	LOC
8	the	the	DT	_	12	NMOD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	12	NMOD
12	mice	mouse	NNS	_	7	PMOD
13	is	be	VBZ	_	0	ROOT
14	also	also	RB	_	13	ADV
15	increased	increase	VBN	_	13	VC
16	compared	compare	VBN	_	15	ADV
17	to	to	IN	_	16	PMOD
18	the	the	DT	_	20	NMOD
19	B6	b0	NN	_	20	NMOD
20	mice	mouse	NNS	_	17	PMOD
21	(	(	-LRB-	_	24	P
22	data	datum	NNS	_	24	SBJ
23	not	not	RB	_	24	ADV
24	shown	show	VBN	_	15	PRN
25	)	)	-RRB-	_	24	P
26	.	.	.	_	13	P

1	Figure	figure	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Tail	tail	NN	_	2	NMOD
2	morphology	morphology	NN	_	0	ROOT
3	and	and	CC	_	2	COORD
4	collagen	collagen	NN	_	3	CONJ
5	.	.	.	_	2	P

1	Tails	tail	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	excised	excise	VBN	_	2	VC
4	,	,	,	_	3	P
5	embedded	embed	VBN	_	3	CONJ
6	in	in	IN	_	5	LOC
7	OCT	oct	NN	_	6	PMOD
8	,	,	,	_	5	P
9	sectioned	section	VBN	_	5	CONJ
10	,	,	,	_	9	P
11	and	and	CC	_	9	COORD
12	stained	stain	VBD	_	11	CONJ
13	with	with	IN	_	12	MNR
14	Hematoxylin	hematoxylin	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	Eosin	eosin	NN	_	13	PMOD
17	or	or	CC	_	16	COORD
18	Masson	masson	NNP	_	20	NMOD
19	's	's	POS	_	18	NMOD
20	Trichrome	trichrome	NN	_	17	CONJ
21	.	.	.	_	2	P

1	Panel	panel	NN	_	2	NMOD
2	A	a	NN	_	5	NMOD
3	:	:	:	_	5	P
4	Representative	representative	JJ	_	5	NMOD
5	sections	section	NNS	_	0	ROOT
6	stained	stain	VBN	_	5	NMOD
7	with	with	IN	_	6	MNR
8	hematoxylin	hematoxylin	NN	_	7	PMOD
9	and	and	CC	_	8	COORD
10	eosin	eosin	NN	_	9	CONJ
11	from	from	IN	_	5	NMOD
12	B6	b0	NN	_	17	NMOD
13	and	and	CC	_	12	COORD
14	A	a	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	J	j	NN	_	13	CONJ
17	mice	mouse	NNS	_	11	PMOD
18	.	.	.	_	5	P

1	Panel	panel	NN	_	2	NMOD
2	B	b	NN	_	5	NMOD
3	:	:	:	_	5	P
4	Representative	representative	JJ	_	5	NMOD
5	sections	section	NNS	_	0	ROOT
6	stained	stain	VBN	_	5	NMOD
7	with	with	IN	_	6	MNR
8	Masson	masson	NNP	_	10	NMOD
9	's	's	POS	_	8	NMOD
10	Trichrome	trichrome	NN	_	7	PMOD
11	from	from	IN	_	5	NMOD
12	B6	b0	NN	_	17	NMOD
13	and	and	CC	_	12	COORD
14	A	a	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	J	j	NN	_	13	CONJ
17	mice	mouse	NNS	_	11	PMOD
18	.	.	.	_	5	P

1	The	the	DT	_	3	NMOD
2	blue	blue	JJ	_	3	NMOD
3	color	color	NN	_	4	SBJ
4	identifies	identify	VBZ	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	collagen	collagen	NN	_	4	OBJ
7	.	.	.	_	4	P

1	Panel	panel	NN	_	2	NMOD
2	C	c	NN	_	0	ROOT
3	:	:	:	_	2	P
4	The	the	DT	_	5	NMOD
5	percentage	percentage	NN	_	25	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	collagen	collagen	NN	_	9	NMOD
9	area	area	NN	_	6	PMOD
10	(	(	-LRB-	_	9	P
11	excluding	exclude	VBG	_	9	NMOD
12	center	center	NN	_	13	NMOD
13	bone	bone	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	cartilage	cartilage	NN	_	11	OBJ
16	)	)	-RRB-	_	5	P
17	of	of	IN	_	5	NMOD
18	the	the	DT	_	21	NMOD
19	total	total	JJ	_	21	NMOD
20	tail	tail	NN	_	21	NMOD
21	area	area	NN	_	17	PMOD
22	of	of	IN	_	21	NMOD
23	each	each	DT	_	24	NMOD
24	section	section	NN	_	22	PMOD
25	was	be	VBD	_	2	DEP
26	determined	determine	VBN	_	25	VC
27	in	in	IN	_	26	ADV
28	3	0	CD	_	31	NMOD
29	–	–	SYM	_	28	P
30	4	0	CD	_	28	QMOD
31	sections	section	NNS	_	27	PMOD
32	at	at	IN	_	26	LOC
33	2	0	CD	_	36	NMOD
34	–	–	SYM	_	33	P
35	3	0	CD	_	33	QMOD
36	sites	site	NNS	_	32	PMOD
37	for	for	IN	_	36	NMOD
38	each	each	DT	_	39	NMOD
39	tail	tail	NN	_	37	PMOD
40	and	and	CC	_	26	COORD
41	averaged	average	VBD	_	40	CONJ
42	for	for	IN	_	41	ADV
43	each	each	DT	_	44	NMOD
44	mouse	mouse	NN	_	42	PMOD
45	.	.	.	_	2	P

1	Values	value	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	the	the	DT	_	6	NMOD
4	mean	mean	NN	_	6	NMOD
5	±	±	SYM	_	6	P
6	SEM	sem	NN	_	2	PRD
7	of	of	IN	_	6	NMOD
8	4	0	CD	_	11	NMOD
9	–	–	SYM	_	8	P
10	8	0	CD	_	8	QMOD
11	mice	mouse	NNS	_	7	PMOD
12	per	per	IN	_	11	NMOD
13	genotype	genotype	NN	_	12	PMOD
14	.	.	.	_	2	P

1	Symbol	symbol	NN	_	2	SBJ
2	indicates	indicate	VBZ	_	0	ROOT
3	a	a	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	2	OBJ
6	(	(	-LRB-	_	10	P
7	*	*	SYM	_	8	P
8	P	p	NN	_	10	SBJ
9	<	<	SYM	_	10	P
10	0.05	0	CD	_	5	PRN
11	)	)	-RRB-	_	10	P
12	between	between	IN	_	5	NMOD
13	B6	b0	NN	_	14	NMOD
14	mice	mouse	NNS	_	12	PMOD
15	determined	determine	VBN	_	5	NMOD
16	by	by	IN	_	15	LGS
17	t	t	NN	_	19	NMOD
18	-	-	HYPH	_	17	P
19	test	test	NN	_	16	PMOD
20	.	.	.	_	2	P

1	Tail	tail	NN	_	2	NMOD
2	bleeding	bleeding	NN	_	3	NMOD
3	assay	assay	NN	_	4	SBJ
4	identifies	identify	VBZ	_	0	ROOT
5	three	three	CD	_	6	NMOD
6	chromosomes	chromosome	NNS	_	4	OBJ
7	with	with	IN	_	6	NMOD
8	QTL	qtl	NN	_	7	PMOD
9	for	for	IN	_	8	NMOD
10	rebleeding	rebleeding	NN	_	9	PMOD
11	in	in	IN	_	4	LOC
12	CSS	cs	NN	_	11	PMOD

1	Using	use	VBG	_	19	MNR
2	the	the	DT	_	7	NMOD
3	tail	tail	NN	_	6	NMOD
4	bleeding	bleeding	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	rebleeding	rebleeding	NN	_	7	NMOD
7	assay	assay	NN	_	1	OBJ
8	as	as	IN	_	1	ADV
9	a	a	DT	_	11	NMOD
10	surrogate	surrogate	JJ	_	11	NMOD
11	marker	marker	NN	_	8	PMOD
12	for	for	IN	_	11	NMOD
13	hemostasis	hemostasis	NN	_	12	PMOD
14	and	and	CC	_	13	COORD
15	thrombosis	thrombosis	NN	_	14	CONJ
16	,	,	,	_	19	P
17	the	the	DT	_	18	NMOD
18	CSS	cs	NN	_	19	SBJ
19	were	be	VBD	_	0	ROOT
20	screened	screen	VBN	_	19	VC
21	.	.	.	_	19	P

1	The	the	DT	_	3	NMOD
2	bleeding	bleeding	NN	_	3	NMOD
3	times	time	NNS	_	17	SBJ
4	(	(	-LRB-	_	6	P
5	Figure	figure	NN	_	6	NMOD
6	4A	0a	NN	_	3	PRN
7	)	)	-RRB-	_	6	P
8	for	for	IN	_	3	NMOD
9	the	the	DT	_	10	NMOD
10	B6	b0	NN	_	8	PMOD
11	and	and	CC	_	10	COORD
12	the	the	DT	_	15	NMOD
13	A	a	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	J	j	NN	_	11	CONJ
16	mice	mouse	NNS	_	15	NMOD
17	were	be	VBD	_	0	ROOT
18	not	not	RB	_	17	ADV
19	different	different	JJ	_	17	PRD
20	,	,	,	_	17	P
21	but	but	CC	_	17	COORD
22	6six	0six	NN	_	44	SBJ
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	25	NMOD
25	strains	strain	NNS	_	23	PMOD
26	,	,	,	_	22	P
27	B6	b0	NN	_	29	NMOD
28	-	-	HYPH	_	27	P
29	Chr5	chr0	NN	_	22	APPO
30	,	,	,	_	29	P
31	6	0	CD	_	29	CONJ
32	,	,	,	_	31	P
33	8	0	CD	_	31	CONJ
34	,	,	,	_	33	P
35	14	0	CD	_	33	CONJ
36	,	,	,	_	35	P
37	15	0	CD	_	35	CONJ
38	,	,	,	_	37	P
39	and	and	CC	_	37	COORD
40	YA	ya	NN	_	42	NMOD
41	/	/	HYPH	_	40	P
42	J	j	NN	_	39	CONJ
43	,	,	,	_	44	P
44	had	have	VBD	_	21	CONJ
45	lower	low	JJR	_	52	NMOD
46	(	(	-LRB-	_	49	P
47	P	p	NN	_	49	SBJ
48	<	<	SYM	_	49	P
49	0.002	0	CD	_	45	PRN
50	)	)	-RRB-	_	49	P
51	bleeding	bleeding	NN	_	52	NMOD
52	times	time	NNS	_	57	NMOD
53	(	(	-LRB-	_	57	P
54	49	0	CD	_	57	NMOD
55	–	–	SYM	_	54	P
56	79	0	CD	_	54	QMOD
57	seconds	second	NNS	_	44	OBJ
58	)	)	-RRB-	_	44	P
59	compared	compare	VBN	_	44	ADV
60	to	to	IN	_	59	PMOD
61	the	the	DT	_	62	NMOD
62	value	value	NN	_	69	NMOD
63	for	for	IN	_	62	NMOD
64	the	the	DT	_	66	NMOD
65	B6	b0	NN	_	66	NMOD
66	mice	mouse	NNS	_	63	PMOD
67	(	(	-LRB-	_	69	P
68	121	0	CD	_	69	NMOD
69	sec	sec	NN	_	60	PMOD
70	)	)	-RRB-	_	17	P
71	.	.	.	_	17	P

1	The	the	DT	_	3	NMOD
2	rebleeding	rebleeding	NN	_	3	NMOD
3	time	time	NN	_	23	SBJ
4	(	(	-LRB-	_	6	P
5	Figure	figure	NN	_	6	NMOD
6	4B	0b	NN	_	3	PRN
7	)	)	-RRB-	_	6	P
8	,	,	,	_	3	P
9	determined	determine	VBN	_	3	NMOD
10	as	as	IN	_	9	ADV
11	the	the	DT	_	12	NMOD
12	time	time	NN	_	10	PMOD
13	between	between	IN	_	12	TMP
14	bleeding	bleeding	NN	_	15	NMOD
15	cessation	cessation	NN	_	13	PMOD
16	and	and	CC	_	15	COORD
17	initiation	initiation	NN	_	16	CONJ
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	21	NMOD
20	second	$#ORD#$	JJ	_	21	NMOD
21	bleeding	bleeding	NN	_	18	PMOD
22	,	,	,	_	23	P
23	was	be	VBD	_	0	ROOT
24	markedly	markedly	RB	_	23	ADV
25	increased	increase	VBN	_	23	VC
26	in	in	IN	_	25	LOC
27	the	the	DT	_	31	NMOD
28	A	a	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	J	j	NN	_	31	NMOD
31	mice	mouse	NNS	_	26	PMOD
32	compared	compare	VBN	_	25	ADV
33	to	to	IN	_	32	PMOD
34	the	the	DT	_	36	NMOD
35	B6	b0	NN	_	36	NMOD
36	mice	mouse	NNS	_	33	PMOD
37	and	and	CC	_	23	COORD
38	two	two	CD	_	39	NMOD
39	strains	strain	NNS	_	63	SBJ
40	,	,	,	_	39	P
41	B6	b0	NN	_	43	NMOD
42	-	-	HYPH	_	41	P
43	Chr11A	chr0a	NN	_	45	NMOD
44	/	/	HYPH	_	43	P
45	J	j	NN	_	47	NMOD
46	(	(	-LRB-	_	47	P
47	CSS	cs	NN	_	39	APPO
48	-	-	HYPH	_	47	P
49	11	0	CD	_	47	NMOD
50	)	)	-RRB-	_	47	P
51	and	and	CC	_	47	COORD
52	B6	b0	NN	_	54	NMOD
53	-	-	HYPH	_	52	P
54	Chr17A	chr0a	NN	_	56	NMOD
55	/	/	HYPH	_	54	P
56	J	j	NN	_	58	NMOD
57	(	(	-LRB-	_	58	P
58	CSS	cs	NN	_	51	CONJ
59	-	-	HYPH	_	58	P
60	17	0	CD	_	58	NMOD
61	)	)	-RRB-	_	63	P
62	,	,	,	_	63	P
63	had	have	VBD	_	37	CONJ
64	significantly	significantly	RB	_	70	AMOD
65	(	(	-LRB-	_	68	P
66	P	p	NN	_	68	SBJ
67	<	<	SYM	_	68	P
68	0.002	0	CD	_	64	PRN
69	)	)	-RRB-	_	68	P
70	longer	long	JJR	_	72	NMOD
71	rebleeding	rebleeding	NN	_	72	NMOD
72	times	time	NNS	_	63	OBJ
73	compared	compare	VBN	_	63	ADV
74	to	to	IN	_	73	PMOD
75	the	the	DT	_	77	NMOD
76	B6	b0	NN	_	77	NMOD
77	mice	mouse	NNS	_	74	PMOD
78	that	that	WDT	_	79	SBJ
79	were	be	VBD	_	77	NMOD
80	similar	similar	JJ	_	79	PRD
81	to	to	IN	_	80	AMOD
82	values	value	NNS	_	81	PMOD
83	from	from	IN	_	82	NMOD
84	the	the	DT	_	88	NMOD
85	A	a	NN	_	87	NMOD
86	/	/	HYPH	_	85	P
87	J	j	NN	_	88	NMOD
88	mice	mouse	NNS	_	83	PMOD
89	.	.	.	_	23	P

1	Another	another	DT	_	2	NMOD
2	strain	strain	NN	_	15	SBJ
3	,	,	,	_	2	P
4	B6	b0	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	Chr5A	chr0a	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	J	j	NN	_	10	NMOD
9	(	(	-LRB-	_	10	P
10	CSS	cs	NN	_	2	APPO
11	-	-	HYPH	_	10	P
12	5	0	CD	_	10	NMOD
13	)	)	-RRB-	_	15	P
14	,	,	,	_	15	P
15	approached	approach	VBN	_	0	ROOT
16	significance	significance	NN	_	15	OBJ
17	at	at	IN	_	15	ADV
18	P	p	NN	_	17	PMOD
19	<	<	SYM	_	20	P
20	0.008	0	CD	_	18	NMOD
21	.	.	.	_	15	P

1	The	the	DT	_	3	NMOD
2	rebleeding	rebleeding	NN	_	3	NMOD
3	time	time	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	stopped	stop	VBN	_	4	VC
6	at	at	IN	_	5	TMP
7	600	0	CD	_	8	NMOD
8	sec	sec	NN	_	6	PMOD
9	,	,	,	_	4	P
10	and	and	CC	_	4	COORD
11	the	the	DT	_	12	NMOD
12	percentage	percentage	NN	_	18	SBJ
13	of	of	IN	_	12	NMOD
14	mice	mouse	NNS	_	13	PMOD
15	with	with	IN	_	14	NMOD
16	this	this	DT	_	17	NMOD
17	value	value	NN	_	15	PMOD
18	determined	determine	VBN	_	10	GAP
19	for	for	IN	_	18	ADV
20	the	the	DT	_	22	NMOD
21	three	three	CD	_	22	NMOD
22	strains	strain	NNS	_	19	PMOD
23	:	:	:	_	4	P
24	CSS	cs	NN	_	4	DEP
25	-	-	HYPH	_	24	P
26	5	0	CD	_	24	NMOD
27	–	–	:	_	24	P
28	60	0	CD	_	29	NMOD
29	%	%	NN	_	24	DEP
30	,	,	,	_	24	P
31	CSS	cs	NN	_	24	CONJ
32	-	-	HYPH	_	31	P
33	11	0	CD	_	31	NMOD
34	–	–	:	_	31	P
35	60	0	NN	_	36	NMOD
36	%	%	NN	_	31	DEP
37	and	and	CC	_	31	COORD
38	CSS	cs	NN	_	40	NMOD
39	-	-	HYPH	_	38	P
40	A17	a0	NN	_	37	CONJ
41	–	–	:	_	40	P
42	46	0	CD	_	43	NMOD
43	%	%	NN	_	40	DEP
44	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	percentage	percentage	NN	_	13	SBJ
3	of	of	IN	_	2	NMOD
4	B6	b0	NN	_	5	NMOD
5	mice	mouse	NNS	_	3	PMOD
6	with	with	IN	_	2	NMOD
7	a	a	DT	_	9	NMOD
8	rebleeding	rebleeding	NN	_	9	NMOD
9	time	time	NN	_	6	PMOD
10	of	of	IN	_	9	NMOD
11	600	0	CD	_	12	NMOD
12	sec	sec	NN	_	10	PMOD
13	was	be	VBD	_	0	ROOT
14	7	0	CD	_	15	NMOD
15	%	%	NN	_	13	PRD
16	and	and	CC	_	13	COORD
17	for	for	IN	_	25	ADV
18	the	the	DT	_	22	NMOD
19	A	a	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	J	j	NN	_	22	NMOD
22	mice	mouse	NNS	_	17	PMOD
23	the	the	DT	_	24	NMOD
24	percentage	percentage	NN	_	25	SBJ
25	was	be	VBD	_	16	CONJ
26	85	0	CD	_	27	NMOD
27	%	%	NN	_	25	PRD
28	.	.	.	_	13	P

1	Figure	figure	NN	_	0	ROOT
2	4	0	CD	_	1	NMOD

1	Bleeding	bleeding	NN	_	4	NMOD
2	and	and	CC	_	1	COORD
3	rebleeding	rebleeding	NN	_	2	CONJ
4	time	time	NN	_	0	ROOT
5	in	in	IN	_	4	LOC
6	the	the	DT	_	7	NMOD
7	CSS	cs	NN	_	5	PMOD
8	.	.	.	_	4	P

1	Panel	panel	NN	_	2	NMOD
2	A	a	NN	_	5	NMOD
3	:	:	:	_	5	P
4	Bleeding	bleeding	NN	_	5	NMOD
5	Time	time	NN	_	0	ROOT
6	(	(	-LRB-	_	7	P
7	seconds	second	NNS	_	5	PRN
8	)	)	-RRB-	_	7	P
9	.	.	.	_	5	P

1	Panel	panel	NN	_	2	NMOD
2	B	b	NN	_	5	NMOD
3	:	:	:	_	5	P
4	Rebleeding	rebleeding	NN	_	5	NMOD
5	Time	time	NN	_	0	ROOT
6	(	(	-LRB-	_	7	P
7	seconds	second	NNS	_	5	PRN
8	)	)	-RRB-	_	7	P
9	.	.	.	_	5	P

1	Bars	bar	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	the	the	DT	_	6	NMOD
4	mean	mean	NN	_	6	NMOD
5	±	±	SYM	_	6	P
6	SEM	sem	NN	_	2	PRD
7	of	of	IN	_	6	NMOD
8	7	0	CD	_	11	NMOD
9	–	–	SYM	_	8	P
10	28	0	CD	_	8	QMOD
11	mice	mouse	NNS	_	7	PMOD
12	.	.	.	_	2	P

1	Statistical	statistical	JJ	_	2	NMOD
2	differences	difference	NNS	_	8	SBJ
3	between	between	IN	_	2	NMOD
4	B6	b0	NN	_	5	NMOD
5	mice	mouse	NNS	_	3	PMOD
6	and	and	CC	_	5	COORD
7	CSS	cs	NN	_	6	CONJ
8	were	be	VBD	_	0	ROOT
9	determined	determine	VBN	_	8	VC
10	with	with	IN	_	9	MNR
11	a	a	DT	_	14	NMOD
12	t	t	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	test	test	NN	_	10	PMOD
15	,	,	,	_	8	P
16	and	and	CC	_	8	COORD
17	a	a	DT	_	19	NMOD
18	Bonferroni	bonferroni	NNP	_	19	NMOD
19	correction	correction	NN	_	20	SBJ
20	was	be	VBD	_	16	CONJ
21	made	make	VBN	_	20	VC
22	to	to	TO	_	21	PRP
23	determine	determine	VB	_	22	IM
24	significance	significance	NN	_	25	NMOD
25	value	value	NN	_	23	OBJ
26	(	(	-LRB-	_	29	P
27	P	p	NN	_	29	SBJ
28	<	<	SYM	_	29	P
29	0.002	0	CD	_	25	PRN
30	)	)	-RRB-	_	29	P
31	.	.	.	_	8	P

1	Symbols	symbol	NNS	_	2	SBJ
2	indicate	indicate	VBP	_	0	ROOT
3	a	a	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	2	OBJ
6	between	between	IN	_	5	NMOD
7	B6	b0	NN	_	8	NMOD
8	values	value	NNS	_	6	PMOD
9	.	.	.	_	2	P

1	*	*	SYM	_	2	P
2	P	p	NN	_	4	SBJ
3	<	<	SYM	_	4	P
4	0.002	0	CD	_	0	ROOT
5	.	.	.	_	4	P

1	Rebleeding	rebleeding	NN	_	2	NMOD
2	time	time	NN	_	9	SBJ
3	in	in	IN	_	2	LOC
4	the	the	DT	_	6	NMOD
5	parent	parent	NN	_	6	NMOD
6	strains	strain	NNS	_	3	PMOD
7	and	and	CC	_	6	COORD
8	CSS	cs	NN	_	7	CONJ
9	were	be	VBD	_	0	ROOT
10	compared	compare	VBN	_	9	VC
11	to	to	IN	_	10	ADV
12	values	value	NNS	_	11	PMOD
13	from	from	IN	_	12	NMOD
14	the	the	DT	_	15	NMOD
15	progeny	progeny	NN	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	mice	mouse	NNS	_	16	PMOD
18	that	that	WDT	_	19	SBJ
19	were	be	VBD	_	17	NMOD
20	crossed	cross	VBN	_	19	VC
21	with	with	IN	_	20	ADV
22	B6	b0	NN	_	23	NMOD
23	mice	mouse	NNS	_	21	PMOD
24	to	to	TO	_	20	PRP
25	produce	produce	VB	_	24	IM
26	heterosomic	heterosomic	JJ	_	27	NMOD
27	mice	mouse	NNS	_	25	OBJ
28	for	for	IN	_	25	ADV
29	the	the	DT	_	50	NMOD
30	CSS	cs	NN	_	35	NMOD
31	-	-	HYPH	_	30	P
32	5	0	CD	_	30	NMOD
33	,	,	,	_	35	P
34	(	(	-LRB-	_	35	P
35	B6xCSS	b0xcss	NN	_	39	NMOD
36	-	-	HYPH	_	35	P
37	5	0	CD	_	35	NMOD
38	)	)	-RRB-	_	39	P
39	F1	f0	NN	_	50	NMOD
40	and	and	CC	_	39	COORD
41	CSS	cs	NN	_	45	NMOD
42	-	-	HYPH	_	41	P
43	17	0	CD	_	41	NMOD
44	(	(	-LRB-	_	45	P
45	B6xCSS	b0xcss	NN	_	49	NMOD
46	-	-	HYPH	_	45	P
47	17	0	CD	_	45	NMOD
48	)	)	-RRB-	_	49	P
49	F1	f0	NN	_	40	CONJ
50	strains	strain	NNS	_	28	PMOD
51	(	(	-LRB-	_	52	P
52	Figure	figure	NN	_	25	PRN
53	5	0	CD	_	52	NMOD
54	)	)	-RRB-	_	52	P
55	.	.	.	_	9	P

1	The	the	DT	_	3	NMOD
2	rebleeding	rebleeding	NN	_	3	NMOD
3	values	value	NNS	_	13	SBJ
4	for	for	IN	_	3	NMOD
5	CSS	cs	NN	_	7	NMOD
6	-	-	HYPH	_	5	P
7	5F1	0f0	NN	_	12	NMOD
8	and	and	CC	_	7	COORD
9	CSS	cs	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	17F1	0f0	NN	_	8	CONJ
12	mice	mouse	NNS	_	4	PMOD
13	were	be	VBD	_	0	ROOT
14	similar	similar	JJ	_	13	PRD
15	to	to	IN	_	14	AMOD
16	the	the	DT	_	17	NMOD
17	B6	b0	NN	_	15	PMOD
18	rather	rather	RB	_	19	ADV
19	than	than	IN	_	17	COORD
20	the	the	DT	_	23	NMOD
21	A	a	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	J	j	NN	_	19	CONJ
24	mice	mouse	NNS	_	23	NMOD
25	,	,	,	_	13	P
26	suggesting	suggest	VBG	_	13	ADV
27	the	the	DT	_	31	NMOD
28	A	a	NN	_	30	NMOD
29	/	/	HYPH	_	28	P
30	J	j	NN	_	31	NMOD
31	trait	trait	NN	_	32	SBJ
32	is	be	VBZ	_	26	OBJ
33	recessive	recessive	JJ	_	32	PRD
34	.	.	.	_	13	P

1	Bleeding	bleeding	NN	_	31	SBJ
2	and	and	CC	_	1	COORD
3	rebleeding	rebleeding	NN	_	2	CONJ
4	in	in	IN	_	1	NMOD
5	the	the	DT	_	6	NMOD
6	progeny	progeny	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	the	the	DT	_	9	NMOD
9	cross	cross	NN	_	7	PMOD
10	,	,	,	_	9	P
11	B6	b0	NN	_	15	NMOD
12	-	-	HYPH	_	11	P
13	Chr5A	chr0a	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	J	j	NN	_	21	NMOD
16	×	×	SYM	_	21	P
17	B6	b0	NN	_	21	NMOD
18	-	-	HYPH	_	17	P
19	Chr17A	chr0a	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	J	j	NN	_	27	NMOD
22	(	(	-LRB-	_	27	P
23	CSS	cs	NN	_	27	NMOD
24	-	-	HYPH	_	23	P
25	5	0	CD	_	23	NMOD
26	×	×	SYM	_	27	P
27	CSS	cs	NN	_	9	APPO
28	-	-	HYPH	_	27	P
29	17	0	CD	_	27	NMOD
30	)	)	-RRB-	_	31	P
31	resulted	result	VBD	_	0	ROOT
32	in	in	IN	_	31	ADV
33	the	the	DT	_	34	NMOD
34	recovery	recovery	NN	_	32	PMOD
35	of	of	IN	_	34	NMOD
36	the	the	DT	_	40	NMOD
37	A	a	NN	_	39	NMOD
38	/	/	HYPH	_	37	P
39	J	j	NN	_	40	NMOD
40	phenotype	phenotype	NN	_	35	PMOD
41	in	in	IN	_	34	LOC
42	the	the	DT	_	43	NMOD
43	progeny	progeny	NN	_	41	PMOD
44	of	of	IN	_	43	NMOD
45	these	these	DT	_	48	NMOD
46	double	double	JJ	_	47	AMOD
47	heterosomic	heterosomic	JJ	_	48	NMOD
48	strains	strain	NNS	_	44	PMOD
49	.	.	.	_	31	P

1	Thus	thus	RB	_	26	ADV
2	,	,	,	_	26	P
3	despite	despite	IN	_	26	ADV
4	the	the	DT	_	6	NMOD
5	heterosomic	heterosomic	JJ	_	6	NMOD
6	chromosomes	chromosome	NNS	_	3	PMOD
7	of	of	IN	_	6	NMOD
8	5	0	CD	_	7	PMOD
9	and	and	CC	_	8	COORD
10	17	0	CD	_	9	CONJ
11	in	in	IN	_	6	LOC
12	the	the	DT	_	13	NMOD
13	progeny	progeny	NN	_	11	PMOD
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	20	NMOD
16	CSS	cs	NN	_	20	NMOD
17	-	-	HYPH	_	16	P
18	5	0	CD	_	16	NMOD
19	×	×	SYM	_	20	P
20	CSS	cs	NN	_	14	PMOD
21	-	-	HYPH	_	20	P
22	17	0	CD	_	20	NMOD
23	,	,	,	_	26	P
24	the	the	DT	_	25	NMOD
25	phenotype	phenotype	NN	_	26	SBJ
26	was	be	VBD	_	0	ROOT
27	now	now	RB	_	26	ADV
28	similar	similar	JJ	_	26	PRD
29	to	to	IN	_	28	AMOD
30	A	a	NN	_	32	NMOD
31	/	/	HYPH	_	30	P
32	J	j	NN	_	29	PMOD
33	.	.	.	_	26	P

1	This	this	DT	_	2	SBJ
2	suggested	suggest	VBD	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	traits	trait	NNS	_	11	SBJ
5	on	on	IN	_	4	NMOD
6	the	the	DT	_	10	NMOD
7	A	a	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	J	j	NN	_	10	NMOD
10	chromosomes	chromosome	NNS	_	5	PMOD
11	were	be	VBD	_	3	SUB
12	interacting	interact	VBG	_	11	VC
13	to	to	TO	_	12	PRP
14	produce	produce	VB	_	13	IM
15	the	the	DT	_	16	NMOD
16	phenotype	phenotype	NN	_	14	OBJ
17	.	.	.	_	2	P

1	Figure	figure	NN	_	0	ROOT
2	5	0	CD	_	1	NMOD

1	Bleeding	bleeding	NN	_	4	NMOD
2	and	and	CC	_	1	COORD
3	rebleeding	rebleeding	NN	_	2	CONJ
4	time	time	NN	_	0	ROOT
5	in	in	IN	_	4	NMOD
6	the	the	DT	_	8	NMOD
7	CSS	cs	NN	_	8	NMOD
8	backcrosses	backcrosses	NNS	_	5	PMOD
9	.	.	.	_	4	P

1	Panel	panel	NN	_	2	NMOD
2	A	a	NN	_	5	NMOD
3	:	:	:	_	5	P
4	Bleeding	bleeding	NN	_	5	NMOD
5	Time	time	NN	_	18	SBJ
6	(	(	-LRB-	_	7	P
7	seconds	second	NNS	_	5	PRN
8	)	)	-RRB-	_	7	P
9	and	and	CC	_	5	COORD
10	Panel	panel	NN	_	11	NMOD
11	B	b	NN	_	14	NMOD
12	:	:	:	_	14	P
13	Rebleeding	rebleeding	NN	_	14	NMOD
14	Time	time	NN	_	9	CONJ
15	(	(	-LRB-	_	16	P
16	seconds	second	NNS	_	14	PRN
17	)	)	-RRB-	_	16	P
18	were	be	VBD	_	0	ROOT
19	tested	test	VBN	_	18	VC
20	in	in	IN	_	19	LOC
21	heterosomic	heterosomic	JJ	_	22	NMOD
22	mice	mouse	NNS	_	20	PMOD
23	,	,	,	_	22	P
24	(	(	-LRB-	_	29	P
25	B6xCSS	b0xcss	NN	_	29	NMOD
26	-	-	HYPH	_	25	P
27	5	0	CD	_	25	NMOD
28	)	)	-RRB-	_	29	P
29	F1	f0	NN	_	31	NMOD
30	(	(	-LRB-	_	31	P
31	5F1	0f0	NN	_	22	APPO
32	)	)	-RRB-	_	31	P
33	and	and	CC	_	31	COORD
34	(	(	-LRB-	_	41	P
35	B6xCSS	b0xcss	NN	_	39	NMOD
36	-	-	HYPH	_	35	P
37	17	0	CD	_	35	NMOD
38	)	)	-RRB-	_	39	P
39	F1	f0	NN	_	41	NMOD
40	(	(	-LRB-	_	41	P
41	17F1	0f0	NN	_	33	CONJ
42	)	)	-RRB-	_	22	P
43	and	and	CC	_	22	COORD
44	doubly	doubly	RB	_	45	AMOD
45	heterosomic	heterosomic	JJ	_	46	NMOD
46	mice	mouse	NNS	_	55	NMOD
47	for	for	IN	_	46	NMOD
48	chromosomes	chromosome	NNS	_	49	NMOD
49	5	0	CD	_	47	PMOD
50	and	and	CC	_	49	COORD
51	17	0	CD	_	50	CONJ
52	(	(	-LRB-	_	55	P
53	5	0	CD	_	55	NMOD
54	×	×	SYM	_	55	P
55	17	0	CD	_	43	CONJ
56	)	)	-RRB-	_	18	P
57	.	.	.	_	18	P

1	Bars	bar	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	the	the	DT	_	6	NMOD
4	mean	mean	NN	_	6	NMOD
5	±	±	SYM	_	6	P
6	SEM	sem	NN	_	2	PRD
7	of	of	IN	_	6	NMOD
8	5	0	CD	_	12	NMOD
9	–	–	SYM	_	8	P
10	2	0	CD	_	8	QMOD
11	8	0	CD	_	8	QMOD
12	mice	mouse	NNS	_	7	PMOD
13	.	.	.	_	2	P

1	Statistical	statistical	JJ	_	2	NMOD
2	differences	difference	NNS	_	9	SBJ
3	between	between	IN	_	2	NMOD
4	B6	b0	NN	_	5	NMOD
5	mice	mouse	NNS	_	3	PMOD
6	and	and	CC	_	5	COORD
7	the	the	DT	_	8	NMOD
8	CSS	cs	NN	_	6	CONJ
9	were	be	VBD	_	0	ROOT
10	determined	determine	VBN	_	9	VC
11	with	with	IN	_	10	MNR
12	a	a	DT	_	15	NMOD
13	t	t	NN	_	15	NMOD
14	-	-	HYPH	_	13	P
15	test	test	NN	_	11	PMOD
16	,	,	,	_	9	P
17	and	and	CC	_	9	COORD
18	a	a	DT	_	20	NMOD
19	Bonferroni	bonferroni	NNP	_	20	NMOD
20	correction	correction	NN	_	21	SBJ
21	was	be	VBD	_	17	CONJ
22	made	make	VBN	_	21	VC
23	to	to	TO	_	22	PRP
24	determine	determine	VB	_	23	IM
25	significance	significance	NN	_	26	NMOD
26	value	value	NN	_	24	OBJ
27	(	(	-LRB-	_	30	P
28	P	p	NN	_	30	SBJ
29	<	<	SYM	_	30	P
30	0.01	0	CD	_	26	PRN
31	)	)	-RRB-	_	30	P
32	.	.	.	_	9	P

1	Symbols	symbol	NNS	_	2	SBJ
2	indicate	indicate	VBP	_	0	ROOT
3	a	a	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	2	OBJ
6	between	between	IN	_	5	NMOD
7	B6	b0	NN	_	8	NMOD
8	values	value	NNS	_	6	PMOD
9	.	.	.	_	2	P

1	*	*	SYM	_	4	P
2	P	p	NN	_	4	SBJ
3	<	<	SYM	_	4	P
4	0.01	0	CD	_	0	ROOT
5	.	.	.	_	4	P

1	Interactions	interaction	NNS	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	CSS	cs	NN	_	2	PMOD
4	for	for	IN	_	1	NMOD
5	PAI	pai	NN	_	8	NMOD
6	-	-	HYPH	_	5	P
7	1	0	CD	_	5	NMOD
8	antigen	antigen	NN	_	4	PMOD
9	and	and	CC	_	8	COORD
10	activity	activity	NN	_	9	CONJ

1	Components	component	NNS	_	6	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	Plg	plg	NN	_	5	NMOD
5	system	system	NN	_	2	PMOD
6	reside	reside	VBP	_	0	ROOT
7	on	on	IN	_	6	LOC
8	chromosomes	chromosome	NNS	_	13	NMOD
9	CSS	cs	NN	_	13	NMOD
10	-	-	HYPH	_	9	P
11	5	0	CD	_	9	NMOD
12	(	(	-LRB-	_	13	P
13	PAI	pai	NN	_	7	PMOD
14	-	-	HYPH	_	13	P
15	1	0	CD	_	13	NMOD
16	)	)	-RRB-	_	13	P
17	,	,	,	_	13	P
18	CSS	cs	NN	_	24	NMOD
19	-	-	HYPH	_	18	P
20	11	0	CD	_	18	NMOD
21	(	(	-LRB-	_	24	P
22	α2	α0	NN	_	24	NMOD
23	-	-	HYPH	_	22	P
24	antiplasmin	antiplasmin	NN	_	13	CONJ
25	)	)	-RRB-	_	24	P
26	,	,	,	_	24	P
27	and	and	CC	_	24	COORD
28	CSS	cs	NN	_	32	NMOD
29	-	-	HYPH	_	28	P
30	17	0	CD	_	28	NMOD
31	(	(	-LRB-	_	32	P
32	Plg	plg	NN	_	27	CONJ
33	)	)	-RRB-	_	6	P
34	.	.	.	_	6	P

1	As	as	IN	_	12	ADV
2	reported	report	VBN	_	1	SUB
3	in	in	IN	_	2	ADV
4	Table	table	NN	_	3	PMOD
5	2	0	CD	_	4	NMOD
6	,	,	,	_	12	P
7	the	the	DT	_	11	NMOD
8	A	a	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	J	j	NN	_	11	NMOD
11	mice	mouse	NNS	_	12	SBJ
12	had	have	VBD	_	0	ROOT
13	increased	increase	VBN	_	15	NMOD
14	Plg	plg	NN	_	15	NMOD
15	antigen	antigen	NN	_	12	OBJ
16	,	,	,	_	15	P
17	fibrinolytic	fibrinolytic	JJ	_	18	NMOD
18	activity	activity	NN	_	15	CONJ
19	,	,	,	_	18	P
20	α2	α0	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	antiplasmin	antiplasmin	NN	_	18	CONJ
23	,	,	,	_	22	P
24	PAI	pai	NN	_	27	NMOD
25	-	-	HYPH	_	24	P
26	1	0	CD	_	24	NMOD
27	activity	activity	NN	_	22	CONJ
28	and	and	CC	_	27	COORD
29	fibrinogen	fibrinogen	NN	_	28	CONJ
30	when	when	WRB	_	31	TMP
31	compared	compare	VBN	_	12	TMP
32	to	to	IN	_	31	ADV
33	B6	b0	NN	_	34	NMOD
34	mice	mouse	NNS	_	32	PMOD
35	.	.	.	_	12	P

1	In	in	IN	_	10	LOC
2	CSS	cs	NN	_	5	NMOD
3	-	-	HYPH	_	2	P
4	17	0	CD	_	2	NMOD
5	mice	mouse	NNS	_	1	PMOD
6	,	,	,	_	10	P
7	the	the	DT	_	9	NMOD
8	Plg	plg	NN	_	9	NMOD
9	antigen	antigen	NN	_	10	SBJ
10	was	be	VBD	_	0	ROOT
11	also	also	RB	_	10	ADV
12	significantly	significantly	RB	_	18	AMOD
13	(	(	-LRB-	_	16	P
14	P	p	NN	_	16	SBJ
15	=	=	SYM	_	16	P
16	0.015	0	CD	_	12	PRN
17	)	)	-RRB-	_	16	P
18	increased	increased	JJ	_	10	PRD
19	(	(	-LRB-	_	26	P
20	152	0	CD	_	22	NMOD
21	±	±	SYM	_	22	P
22	6	0	CD	_	26	DEP
23	,	,	,	_	26	P
24	n	n	NN	_	26	SBJ
25	=	=	SYM	_	26	P
26	12	0	CD	_	18	PRN
27	)	)	-RRB-	_	26	P
28	when	when	WRB	_	29	TMP
29	compared	compare	VBN	_	10	TMP
30	to	to	IN	_	29	ADV
31	the	the	DT	_	33	NMOD
32	B6	b0	NN	_	33	NMOD
33	mice	mouse	NNS	_	30	PMOD
34	,	,	,	_	10	P
35	but	but	CC	_	10	COORD
36	for	for	IN	_	50	ADV
37	CSS	cs	NN	_	36	PMOD
38	-	-	HYPH	_	37	P
39	5	0	CD	_	37	NMOD
40	and	and	CC	_	37	COORD
41	CSS	cs	NN	_	40	CONJ
42	-	-	HYPH	_	41	P
43	5	0	CD	_	41	NMOD
44	×	×	SYM	_	41	P
45	17	0	CD	_	41	NMOD
46	,	,	,	_	50	P
47	the	the	DT	_	49	NMOD
48	Plg	plg	NN	_	49	NMOD
49	antigen	antigen	NN	_	50	SBJ
50	was	be	VBD	_	35	CONJ
51	similar	similar	JJ	_	50	PRD
52	to	to	IN	_	51	AMOD
53	values	value	NNS	_	52	PMOD
54	for	for	IN	_	53	NMOD
55	the	the	DT	_	57	NMOD
56	B6	b0	NN	_	57	NMOD
57	mice	mouse	NNS	_	54	PMOD
58	.	.	.	_	10	P

1	Fibrinolytic	fibrinolytic	JJ	_	2	NMOD
2	activity	activity	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	not	not	RB	_	3	ADV
5	different	different	JJ	_	3	PRD
6	in	in	IN	_	5	AMOD
7	the	the	DT	_	15	NMOD
8	CSS	cs	NN	_	15	NMOD
9	-	-	HYPH	_	8	P
10	5	0	CD	_	8	NMOD
11	or	or	CC	_	8	COORD
12	CSS	cs	NN	_	11	CONJ
13	-	-	HYPH	_	12	P
14	17	0	CD	_	12	NMOD
15	strains	strain	NNS	_	6	PMOD
16	compared	compare	VBN	_	3	ADV
17	to	to	IN	_	16	PMOD
18	the	the	DT	_	20	NMOD
19	B6	b0	NN	_	20	NMOD
20	mice	mouse	NNS	_	17	PMOD
21	.	.	.	_	3	P

1	α2	α0	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	antiplasmin	antiplasmin	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	significantly	significantly	RB	_	12	AMOD
6	(	(	-LRB-	_	10	P
7	P	p	NN	_	10	SBJ
8	=	=	SYM	_	10	P
9	<	<	SYM	_	10	P
10	0.01	0	CD	_	5	PRN
11	)	)	-RRB-	_	10	P
12	reduced	reduced	JJ	_	4	PRD
13	in	in	IN	_	4	LOC
14	CSS	cs	NN	_	17	NMOD
15	-	-	HYPH	_	14	P
16	5	0	CD	_	14	NMOD
17	mice	mouse	NNS	_	13	PMOD
18	(	(	-LRB-	_	28	P
19	142	0	CD	_	22	NMOD
20	±	±	SYM	_	19	P
21	4	0	CD	_	19	QMOD
22	μg	μg	NNS	_	28	DEP
23	/	/	SYM	_	24	P
24	mL	ml	NN	_	22	NMOD
25	,	,	,	_	28	P
26	n	n	NN	_	28	SBJ
27	=	=	SYM	_	28	P
28	5	0	CD	_	17	PRN
29	)	)	-RRB-	_	28	P
30	,	,	,	_	4	P
31	significantly	significantly	RB	_	37	AMOD
32	(	(	-LRB-	_	35	P
33	P	p	NN	_	35	SBJ
34	<	<	SYM	_	35	P
35	0.05	0	CD	_	31	PRN
36	)	)	-RRB-	_	35	P
37	higher	high	JJR	_	4	GAP-PRD
38	in	in	IN	_	37	LOC
39	the	the	DT	_	40	NMOD
40	CSS	cs	NN	_	38	PMOD
41	-	-	HYPH	_	40	P
42	11	0	CD	_	40	NMOD
43	(	(	-LRB-	_	50	P
44	201	0	CD	_	50	DEP
45	±	±	SYM	_	44	P
46	6	0	CD	_	44	QMOD
47	,	,	,	_	50	P
48	n	n	NN	_	50	SBJ
49	=	=	SYM	_	50	P
50	8	0	CD	_	40	PRN
51	)	)	-RRB-	_	50	P
52	,	,	,	_	37	P
53	but	but	CC	_	37	COORD
54	not	not	RB	_	55	ADV
55	different	different	JJ	_	53	GAP-PRD
56	in	in	IN	_	55	LOC
57	CSS	cs	NN	_	66	NMOD
58	-	-	HYPH	_	57	P
59	17	0	CD	_	57	NMOD
60	or	or	CC	_	57	COORD
61	CSS	cs	NN	_	60	CONJ
62	-	-	HYPH	_	61	P
63	5	0	CD	_	61	NMOD
64	×	×	SYM	_	61	P
65	17	0	CD	_	61	NMOD
66	mice	mouse	NNS	_	56	PMOD
67	compared	compare	VBN	_	55	ADV
68	to	to	IN	_	67	PMOD
69	the	the	DT	_	71	NMOD
70	B6	b0	NN	_	71	NMOD
71	mice	mouse	NNS	_	68	PMOD
72	.	.	.	_	4	P

1	PAI	pai	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	1	0	CD	_	1	NMOD
4	antigen	antigen	NN	_	7	SBJ
5	and	and	CC	_	4	COORD
6	activity	activity	NN	_	5	CONJ
7	were	be	VBD	_	0	ROOT
8	determined	determine	VBN	_	7	VC
9	in	in	IN	_	8	LOC
10	the	the	DT	_	11	NMOD
11	CSS	cs	NNS	_	9	PMOD
12	with	with	IN	_	11	NMOD
13	increased	increase	VBN	_	15	NMOD
14	rebleeding	rebleeding	NN	_	15	NMOD
15	times	time	NNS	_	12	PMOD
16	,	,	,	_	11	P
17	CSS	cs	NN	_	11	APPO
18	-	-	HYPH	_	17	P
19	5	0	CD	_	17	NMOD
20	,	,	,	_	17	P
21	CSS	cs	NN	_	17	CONJ
22	-	-	HYPH	_	21	P
23	11	0	CD	_	21	NMOD
24	,	,	,	_	21	P
25	and	and	CC	_	21	COORD
26	CSS	cs	NN	_	25	CONJ
27	-	-	HYPH	_	26	P
28	17	0	CD	_	26	NMOD
29	(	(	-LRB-	_	30	P
30	Figure	figure	NN	_	26	PRN
31	6	0	CD	_	30	NMOD
32	)	)	-RRB-	_	30	P
33	,	,	,	_	11	P
34	the	the	DT	_	35	NMOD
35	heterosomic	heterosomic	JJ	_	11	CONJ
36	,	,	,	_	35	P
37	CSS	cs	NN	_	39	NMOD
38	-	-	HYPH	_	37	P
39	5F1	0f0	NN	_	35	APPO
40	,	,	,	_	39	P
41	CSS	cs	NN	_	43	NMOD
42	-	-	HYPH	_	41	P
43	17F1	0f0	NN	_	39	APPO
44	,	,	,	_	35	P
45	and	and	CC	_	35	COORD
46	double	double	JJ	_	47	NMOD
47	hetersomic	hetersomic	JJ	_	45	CONJ
48	,	,	,	_	47	P
49	CSS	cs	NN	_	47	APPO
50	-	-	HYPH	_	49	P
51	5	0	CD	_	49	NMOD
52	×	×	SYM	_	49	P
53	17	0	CD	_	49	NMOD
54	.	.	.	_	7	P

1	CSS	cs	NN	_	18	SBJ
2	-	-	HYPH	_	1	P
3	5	0	CD	_	1	NMOD
4	,	,	,	_	1	P
5	CSS	cs	NN	_	1	CONJ
6	-	-	HYPH	_	5	P
7	17	0	CD	_	5	NMOD
8	,	,	,	_	5	P
9	CSS	cs	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	5F1	0f0	NN	_	5	CONJ
12	,	,	,	_	11	P
13	and	and	CC	_	11	COORD
14	CSS	cs	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	17F1	0f0	NN	_	13	CONJ
17	generally	generally	RB	_	18	ADV
18	had	have	VBD	_	0	ROOT
19	reduced	reduce	VBN	_	23	NMOD
20	PAI	pai	NN	_	23	NMOD
21	-	-	HYPH	_	20	P
22	1	0	CD	_	20	NMOD
23	antigen	antigen	NN	_	18	OBJ
24	when	when	WRB	_	25	TMP
25	compared	compare	VBN	_	18	TMP
26	to	to	IN	_	25	ADV
27	B6	b0	NN	_	28	NMOD
28	mice	mouse	NNS	_	26	PMOD
29	.	.	.	_	18	P

1	The	the	DT	_	6	NMOD
2	reduced	reduce	VBN	_	6	NMOD
3	PAI	pai	NN	_	6	NMOD
4	-	-	HYPH	_	3	P
5	1	0	CD	_	3	NMOD
6	antigen	antigen	NN	_	7	SBJ
7	was	be	VBD	_	0	ROOT
8	a	a	DT	_	10	NMOD
9	dominant	dominant	JJ	_	10	NMOD
10	trait	trait	NN	_	7	PRD
11	due	due	IN	_	7	PRP
12	to	to	IN	_	11	PMOD
13	the	the	DT	_	14	NMOD
14	fact	fact	NN	_	11	PMOD
15	that	that	IN	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	values	value	NNS	_	18	SBJ
18	were	be	VBD	_	15	SUB
19	similar	similar	JJ	_	18	PRD
20	in	in	IN	_	19	AMOD
21	the	the	DT	_	25	NMOD
22	homosomic	homosomic	JJ	_	25	NMOD
23	and	and	CC	_	22	COORD
24	heterosomic	heterosomic	JJ	_	23	CONJ
25	CSS	cs	NN	_	20	PMOD
26	-	-	HYPH	_	25	P
27	5	0	CD	_	25	NMOD
28	and	and	CC	_	25	COORD
29	CSS	cs	NN	_	28	CONJ
30	-	-	HYPH	_	29	P
31	17	0	CD	_	29	NMOD
32	.	.	.	_	7	P

1	The	the	DT	_	11	NMOD
2	CSS	cs	NN	_	6	NMOD
3	-	-	HYPH	_	2	P
4	5	0	CD	_	2	NMOD
5	×	×	SYM	_	6	P
6	CSS	cs	NN	_	11	NMOD
7	-	-	HYPH	_	6	P
8	17	0	CD	_	6	NMOD
9	double	double	JJ	_	10	AMOD
10	heterosomic	heterosomic	JJ	_	11	NMOD
11	strains	strain	NNS	_	12	SBJ
12	had	have	VBD	_	0	ROOT
13	values	value	NNS	_	12	OBJ
14	similar	similar	JJ	_	13	NMOD
15	to	to	IN	_	14	AMOD
16	the	the	DT	_	23	NMOD
17	B6	b0	NN	_	23	NMOD
18	and	and	CC	_	17	COORD
19	A	a	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	J	j	NN	_	18	CONJ
22	parent	parent	NN	_	23	NMOD
23	strains	strain	NNS	_	15	PMOD
24	.	.	.	_	12	P

1	PAI	pai	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	1	0	CD	_	1	NMOD
4	activity	activity	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	significantly	significantly	RB	_	5	ADV
7	reduced	reduce	VBN	_	5	VC
8	in	in	IN	_	7	LOC
9	the	the	DT	_	17	NMOD
10	CSS	cs	NN	_	17	NMOD
11	-	-	HYPH	_	10	P
12	5	0	CD	_	10	NMOD
13	and	and	CC	_	10	COORD
14	CSS	cs	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	17F1	0f0	NN	_	13	CONJ
17	mice	mouse	NNS	_	8	PMOD
18	,	,	,	_	5	P
19	but	but	CC	_	5	COORD
20	again	again	RB	_	38	TMP
21	in	in	IN	_	38	LOC
22	the	the	DT	_	30	NMOD
23	CSS	cs	NN	_	27	NMOD
24	-	-	HYPH	_	23	P
25	5	0	CD	_	23	NMOD
26	×	×	SYM	_	27	P
27	CSS	cs	NN	_	30	NMOD
28	-	-	HYPH	_	27	P
29	17	0	CD	_	27	NMOD
30	strain	strain	NN	_	21	PMOD
31	the	the	DT	_	32	NMOD
32	value	value	NN	_	38	SBJ
33	for	for	IN	_	32	NMOD
34	PAI	pai	NN	_	37	NMOD
35	-	-	HYPH	_	34	P
36	1	0	CD	_	34	NMOD
37	activity	activity	NN	_	33	PMOD
38	was	be	VBD	_	19	CONJ
39	restored	restore	VBN	_	38	VC
40	to	to	IN	_	39	ADV
41	the	the	DT	_	42	NMOD
42	value	value	NN	_	40	PMOD
43	of	of	IN	_	42	NMOD
44	the	the	DT	_	51	NMOD
45	B6	b0	NN	_	51	NMOD
46	and	and	CC	_	45	COORD
47	A	a	NN	_	49	NMOD
48	/	/	HYPH	_	47	P
49	J	j	NN	_	46	CONJ
50	parent	parent	NN	_	51	NMOD
51	strains	strain	NNS	_	43	PMOD
52	.	.	.	_	5	P

1	The	the	DT	_	5	NMOD
2	PAI	pai	NN	_	5	NMOD
3	-	-	HYPH	_	2	P
4	1	0	CD	_	2	NMOD
5	antigen	antigen	NN	_	38	SBJ
6	(	(	-LRB-	_	16	P
7	5.4	0	CD	_	8	NMOD
8	ng	ng	NNS	_	16	DEP
9	/	/	SYM	_	10	P
10	mL	ml	NN	_	12	NMOD
11	±	±	SYM	_	12	P
12	0.5	0	CD	_	7	QMOD
13	,	,	,	_	16	P
14	n	n	NN	_	16	SBJ
15	=	=	SYM	_	16	P
16	7	0	CD	_	5	PRN
17	)	)	-RRB-	_	16	P
18	and	and	CC	_	5	COORD
19	activity	activity	NN	_	18	CONJ
20	(	(	-LRB-	_	30	P
21	170	0	CD	_	22	NMOD
22	U	u	NNS	_	30	DEP
23	/	/	SYM	_	24	P
24	mL	ml	NN	_	26	NMOD
25	±	±	SYM	_	26	P
26	20	0	CD	_	21	QMOD
27	,	,	,	_	30	P
28	n	n	NN	_	30	SBJ
29	=	=	SYM	_	30	P
30	6	0	CD	_	19	PRN
31	)	)	-RRB-	_	30	P
32	in	in	IN	_	5	LOC
33	the	the	DT	_	37	NMOD
34	CSS	cs	NN	_	37	NMOD
35	-	-	HYPH	_	34	P
36	11	0	CD	_	34	NMOD
37	mice	mouse	NNS	_	32	PMOD
38	was	be	VBD	_	0	ROOT
39	not	not	RB	_	38	ADV
40	different	different	JJ	_	38	PRD
41	than	than	IN	_	40	AMOD
42	for	for	IN	_	41	PMOD
43	B6	b0	NN	_	44	NMOD
44	mice	mouse	NNS	_	42	PMOD
45	.	.	.	_	38	P

1	Figure	figure	NN	_	0	ROOT
2	6	0	CD	_	1	NMOD

1	PAI	pai	NN	_	0	ROOT
2	-	-	HYPH	_	1	P
3	1	0	CD	_	1	NMOD
4	in	in	IN	_	1	NMOD
5	the	the	DT	_	7	NMOD
6	CSS	cs	NN	_	7	NMOD
7	backcrosses	backcrosses	NNS	_	4	PMOD
8	.	.	.	_	1	P

1	Panel	panel	NN	_	2	NMOD
2	A	a	NN	_	8	NMOD
3	:	:	:	_	8	P
4	Plasma	plasma	NN	_	8	NMOD
5	PAI	pai	NN	_	8	NMOD
6	-	-	HYPH	_	5	P
7	1	0	CD	_	5	NMOD
8	antigen	antigen	NN	_	28	SBJ
9	(	(	-LRB-	_	10	P
10	ng	ng	NNS	_	8	PRN
11	/	/	SYM	_	12	P
12	mL	ml	NN	_	10	NMOD
13	)	)	-RRB-	_	10	P
14	and	and	CC	_	8	COORD
15	Panel	panel	NN	_	16	NMOD
16	B	b	NN	_	22	NMOD
17	:	:	:	_	22	P
18	Plasma	plasma	NN	_	22	NMOD
19	PAI	pai	NN	_	22	NMOD
20	-	-	HYPH	_	19	P
21	1	0	CD	_	19	NMOD
22	activity	activity	NN	_	14	CONJ
23	(	(	-LRB-	_	24	P
24	U	u	NNS	_	22	PRN
25	/	/	SYM	_	26	P
26	mL	ml	NN	_	24	NMOD
27	)	)	-RRB-	_	24	P
28	were	be	VBD	_	0	ROOT
29	tested	test	VBN	_	28	VC
30	in	in	IN	_	29	LOC
31	heterosomic	heterosomic	JJ	_	32	NMOD
32	mice	mouse	NNS	_	30	PMOD
33	,	,	,	_	32	P
34	(	(	-LRB-	_	41	P
35	B6xCSS	b0xcss	NN	_	39	NMOD
36	-	-	HYPH	_	35	P
37	5	0	CD	_	35	NMOD
38	)	)	-RRB-	_	39	P
39	F1	f0	NN	_	41	NMOD
40	(	(	-LRB-	_	41	P
41	5F1	0f0	NN	_	32	APPO
42	)	)	-RRB-	_	41	P
43	and	and	CC	_	41	COORD
44	(	(	-LRB-	_	51	P
45	B6xCSS	b0xcss	NN	_	49	NMOD
46	-	-	HYPH	_	45	P
47	17	0	CD	_	45	NMOD
48	)	)	-RRB-	_	49	P
49	F1	f0	NN	_	51	NMOD
50	(	(	-LRB-	_	51	P
51	17F1	0f0	NN	_	43	CONJ
52	)	)	-RRB-	_	32	P
53	and	and	CC	_	32	COORD
54	doubly	doubly	RB	_	55	AMOD
55	heterosomic	heterosomic	JJ	_	56	NMOD
56	mice	mouse	NNS	_	65	NMOD
57	for	for	IN	_	56	NMOD
58	chromosomes	chromosome	NNS	_	59	NMOD
59	5	0	CD	_	57	PMOD
60	and	and	CC	_	59	COORD
61	17	0	CD	_	60	CONJ
62	(	(	-LRB-	_	65	P
63	5	0	CD	_	65	NMOD
64	×	×	SYM	_	65	P
65	17	0	CD	_	53	CONJ
66	)	)	-RRB-	_	28	P
67	.	.	.	_	28	P

1	Bars	bar	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	the	the	DT	_	6	NMOD
4	mean	mean	NN	_	6	NMOD
5	±	±	SYM	_	6	P
6	SEM	sem	NN	_	2	PRD
7	of	of	IN	_	6	NMOD
8	5	0	CD	_	11	NMOD
9	–	–	SYM	_	8	P
10	18	0	CD	_	8	QMOD
11	mice	mouse	NNS	_	7	PMOD
12	.	.	.	_	2	P

1	Statistical	statistical	JJ	_	2	NMOD
2	differences	difference	NNS	_	8	SBJ
3	between	between	IN	_	2	NMOD
4	B6	b0	NN	_	5	NMOD
5	mice	mouse	NNS	_	3	PMOD
6	and	and	CC	_	5	COORD
7	CSS	cs	NN	_	6	CONJ
8	were	be	VBD	_	0	ROOT
9	determined	determine	VBN	_	8	VC
10	with	with	IN	_	9	MNR
11	a	a	DT	_	14	NMOD
12	t	t	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	test	test	NN	_	10	PMOD
15	,	,	,	_	8	P
16	and	and	CC	_	8	COORD
17	a	a	DT	_	19	NMOD
18	Bonferroni	bonferroni	NNP	_	19	NMOD
19	correction	correction	NN	_	20	SBJ
20	was	be	VBD	_	16	CONJ
21	made	make	VBN	_	20	VC
22	to	to	TO	_	21	PRP
23	determine	determine	VB	_	22	IM
24	significance	significance	NN	_	25	NMOD
25	value	value	NN	_	23	OBJ
26	(	(	-LRB-	_	29	P
27	P	p	NN	_	29	SBJ
28	<	<	SYM	_	29	P
29	0.01	0	CD	_	23	PRN
30	)	)	-RRB-	_	29	P
31	.	.	.	_	8	P

1	Symbols	symbol	NNS	_	2	SBJ
2	indicate	indicate	VBP	_	0	ROOT
3	a	a	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	2	OBJ
6	between	between	IN	_	5	NMOD
7	B6	b0	NN	_	8	NMOD
8	values	value	NNS	_	6	PMOD
9	.	.	.	_	2	P

1	*	*	SYM	_	2	P
2	P	p	NN	_	4	SBJ
3	<	<	SYM	_	4	P
4	0.01	0	CD	_	0	ROOT
5	.	.	.	_	4	P

1	Interactions	interaction	NNS	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	CSS	cs	NN	_	2	PMOD
4	for	for	IN	_	1	NMOD
5	arterial	arterial	JJ	_	6	NMOD
6	thrombus	thrombus	NN	_	7	NMOD
7	formation	formation	NN	_	4	PMOD

1	The	the	DT	_	4	NMOD
2	tail	tail	NN	_	3	NMOD
3	bleeding	bleeding	NN	_	4	NMOD
4	assay	assay	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	rapid	rapid	JJ	_	5	PRD
7	and	and	CC	_	5	COORD
8	facilitated	facilitate	VBD	_	7	CONJ
9	the	the	DT	_	10	NMOD
10	screening	screening	NN	_	8	OBJ
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	15	NMOD
13	21	0	CD	_	15	NMOD
14	CSS	cs	NN	_	15	NMOD
15	strains	strain	NNS	_	11	PMOD
16	,	,	,	_	5	P
17	and	and	CC	_	5	COORD
18	subsequently	subsequently	RB	_	22	TMP
19	the	the	DT	_	21	NMOD
20	identified	identify	VBN	_	21	NMOD
21	strains	strain	NNS	_	22	SBJ
22	were	be	VBD	_	17	CONJ
23	tested	test	VBN	_	22	VC
24	for	for	IN	_	23	ADV
25	arterial	arterial	JJ	_	26	NMOD
26	occlusion	occlusion	NN	_	24	PMOD
27	after	after	IN	_	23	TMP
28	the	the	DT	_	30	NMOD
29	FeCl3	fecl0	NN	_	30	NMOD
30	injury	injury	NN	_	27	PMOD
31	(	(	-LRB-	_	32	P
32	Figure	figure	NN	_	23	PRN
33	7	0	CD	_	32	NMOD
34	)	)	-RRB-	_	32	P
35	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	CSS	cs	NN	_	9	SBJ
3	-	-	HYPH	_	2	P
4	5	0	CD	_	2	NMOD
5	and	and	CC	_	2	COORD
6	CSS	cs	NN	_	5	CONJ
7	-	-	HYPH	_	6	P
8	17	0	CD	_	6	NMOD
9	had	have	VBD	_	0	ROOT
10	occlusion	occlusion	NN	_	11	NMOD
11	times	time	NNS	_	9	OBJ
12	similar	similar	JJ	_	11	NMOD
13	to	to	IN	_	12	AMOD
14	the	the	DT	_	16	NMOD
15	B6	b0	NN	_	16	NMOD
16	mice	mouse	NNS	_	13	PMOD
17	,	,	,	_	9	P
18	but	but	CC	_	9	COORD
19	the	the	DT	_	29	NMOD
20	doubly	doubly	RB	_	21	AMOD
21	heterosomic	heterosomic	JJ	_	29	NMOD
22	CSS	cs	NN	_	26	NMOD
23	-	-	HYPH	_	22	P
24	5	0	CD	_	22	NMOD
25	×	×	SYM	_	26	P
26	CSS	cs	NN	_	29	NMOD
27	-	-	HYPH	_	26	P
28	17	0	CD	_	26	NMOD
29	progeny	progeny	NN	_	30	SBJ
30	had	have	VBD	_	18	CONJ
31	occlusion	occlusion	NN	_	32	NMOD
32	times	time	NNS	_	30	OBJ
33	higher	high	JJR	_	32	NMOD
34	than	than	IN	_	33	AMOD
35	either	either	CC	_	38	COORD
36	the	the	DT	_	38	NMOD
37	B6	b0	NN	_	38	NMOD
38	mice	mouse	NNS	_	34	PMOD
39	or	or	CC	_	38	COORD
40	the	the	DT	_	44	NMOD
41	heterosomic	heterosomic	JJ	_	44	NMOD
42	CSS	cs	NN	_	44	NMOD
43	-	-	HYPH	_	42	P
44	5F1	0f0	NN	_	39	CONJ
45	and	and	CC	_	44	COORD
46	CSS	cs	NN	_	48	NMOD
47	-	-	HYPH	_	46	P
48	17F1	0f0	NN	_	45	CONJ
49	or	or	CC	_	44	COORD
50	the	the	DT	_	53	NMOD
51	A	a	NN	_	53	NMOD
52	/	/	HYPH	_	51	P
53	J	j	NN	_	49	CONJ
54	strains	strain	NNS	_	53	NMOD
55	.	.	.	_	9	P

1	In	in	IN	_	19	LOC
2	double	double	JJ	_	3	AMOD
3	heterosomic	heterosomic	JJ	_	11	NMOD
4	CSS	cs	NN	_	8	NMOD
5	-	-	HYPH	_	4	P
6	5	0	CD	_	4	NMOD
7	×	×	SYM	_	8	P
8	CSS	cs	NN	_	11	NMOD
9	-	-	HYPH	_	8	P
10	17	0	CD	_	8	NMOD
11	mice	mouse	NNS	_	1	PMOD
12	,	,	,	_	19	P
13	only	only	RB	_	17	NMOD
14	one	one	CD	_	17	NMOD
15	or	or	CC	_	14	COORD
16	three	three	CD	_	15	CONJ
17	mice	mouse	NNS	_	19	SBJ
18	tested	test	VBN	_	17	NMOD
19	had	have	VBD	_	29	DEP
20	occluded	occlude	VBN	_	19	VC
21	by	by	IN	_	20	TMP
22	30	0	CD	_	23	NMOD
23	min	min	NNS	_	21	PMOD
24	;	;	:	_	29	P
25	the	the	DT	_	28	NMOD
26	other	other	JJ	_	28	NMOD
27	two	two	CD	_	28	NMOD
28	mice	mouse	NNS	_	29	SBJ
29	did	do	VBD	_	0	ROOT
30	not	not	RB	_	29	ADV
31	occlude	occlude	VB	_	29	VC
32	by	by	IN	_	31	TMP
33	30	0	CD	_	34	NMOD
34	min	min	NNS	_	32	PMOD
35	.	.	.	_	29	P

1	While	while	IN	_	19	ADV
2	only	only	RB	_	5	NMOD
3	a	a	DT	_	5	NMOD
4	small	small	JJ	_	5	NMOD
5	number	number	NN	_	9	SBJ
6	of	of	IN	_	5	NMOD
7	CSS	cs	NN	_	8	NMOD
8	mice	mouse	NNS	_	6	PMOD
9	have	have	VBP	_	1	SUB
10	been	be	VBN	_	9	VC
11	tested	test	VBN	_	10	VC
12	for	for	IN	_	11	ADV
13	the	the	DT	_	15	NMOD
14	arterial	arterial	JJ	_	15	NMOD
15	occlusion	occlusion	NN	_	12	PMOD
16	,	,	,	_	19	P
17	the	the	DT	_	18	NMOD
18	results	result	NNS	_	19	SBJ
19	suggest	suggest	VBP	_	0	ROOT
20	that	that	IN	_	19	OBJ
21	interaction	interaction	NN	_	31	SBJ
22	of	of	IN	_	21	NMOD
23	the	the	DT	_	24	NMOD
24	genes	gene	NNS	_	22	PMOD
25	on	on	IN	_	24	LOC
26	chromosome	chromosome	NN	_	27	NMOD
27	5	0	CD	_	25	PMOD
28	and	and	CC	_	27	COORD
29	17	0	CD	_	28	CONJ
30	also	also	RB	_	31	ADV
31	determines	determine	VBZ	_	20	SUB
32	arterial	arterial	JJ	_	33	NMOD
33	occlusion	occlusion	NN	_	34	NMOD
34	time	time	NN	_	31	OBJ
35	.	.	.	_	19	P

1	Figure	figure	NN	_	0	ROOT
2	7	0	CD	_	1	NMOD

1	Arterial	arterial	JJ	_	2	NMOD
2	occlusion	occlusion	NN	_	3	NMOD
3	time	time	NN	_	0	ROOT
4	in	in	IN	_	3	LOC
5	the	the	DT	_	7	NMOD
6	CSS	cs	NN	_	7	NMOD
7	backcrosses	backcrosses	NNS	_	4	PMOD
8	.	.	.	_	3	P

1	Occlusion	occlusion	NN	_	2	NMOD
2	time	time	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	determined	determine	VBN	_	3	VC
5	in	in	IN	_	4	LOC
6	heterosomic	heterosomic	JJ	_	7	NMOD
7	mice	mouse	NNS	_	16	NMOD
8	,	,	,	_	16	P
9	(	(	-LRB-	_	16	P
10	B6xCSS	b0xcss	NN	_	14	NMOD
11	-	-	HYPH	_	10	P
12	5	0	CD	_	10	NMOD
13	)	)	-RRB-	_	14	P
14	F1	f0	NN	_	16	NMOD
15	(	(	-LRB-	_	16	P
16	5F1	0f0	NN	_	5	PMOD
17	)	)	-RRB-	_	16	P
18	and	and	CC	_	16	COORD
19	(	(	-LRB-	_	26	P
20	B6xCSS	b0xcss	NN	_	24	NMOD
21	-	-	HYPH	_	20	P
22	17	0	CD	_	20	NMOD
23	)	)	-RRB-	_	24	P
24	F1	f0	NN	_	26	NMOD
25	(	(	-LRB-	_	26	P
26	17F1	0f0	NN	_	18	CONJ
27	)	)	-RRB-	_	16	P
28	,	,	,	_	16	P
29	and	and	CC	_	16	COORD
30	doubly	doubly	RB	_	31	AMOD
31	heterosomic	heterosomic	JJ	_	32	NMOD
32	mice	mouse	NNS	_	41	NMOD
33	for	for	IN	_	32	NMOD
34	chromosomes	chromosome	NNS	_	35	NMOD
35	5	0	CD	_	33	PMOD
36	and	and	CC	_	35	COORD
37	17	0	CD	_	36	CONJ
38	(	(	-LRB-	_	41	P
39	5	0	CD	_	41	NMOD
40	×	×	SYM	_	41	P
41	17	0	CD	_	29	CONJ
42	)	)	-RRB-	_	3	P
43	.	.	.	_	3	P

1	Bars	bar	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	the	the	DT	_	6	NMOD
4	mean	mean	NN	_	6	NMOD
5	±	±	SYM	_	6	P
6	SEM	sem	NN	_	2	PRD
7	of	of	IN	_	6	NMOD
8	5	0	CD	_	11	NMOD
9	–	–	SYM	_	8	P
10	18	0	CD	_	8	QMOD
11	mice	mouse	NNS	_	7	PMOD
12	.	.	.	_	2	P

1	Statistical	statistical	JJ	_	2	NMOD
2	differences	difference	NNS	_	8	SBJ
3	between	between	IN	_	2	NMOD
4	B6	b0	NN	_	5	NMOD
5	mice	mouse	NNS	_	3	PMOD
6	and	and	CC	_	5	COORD
7	CSS	cs	NN	_	6	CONJ
8	were	be	VBD	_	0	ROOT
9	determined	determine	VBN	_	8	VC
10	with	with	IN	_	9	MNR
11	a	a	DT	_	14	NMOD
12	t	t	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	test	test	NN	_	10	PMOD
15	,	,	,	_	8	P
16	and	and	CC	_	8	COORD
17	a	a	DT	_	19	NMOD
18	Bonferroni	bonferroni	NNP	_	19	NMOD
19	correction	correction	NN	_	20	SBJ
20	was	be	VBD	_	16	CONJ
21	made	make	VBN	_	20	VC
22	to	to	TO	_	21	PRP
23	determine	determine	VB	_	22	IM
24	significance	significance	NN	_	25	NMOD
25	value	value	NN	_	23	OBJ
26	(	(	-LRB-	_	29	P
27	P	p	NN	_	29	SBJ
28	<	<	SYM	_	29	P
29	0.02	0	CD	_	25	PRN
30	)	)	-RRB-	_	29	P
31	.	.	.	_	8	P

1	Symbols	symbol	NNS	_	2	SBJ
2	indicate	indicate	VBP	_	0	ROOT
3	a	a	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	2	OBJ
6	between	between	IN	_	5	NMOD
7	B6	b0	NN	_	8	NMOD
8	values	value	NNS	_	6	PMOD
9	.	.	.	_	2	P

1	*	*	SYM	_	2	P
2	P	p	NN	_	4	SBJ
3	<	<	SYM	_	4	P
4	0.0001	0	CD	_	0	ROOT
5	.	.	.	_	4	P

1	Discussion	discussion	NN	_	0	ROOT

1	In	in	IN	_	7	ADV
2	this	this	DT	_	3	NMOD
3	study	study	NN	_	1	PMOD
4	,	,	,	_	7	P
5	thrombotic	thrombotic	JJ	_	6	NMOD
6	risk	risk	NN	_	7	SBJ
7	was	be	VBD	_	0	ROOT
8	systematically	systematically	RB	_	7	MNR
9	assessed	assess	VBN	_	7	VC
10	in	in	IN	_	9	LOC
11	two	two	CD	_	13	NMOD
12	inbred	inbred	JJ	_	13	NMOD
13	strains	strain	NNS	_	10	PMOD
14	of	of	IN	_	13	NMOD
15	mice	mouse	NNS	_	14	PMOD
16	that	that	WDT	_	17	SBJ
17	have	have	VBP	_	13	NMOD
18	marked	mark	VBN	_	19	NMOD
19	differences	difference	NNS	_	17	OBJ
20	in	in	IN	_	19	NMOD
21	susceptibility	susceptibility	NN	_	20	PMOD
22	to	to	IN	_	21	NMOD
23	diet	diet	NN	_	25	AMOD
24	-	-	HYPH	_	23	P
25	induced	induce	VBN	_	26	NMOD
26	obesity	obesity	NN	_	22	PMOD
27	,	,	,	_	26	P
28	diet	diet	NN	_	30	AMOD
29	-	-	HYPH	_	28	P
30	induced	induce	VBN	_	31	NMOD
31	atherosclerosis	atherosclerosis	NN	_	26	CONJ
32	,	,	,	_	31	P
33	and	and	CC	_	31	COORD
34	ligation	ligation	NN	_	36	AMOD
35	-	-	HYPH	_	34	P
36	induced	induce	VBN	_	38	NMOD
37	neointimal	neointimal	JJ	_	38	NMOD
38	hyperplasia	hyperplasia	NN	_	33	CONJ
39	and	and	CC	_	38	COORD
40	vessel	vessel	NN	_	41	NMOD
41	remodeling	remodeling	NN	_	39	CONJ
42	.	.	.	_	7	P

1	Arterial	arterial	JJ	_	2	NMOD
2	occlusion	occlusion	NN	_	3	NMOD
3	time	time	NN	_	10	SBJ
4	,	,	,	_	3	P
5	tail	tail	NN	_	6	NMOD
6	bleeding	bleeding	NN	_	9	NMOD
7	and	and	CC	_	6	COORD
8	rebleeding	rebleeding	NN	_	7	CONJ
9	time	time	NN	_	3	APPO
10	were	be	VBD	_	0	ROOT
11	evaluated	evaluate	VBN	_	10	VC
12	as	as	IN	_	11	ADV
13	potential	potential	JJ	_	14	NMOD
14	predictors	predictor	NNS	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	thrombotic	thrombotic	JJ	_	17	NMOD
17	response	response	NN	_	15	PMOD
18	.	.	.	_	10	P

1	Assessments	assessment	NNS	_	7	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	6	NMOD
4	two	two	CD	_	6	NMOD
5	inbred	inbred	JJ	_	6	NMOD
6	strains	strain	NNS	_	2	PMOD
7	were	be	VBD	_	0	ROOT
8	compared	compare	VBN	_	7	VC
9	to	to	IN	_	8	ADV
10	values	value	NNS	_	9	PMOD
11	from	from	IN	_	10	NMOD
12	gene	gene	NN	_	13	AMOD
13	targeted	target	VBN	_	14	NMOD
14	mice	mouse	NNS	_	11	PMOD
15	of	of	IN	_	14	NMOD
16	the	the	DT	_	18	NMOD
17	Plg	plg	NN	_	18	NMOD
18	network	network	NN	_	15	PMOD
19	with	with	IN	_	14	NMOD
20	altered	alter	VBN	_	22	NMOD
21	fibrinolytic	fibrinolytic	JJ	_	22	NMOD
22	responses	response	NNS	_	19	PMOD
23	,	,	,	_	11	P
24	as	as	RB	_	26	ADV
25	well	well	RB	_	26	ADV
26	as	as	IN	_	11	COORD
27	in	in	IN	_	26	CONJ
28	leptin	leptin	NN	_	29	AMOD
29	deficient	deficient	JJ	_	30	NMOD
30	mice	mouse	NNS	_	27	PMOD
31	with	with	IN	_	30	NMOD
32	a	a	DT	_	35	NMOD
33	reduced	reduce	VBN	_	35	NMOD
34	platelet	platelet	NN	_	35	NMOD
35	function	function	NN	_	31	PMOD
36	.	.	.	_	7	P

1	Marked	marked	JJ	_	2	NMOD
2	differences	difference	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	found	find	VBN	_	3	VC
5	in	in	IN	_	4	ADV
6	the	the	DT	_	8	NMOD
7	thrombotic	thrombotic	JJ	_	8	NMOD
8	response	response	NN	_	5	PMOD
9	among	among	IN	_	4	LOC
10	the	the	DT	_	13	NMOD
11	two	two	CD	_	13	NMOD
12	inbred	inbred	JJ	_	13	NMOD
13	strains	strain	NNS	_	9	PMOD
14	,	,	,	_	13	P
15	B6	b0	NN	_	13	APPO
16	and	and	CC	_	15	COORD
17	A	a	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	J	j	NN	_	16	CONJ
20	,	,	,	_	3	P
21	and	and	CC	_	3	COORD
22	the	the	DT	_	24	NMOD
23	observed	observe	VBN	_	24	NMOD
24	differences	difference	NNS	_	25	SBJ
25	were	be	VBD	_	21	CONJ
26	not	not	RB	_	25	ADV
27	correlated	correlate	VBN	_	25	VC
28	with	with	IN	_	27	ADV
29	change	change	NN	_	28	PMOD
30	in	in	IN	_	29	NMOD
31	coagulation	coagulation	NN	_	30	PMOD
32	or	or	CC	_	31	COORD
33	platelet	platelet	NN	_	34	NMOD
34	function	function	NN	_	32	CONJ
35	.	.	.	_	3	P

1	Screening	screen	VBG	_	4	SBJ
2	the	the	DT	_	3	NMOD
3	CSS	cs	NN	_	1	OBJ
4	identified	identify	VBD	_	0	ROOT
5	three	three	CD	_	6	NMOD
6	chromosomes	chromosome	NNS	_	4	OBJ
7	that	that	WDT	_	8	SBJ
8	harbored	harbor	VBD	_	6	NMOD
9	genes	gene	NNS	_	8	OBJ
10	which	which	WDT	_	11	SBJ
11	contributed	contribute	VBD	_	9	NMOD
12	to	to	IN	_	11	ADV
13	the	the	DT	_	17	NMOD
14	A	a	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	J	j	NN	_	17	NMOD
17	phenotype	phenotype	NN	_	12	PMOD
18	of	of	IN	_	17	NMOD
19	increased	increase	VBN	_	21	NMOD
20	rebleeding	rebleeding	NN	_	21	NMOD
21	time	time	NN	_	18	PMOD
22	.	.	.	_	4	P

1	Mice	mouse	NNS	_	19	SBJ
2	homosomic	homosomic	JJ	_	1	NMOD
3	for	for	IN	_	2	AMOD
4	these	these	DT	_	5	NMOD
5	chromosomes	chromosome	NNS	_	3	PMOD
6	or	or	CC	_	2	COORD
7	doubly	doubly	RB	_	8	AMOD
8	heterosomic	heterosomic	JJ	_	6	CONJ
9	for	for	IN	_	8	AMOD
10	two	two	CD	_	9	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	13	NMOD
13	chromosomes	chromosome	NNS	_	11	PMOD
14	,	,	,	_	10	P
15	5	0	CD	_	10	APPO
16	and	and	CC	_	15	COORD
17	17	0	CD	_	16	CONJ
18	,	,	,	_	19	P
19	were	be	VBD	_	0	ROOT
20	required	require	VBN	_	19	VC
21	to	to	TO	_	20	PRP
22	express	express	VB	_	21	IM
23	the	the	DT	_	27	NMOD
24	A	a	NN	_	26	NMOD
25	/	/	HYPH	_	24	P
26	J	j	NN	_	27	NMOD
27	phenotype	phenotype	NN	_	22	OBJ
28	,	,	,	_	27	P
29	elevated	elevate	VBN	_	31	NMOD
30	rebleeding	rebleeding	NN	_	31	NMOD
31	time	time	NN	_	27	APPO
32	.	.	.	_	19	P

1	PAI	pai	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	1	0	CD	_	1	NMOD
4	antigen	antigen	NN	_	7	SBJ
5	and	and	CC	_	4	COORD
6	activity	activity	NN	_	5	CONJ
7	were	be	VBD	_	0	ROOT
8	decreased	decrease	VBN	_	7	VC
9	in	in	IN	_	8	LOC
10	both	both	CC	_	11	COORD
11	CSS	cs	NN	_	9	PMOD
12	-	-	HYPH	_	11	P
13	5	0	CD	_	11	NMOD
14	and	and	CC	_	11	COORD
15	CSS	cs	NN	_	14	CONJ
16	-	-	HYPH	_	15	P
17	17	0	CD	_	15	NMOD
18	and	and	CC	_	11	COORD
19	the	the	DT	_	21	NMOD
20	heterosomic	heterosomic	JJ	_	21	NMOD
21	mice	mouse	NNS	_	18	CONJ
22	,	,	,	_	21	P
23	CSS	cs	NN	_	25	NMOD
24	-	-	HYPH	_	23	P
25	5F1	0f0	NN	_	21	APPO
26	and	and	CC	_	25	COORD
27	CSS	cs	NN	_	29	NMOD
28	-	-	HYPH	_	27	P
29	17F1	0f0	NN	_	26	CONJ
30	,	,	,	_	9	P
31	but	but	CC	_	9	COORD
32	not	not	RB	_	31	ADV
33	in	in	IN	_	31	CONJ
34	the	the	DT	_	38	NMOD
35	CSS	cs	NN	_	38	NMOD
36	-	-	HYPH	_	35	P
37	11	0	CD	_	35	NMOD
38	strain	strain	NN	_	33	PMOD
39	.	.	.	_	7	P

1	Values	value	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	restored	restore	VBN	_	2	VC
4	in	in	IN	_	3	LOC
5	the	the	DT	_	7	NMOD
6	doubly	doubly	RB	_	7	NMOD
7	heterosomic	heterosomic	JJ	_	4	PMOD
8	for	for	IN	_	3	ADV
9	two	two	CD	_	8	PMOD
10	of	of	IN	_	9	NMOD
11	chromosomes	chromosome	NNS	_	10	PMOD
12	,	,	,	_	9	P
13	5	0	CD	_	9	APPO
14	and	and	CC	_	13	COORD
15	17	0	CD	_	14	CONJ
16	.	.	.	_	2	P

1	Arterial	arterial	JJ	_	2	NMOD
2	occlusion	occlusion	NN	_	3	NMOD
3	time	time	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	similar	similar	JJ	_	4	PRD
6	to	to	IN	_	5	AMOD
7	B6	b0	NN	_	6	PMOD
8	in	in	IN	_	4	LOC
9	the	the	DT	_	18	NMOD
10	CSS	cs	NN	_	18	NMOD
11	-	-	HYPH	_	10	P
12	5	0	CD	_	10	NMOD
13	and	and	CC	_	10	COORD
14	CSS	cs	NN	_	13	CONJ
15	-	-	HYPH	_	14	P
16	17	0	CD	_	14	NMOD
17	homozygous	homozygous	JJ	_	18	NMOD
18	strains	strain	NNS	_	8	PMOD
19	,	,	,	_	4	P
20	but	but	CC	_	4	COORD
21	increased	increase	VBD	_	20	CONJ
22	in	in	IN	_	21	LOC
23	doubly	doubly	RB	_	24	NMOD
24	heterosomic	heterosomic	JJ	_	22	PMOD
25	for	for	IN	_	4	ADV
26	two	two	CD	_	25	PMOD
27	of	of	IN	_	26	NMOD
28	chromosomes	chromosome	NNS	_	27	PMOD
29	,	,	,	_	26	P
30	5	0	CD	_	26	APPO
31	and	and	CC	_	30	COORD
32	17	0	CD	_	31	CONJ
33	.	.	.	_	4	P

1	The	the	DT	_	5	NMOD
2	FeCl3	fecl0	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	induced	induce	VBN	_	5	NMOD
5	model	model	NN	_	13	SBJ
6	of	of	IN	_	5	NMOD
7	vascular	vascular	JJ	_	8	NMOD
8	injury	injury	NN	_	6	PMOD
9	and	and	CC	_	8	COORD
10	thrombosis	thrombosis	NN	_	9	CONJ
11	in	in	IN	_	5	LOC
12	mice	mouse	NNS	_	11	PMOD
13	is	be	VBZ	_	0	ROOT
14	now	now	RB	_	13	TMP
15	widely	widely	RB	_	13	MNR
16	used	use	VBN	_	13	VC
17	to	to	TO	_	16	PRP
18	evaluate	evaluate	VB	_	17	IM
19	genetic	genetic	JJ	_	22	NMOD
20	and	and	CC	_	19	COORD
21	pharmacological	pharmacological	JJ	_	20	CONJ
22	interventions	intervention	NNS	_	18	OBJ
23	[	[	-LRB-	_	24	P
24	24	0	CD	_	16	PRN
25	]	]	-RRB-	_	24	P
26	.	.	.	_	13	P

1	The	the	DT	_	4	NMOD
2	two	two	CD	_	4	NMOD
3	inbred	inbred	JJ	_	4	NMOD
4	strains	strain	NNS	_	5	SBJ
5	had	have	VBD	_	0	ROOT
6	marked	marked	JJ	_	7	NMOD
7	differences	difference	NNS	_	5	OBJ
8	in	in	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	time	time	NN	_	8	PMOD
11	for	for	IN	_	10	NMOD
12	occlusion	occlusion	NN	_	11	PMOD
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	16	NMOD
15	carotid	carotid	JJ	_	16	NMOD
16	artery	artery	NN	_	13	PMOD
17	after	after	IN	_	12	TMP
18	FeCl3	fecl0	NN	_	19	NMOD
19	injury	injury	NN	_	17	PMOD
20	.	.	.	_	5	P

1	After	after	IN	_	9	TMP
2	FeCl3	fecl0	NN	_	3	NMOD
3	treatment	treatment	NN	_	1	PMOD
4	,	,	,	_	9	P
5	thrombus	thrombus	NN	_	6	NMOD
6	formation	formation	NN	_	9	SBJ
7	and	and	CC	_	6	COORD
8	occlusion	occlusion	NN	_	7	CONJ
9	was	be	VBD	_	0	ROOT
10	remarkably	remarkably	RB	_	9	ADV
11	shortened	shorten	VBN	_	9	VC
12	in	in	IN	_	11	LOC
13	the	the	DT	_	17	NMOD
14	A	a	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	J	j	NN	_	17	NMOD
17	mice	mouse	NNS	_	12	PMOD
18	compared	compare	VBN	_	11	ADV
19	to	to	IN	_	18	PMOD
20	the	the	DT	_	22	NMOD
21	B6	b0	NN	_	22	NMOD
22	mice	mouse	NNS	_	19	PMOD
23	.	.	.	_	9	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	not	not	RB	_	3	ADV
5	previously	previously	RB	_	3	TMP
6	been	be	VBN	_	3	VC
7	reported	report	VBN	_	6	VC
8	.	.	.	_	3	P

1	A	a	DT	_	3	NMOD
2	recent	recent	JJ	_	3	NMOD
3	study	study	NN	_	13	SBJ
4	[	[	-LRB-	_	5	P
5	25	0	CD	_	3	PRN
6	]	]	-RRB-	_	5	P
7	of	of	IN	_	3	NMOD
8	sheer	sheer	JJ	_	9	NMOD
9	stress	stress	NN	_	7	PMOD
10	in	in	IN	_	3	LOC
11	rats	rat	NNS	_	10	PMOD
12	,	,	,	_	13	P
13	found	find	VBD	_	0	ROOT
14	that	that	IN	_	13	OBJ
15	the	the	DT	_	16	NMOD
16	magnitude	magnitude	NN	_	26	SBJ
17	of	of	IN	_	16	NMOD
18	changes	change	NNS	_	17	PMOD
19	in	in	IN	_	18	NMOD
20	sheer	sheer	JJ	_	21	NMOD
21	stress	stress	NN	_	19	PMOD
22	with	with	IN	_	16	NMOD
23	increased	increase	VBN	_	25	NMOD
24	blood	blood	NN	_	25	NMOD
25	flow	flow	NN	_	22	PMOD
26	varied	vary	VBD	_	14	SUB
27	with	with	IN	_	26	ADV
28	the	the	DT	_	30	NMOD
29	different	different	JJ	_	30	NMOD
30	strains	strain	NNS	_	27	PMOD
31	.	.	.	_	13	P

1	Further	further	JJ	_	2	NMOD
2	investigation	investigation	NN	_	10	SBJ
3	,	,	,	_	2	P
4	beyond	beyond	IN	_	2	NMOD
5	the	the	DT	_	6	NMOD
6	scope	scope	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	this	this	DT	_	9	NMOD
9	study	study	NN	_	7	PMOD
10	would	would	MD	_	0	ROOT
11	be	be	VB	_	10	VC
12	necessary	necessary	JJ	_	11	PRD
13	to	to	TO	_	11	PRP
14	determine	determine	VB	_	13	IM
15	the	the	DT	_	16	NMOD
16	contribution	contribution	NN	_	14	OBJ
17	in	in	IN	_	16	NMOD
18	the	the	DT	_	19	NMOD
19	differences	difference	NNS	_	17	PMOD
20	in	in	IN	_	19	NMOD
21	size	size	NN	_	20	PMOD
22	and	and	CC	_	19	COORD
23	sheer	sheer	JJ	_	24	NMOD
24	stress	stress	NN	_	22	CONJ
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	27	NMOD
27	carotids	carotids	NNS	_	25	PMOD
28	to	to	IN	_	16	NMOD
29	arterial	arterial	JJ	_	31	NMOD
30	occlusion	occlusion	NN	_	31	NMOD
31	rates	rate	NNS	_	28	PMOD
32	in	in	IN	_	31	LOC
33	the	the	DT	_	39	NMOD
34	B6	b0	NN	_	39	NMOD
35	and	and	CC	_	34	COORD
36	A	a	NN	_	38	NMOD
37	/	/	HYPH	_	36	P
38	J	j	NN	_	35	CONJ
39	mice	mouse	NNS	_	32	PMOD
40	.	.	.	_	10	P

1	In	in	IN	_	6	ADV
2	preliminary	preliminary	JJ	_	3	NMOD
3	studies	study	NNS	_	1	PMOD
4	,	,	,	_	6	P
5	we	we	PRP	_	6	SBJ
6	have	have	VBP	_	0	ROOT
7	noted	note	VBN	_	6	VC
8	differences	difference	NNS	_	7	OBJ
9	in	in	IN	_	8	NMOD
10	the	the	DT	_	11	NMOD
11	composition	composition	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	14	NMOD
14	thrombus	thrombus	NN	_	12	PMOD
15	in	in	IN	_	7	LOC
16	B6	b0	NN	_	21	NMOD
17	and	and	CC	_	16	COORD
18	A	a	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	J	j	NN	_	17	CONJ
21	mice	mouse	NNS	_	15	PMOD
22	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	pattern	pattern	NN	_	12	SBJ
3	of	of	IN	_	2	NMOD
4	blood	blood	NN	_	5	NMOD
5	flow	flow	NN	_	6	NMOD
6	cessation	cessation	NN	_	3	PMOD
7	for	for	IN	_	2	NMOD
8	the	the	DT	_	11	NMOD
9	two	two	CD	_	11	NMOD
10	inbred	inbred	JJ	_	11	NMOD
11	strains	strain	NNS	_	7	PMOD
12	was	be	VBD	_	0	ROOT
13	different	different	JJ	_	12	PRD
14	than	than	IN	_	13	AMOD
15	for	for	IN	_	14	PMOD
16	the	the	DT	_	18	NMOD
17	Lepob	lepob	NN	_	18	NMOD
18	mice	mouse	NNS	_	15	PMOD
19	[	[	-LRB-	_	20	P
20	26	0	CD	_	18	PRN
21	]	]	-RRB-	_	20	P
22	with	with	IN	_	18	NMOD
23	impaired	impaired	JJ	_	25	NMOD
24	platelet	platelet	NN	_	25	NMOD
25	function	function	NN	_	22	PMOD
26	,	,	,	_	12	P
27	and	and	CC	_	12	COORD
28	coagulation	coagulation	NN	_	29	NMOD
29	time	time	NN	_	30	SBJ
30	was	be	VBD	_	27	CONJ
31	similar	similar	JJ	_	30	PRD
32	in	in	IN	_	30	LOC
33	the	the	DT	_	35	NMOD
34	two	two	CD	_	35	NMOD
35	strains	strain	NNS	_	32	PMOD
36	.	.	.	_	12	P

1	In	in	IN	_	17	LOC
2	the	the	DT	_	3	NMOD
3	mice	mouse	NNS	_	1	PMOD
4	with	with	IN	_	3	NMOD
5	deficiencies	deficiency	NNS	_	4	PMOD
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	Plg	plg	NN	_	9	NMOD
9	network	network	NN	_	6	PMOD
10	[	[	-LRB-	_	11	P
11	27	0	CD	_	3	PRN
12	]	]	-RRB-	_	11	P
13	,	,	,	_	17	P
14	thrombus	thrombus	NN	_	15	NMOD
15	formation	formation	NN	_	16	NMOD
16	time	time	NN	_	17	SBJ
17	was	be	VBD	_	0	ROOT
18	reduced	reduce	VBN	_	17	VC
19	in	in	IN	_	18	LOC
20	the	the	DT	_	25	NMOD
21	Plg	plg	NN	_	25	NMOD
22	-	-	SYM	_	21	P
23	/	/	HYPH	_	21	P
24	-	-	SYM	_	21	P
25	mice	mouse	NNS	_	19	PMOD
26	,	,	,	_	18	P
27	but	but	CC	_	18	COORD
28	increased	increase	VBD	_	27	CONJ
29	in	in	IN	_	28	LOC
30	the	the	DT	_	35	NMOD
31	PAI	pai	NN	_	35	NMOD
32	-	-	SYM	_	31	P
33	/	/	HYPH	_	31	P
34	-	-	SYM	_	31	P
35	mice	mouse	NNS	_	29	PMOD
36	,	,	,	_	18	P
37	suggesting	suggest	VBG	_	18	ADV
38	that	that	IN	_	37	OBJ
39	alterations	alteration	NNS	_	51	SBJ
40	in	in	IN	_	39	NMOD
41	plasmin	plasmin	NN	_	42	NMOD
42	activity	activity	NN	_	40	PMOD
43	that	that	WDT	_	44	SBJ
44	affect	affect	VBP	_	39	NMOD
45	the	the	DT	_	46	NMOD
46	rate	rate	NN	_	44	OBJ
47	of	of	IN	_	46	NMOD
48	clot	clot	NN	_	49	NMOD
49	lysis	lysis	NN	_	47	PMOD
50	,	,	,	_	51	P
51	can	can	MD	_	38	SUB
52	modulate	modulate	VB	_	51	VC
53	the	the	DT	_	54	NMOD
54	events	event	NNS	_	52	OBJ
55	leading	lead	VBG	_	54	NMOD
56	to	to	IN	_	55	ADV
57	occlusive	occlusive	JJ	_	58	NMOD
58	thrombus	thrombus	NN	_	59	NMOD
59	formation	formation	NN	_	56	PMOD
60	.	.	.	_	17	P

1	The	the	DT	_	5	NMOD
2	tail	tail	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	bleeding	bleeding	NN	_	5	NMOD
5	assay	assay	NN	_	6	SBJ
6	has	have	VBZ	_	0	ROOT
7	been	be	VBN	_	6	VC
8	used	use	VBN	_	7	VC
9	extensively	extensively	RB	_	8	ADV
10	in	in	IN	_	8	LOC
11	mice	mouse	NNS	_	10	PMOD
12	to	to	TO	_	8	PRP
13	assess	assess	VB	_	12	IM
14	the	the	DT	_	15	NMOD
15	impact	impact	NN	_	13	OBJ
16	of	of	IN	_	15	NMOD
17	deficiencies	deficiency	NNS	_	16	PMOD
18	and	and	CC	_	17	COORD
19	over	over	RB	_	20	NMOD
20	expression	expression	NN	_	18	CONJ
21	of	of	IN	_	17	NMOD
22	platelet	platelet	NN	_	25	NMOD
23	and	and	CC	_	22	COORD
24	coagulation	coagulation	NN	_	23	CONJ
25	proteins	protein	NNS	_	21	PMOD
26	in	in	IN	_	17	LOC
27	mice	mouse	NNS	_	26	PMOD
28	.	.	.	_	6	P

1	Sweeny	sweeny	NNP	_	7	SBJ
2	et	et	FW	_	3	AMOD
3	al	al	FW	_	1	NMOD
4	[	[	-LRB-	_	5	P
5	28	0	CD	_	1	PRN
6	]	]	-RRB-	_	5	P
7	screened	screen	VBD	_	0	ROOT
8	25	0	CD	_	9	NMOD
9	strains	strain	NNS	_	7	OBJ
10	of	of	IN	_	9	NMOD
11	mice	mouse	NNS	_	10	PMOD
12	and	and	CC	_	7	COORD
13	found	find	VBN	_	12	CONJ
14	only	only	RB	_	19	NMOD
15	the	the	DT	_	19	NMOD
16	RIIS	riis	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	J	j	NN	_	19	NMOD
19	mice	mouse	NNS	_	20	SBJ
20	to	to	TO	_	13	OPRD
21	have	have	VB	_	20	IM
22	increased	increase	VBN	_	24	NMOD
23	bleeding	bleeding	NN	_	24	NMOD
24	time	time	NN	_	21	OBJ
25	due	due	IN	_	24	NMOD
26	to	to	IN	_	25	PMOD
27	reduced	reduce	VBN	_	30	NMOD
28	von	von	NNP	_	29	NMOD
29	Willebrand	willebrand	NNP	_	30	NMOD
30	antigen	antigen	NN	_	25	PMOD
31	.	.	.	_	7	P

1	Broze	broze	NNP	_	7	SBJ
2	et	et	FW	_	3	AMOD
3	al	al	FW	_	1	NMOD
4	[	[	-LRB-	_	5	P
5	29	0	CD	_	1	PRN
6	]	]	-RRB-	_	5	P
7	evaluated	evaluate	VBN	_	0	ROOT
8	mice	mouse	NNS	_	7	OBJ
9	with	with	IN	_	8	NMOD
10	gene	gene	NN	_	11	NMOD
11	deletions	deletion	NNS	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	15	NMOD
14	coagulation	coagulation	NN	_	15	NMOD
15	pathway	pathway	NN	_	12	PMOD
16	and	and	CC	_	7	COORD
17	found	find	VBD	_	16	CONJ
18	that	that	IN	_	17	OBJ
19	while	while	IN	_	27	TMP
20	bleeding	bleeding	NN	_	21	NMOD
21	time	time	NN	_	22	SBJ
22	was	be	VBD	_	19	SUB
23	not	not	RB	_	22	ADV
24	increased	increase	VBN	_	22	VC
25	,	,	,	_	27	P
26	rebleeding	rebleeding	NN	_	27	SBJ
27	persisted	persist	VBD	_	18	SUB
28	despite	despite	IN	_	27	ADV
29	electrocautery	electrocautery	NN	_	28	PMOD
30	of	of	IN	_	29	NMOD
31	the	the	DT	_	32	NMOD
32	tail	tail	NN	_	30	PMOD
33	in	in	IN	_	27	LOC
34	FVIII	fviii	NN	_	37	AMOD
35	and	and	CC	_	34	COORD
36	FIX	fix	NN	_	35	CONJ
37	deficient	deficient	JJ	_	38	NMOD
38	mice	mouse	NNS	_	33	PMOD
39	.	.	.	_	7	P

1	This	this	DT	_	2	NMOD
2	observation	observation	NN	_	3	SBJ
3	raised	raise	VBD	_	0	ROOT
4	the	the	DT	_	5	NMOD
5	possibility	possibility	NN	_	3	OBJ
6	that	that	IN	_	5	NMOD
7	rebleeding	rebleeding	NN	_	8	NMOD
8	time	time	NN	_	9	SBJ
9	may	may	MD	_	6	SUB
10	be	be	VB	_	9	VC
11	a	a	DT	_	13	NMOD
12	sensitive	sensitive	JJ	_	13	NMOD
13	reporter	reporter	NN	_	10	PRD
14	of	of	IN	_	13	NMOD
15	genetic	genetic	JJ	_	16	NMOD
16	influences	influence	NNS	_	14	PMOD
17	on	on	IN	_	16	NMOD
18	thrombus	thrombus	NN	_	19	NMOD
19	formation	formation	NN	_	17	PMOD
20	and	and	CC	_	19	COORD
21	stability	stability	NN	_	20	CONJ
22	.	.	.	_	3	P

1	Mice	mouse	NNS	_	31	SBJ
2	that	that	WDT	_	3	SBJ
3	are	be	VBP	_	1	NMOD
4	deficient	deficient	JJ	_	3	PRD
5	in	in	IN	_	4	AMOD
6	factors	factor	NNS	_	5	PMOD
7	required	require	VBN	_	6	NMOD
8	for	for	IN	_	7	PRP
9	normal	normal	JJ	_	11	NMOD
10	platelet	platelet	NN	_	11	NMOD
11	function	function	NN	_	8	PMOD
12	,	,	,	_	11	P
13	platelet	platelet	NN	_	15	NMOD
14	glycoprotein	glycoprotein	NN	_	15	NMOD
15	Ib	ib	NN	_	11	CONJ
16	[	[	-LRB-	_	17	P
17	30	0	CD	_	15	PRN
18	]	]	-RRB-	_	17	P
19	,	,	,	_	15	P
20	and	and	CC	_	15	COORD
21	protease	protease	NN	_	23	AMOD
22	-	-	HYPH	_	21	P
23	activated	activate	VBN	_	24	NMOD
24	receptor	receptor	NN	_	20	CONJ
25	-	-	HYPH	_	24	P
26	4	0	CD	_	24	NMOD
27	,	,	,	_	7	P
28	[	[	-LRB-	_	29	P
29	31	0	CD	_	7	PRN
30	]	]	-RRB-	_	29	P
31	have	have	VBP	_	0	ROOT
32	increased	increase	VBN	_	31	VC
33	tail	tail	NN	_	34	NMOD
34	bleeding	bleeding	NN	_	35	NMOD
35	time	time	NN	_	32	OBJ
36	.	.	.	_	31	P

1	The	the	DT	_	3	NMOD
2	leptin	leptin	NN	_	3	NMOD
3	deficiency	deficiency	NN	_	9	SBJ
4	with	with	IN	_	3	NMOD
5	reduced	reduce	VBN	_	7	NMOD
6	platelet	platelet	NN	_	7	NMOD
7	aggregation	aggregation	NN	_	4	PMOD
8	clearly	clearly	RB	_	9	ADV
9	shows	show	VBZ	_	0	ROOT
10	a	a	DT	_	12	NMOD
11	marked	marked	JJ	_	12	NMOD
12	increase	increase	NN	_	9	OBJ
13	in	in	IN	_	12	NMOD
14	bleeding	bleeding	NN	_	15	NMOD
15	time	time	NN	_	13	PMOD
16	and	and	CC	_	9	COORD
17	the	the	DT	_	20	NMOD
18	increased	increase	VBN	_	20	NMOD
19	bleeding	bleeding	NN	_	20	NMOD
20	time	time	NN	_	32	SBJ
21	in	in	IN	_	20	LOC
22	Plg	plg	NN	_	31	NMOD
23	-	-	SYM	_	22	P
24	/	/	HYPH	_	22	P
25	-	-	SYM	_	22	P
26	and	and	CC	_	22	COORD
27	uPA	upa	NN	_	26	CONJ
28	-	-	SYM	_	27	P
29	/	/	HYPH	_	27	P
30	-	-	SYM	_	27	P
31	mice	mouse	NNS	_	21	PMOD
32	suggests	suggest	VBZ	_	16	CONJ
33	that	that	IN	_	32	OBJ
34	Plg	plg	NN	_	37	SBJ
35	and	and	CC	_	34	COORD
36	uPA	upa	NN	_	35	CONJ
37	may	may	MD	_	33	SUB
38	exert	exert	VB	_	37	VC
39	an	an	DT	_	40	NMOD
40	influence	influence	NN	_	38	OBJ
41	on	on	IN	_	40	NMOD
42	platelet	platelet	NN	_	43	NMOD
43	response	response	NN	_	41	PMOD
44	to	to	TO	_	38	PRP
45	promote	promote	VB	_	44	IM
46	normal	normal	JJ	_	48	NMOD
47	thrombus	thrombus	NN	_	48	NMOD
48	formation	formation	NN	_	45	OBJ
49	.	.	.	_	9	P

1	Overall	overall	RB	_	14	ADV
2	,	,	,	_	14	P
3	the	the	DT	_	5	NMOD
4	marked	marked	JJ	_	5	NMOD
5	increase	increase	NN	_	14	SBJ
6	in	in	IN	_	5	NMOD
7	rebleeding	rebleeding	NN	_	8	NMOD
8	times	time	NNS	_	6	PMOD
9	observed	observe	VBN	_	5	NMOD
10	in	in	IN	_	9	LOC
11	certain	certain	JJ	_	13	NMOD
12	mouse	mouse	NN	_	13	NMOD
13	strains	strain	NNS	_	10	PMOD
14	suggests	suggest	VBZ	_	0	ROOT
15	genetic	genetic	JJ	_	16	NMOD
16	factors	factor	NNS	_	20	SBJ
17	other	other	JJ	_	16	NMOD
18	than	than	IN	_	17	AMOD
19	coagulation	coagulation	NN	_	18	PMOD
20	may	may	MD	_	14	OBJ
21	play	play	VB	_	20	VC
22	a	a	DT	_	23	NMOD
23	role	role	NN	_	21	OBJ
24	in	in	IN	_	21	ADV
25	the	the	DT	_	26	NMOD
26	stability	stability	NN	_	24	PMOD
27	of	of	IN	_	26	NMOD
28	a	a	DT	_	29	NMOD
29	thrombus	thrombus	NN	_	27	PMOD
30	.	.	.	_	14	P

1	In	in	IN	_	11	ADV
2	the	the	DT	_	5	NMOD
3	tail	tail	NN	_	4	NMOD
4	bleeding	bleeding	NN	_	5	NMOD
5	assay	assay	NN	_	1	PMOD
6	,	,	,	_	11	P
7	A	a	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	J	j	NN	_	10	NMOD
10	mice	mouse	NNS	_	11	SBJ
11	did	do	VBD	_	0	ROOT
12	not	not	RB	_	11	ADV
13	have	have	VB	_	11	VC
14	changes	change	NNS	_	13	OBJ
15	in	in	IN	_	14	NMOD
16	bleeding	bleeding	NN	_	17	NMOD
17	time	time	NN	_	15	PMOD
18	,	,	,	_	11	P
19	but	but	CC	_	11	COORD
20	rebleeding	rebleeding	NN	_	21	NMOD
21	time	time	NN	_	22	SBJ
22	was	be	VBD	_	19	CONJ
23	higher	high	JJR	_	22	PRD
24	compared	compare	VBN	_	22	ADV
25	to	to	IN	_	24	PMOD
26	B6	b0	NN	_	27	NMOD
27	mice	mouse	NNS	_	25	PMOD
28	.	.	.	_	11	P

1	In	in	IN	_	10	ADV
2	our	our	PRP$	_	3	NMOD
3	study	study	NN	_	1	PMOD
4	,	,	,	_	10	P
5	Plg	plg	NN	_	9	NMOD
6	-	-	SYM	_	5	P
7	/	/	HYPH	_	5	P
8	-	-	SYM	_	5	P
9	mice	mouse	NNS	_	10	SBJ
10	had	have	VBD	_	0	ROOT
11	increased	increase	VBN	_	13	NMOD
12	bleeding	bleeding	NN	_	13	NMOD
13	time	time	NN	_	10	OBJ
14	,	,	,	_	10	P
15	PAI	pai	NN	_	21	SBJ
16	-	-	HYPH	_	15	P
17	1	0	CD	_	15	NMOD
18	-	-	SYM	_	15	P
19	/	/	HYPH	_	15	P
20	-	-	SYM	_	15	P
21	had	have	VBD	_	10	CONJ
22	decreased	decrease	VBN	_	24	NMOD
23	rebleeding	rebleeding	NN	_	24	NMOD
24	time	time	NN	_	21	OBJ
25	,	,	,	_	21	P
26	and	and	CC	_	21	COORD
27	uPA	upa	NN	_	31	NMOD
28	-	-	SYM	_	27	P
29	/	/	HYPH	_	27	P
30	-	-	SYM	_	27	P
31	mice	mouse	NNS	_	32	SBJ
32	had	have	VBD	_	26	CONJ
33	an	an	DT	_	36	NMOD
34	increased	increase	VBN	_	36	NMOD
35	bleeding	bleeding	NN	_	36	NMOD
36	time	time	NN	_	32	OBJ
37	similar	similar	JJ	_	36	NMOD
38	to	to	IN	_	37	AMOD
39	the	the	DT	_	44	NMOD
40	Plg	plg	NN	_	44	NMOD
41	-	-	SYM	_	40	P
42	/	/	HYPH	_	40	P
43	-	-	SYM	_	40	P
44	mice	mouse	NNS	_	38	PMOD
45	(	(	-LRB-	_	46	P
46	J.	j.	NNP	_	32	CIT
47	Hoover	hoover	NNP	_	46	DEP
48	-	-	HYPH	_	47	P
49	Plow	plow	NNP	_	46	DEP
50	,	,	,	_	49	P
51	A.	a.	NNP	_	49	CONJ
52	Shchurin	shchurin	NNP	_	46	DEP
53	,	,	,	_	52	P
54	and	and	CC	_	52	COORD
55	E.	e.	NNP	_	54	CONJ
56	Hart	hart	NNP	_	46	DEP
57	,	,	,	_	46	P
58	unpublished	unpublished	JJ	_	46	DEP
59	results	result	NNS	_	46	DEP
60	)	)	-RRB-	_	46	P
61	.	.	.	_	10	P

1	Increased	increase	VBN	_	5	NMOD
2	bleeding	bleeding	NN	_	5	NMOD
3	or	or	CC	_	2	COORD
4	rebleeding	rebleeding	NN	_	3	CONJ
5	times	time	NNS	_	6	SBJ
6	have	have	VBP	_	0	ROOT
7	not	not	RB	_	6	ADV
8	been	be	VBN	_	6	VC
9	reported	report	VBN	_	8	VC
10	in	in	IN	_	9	LOC
11	any	any	DT	_	10	PMOD
12	of	of	IN	_	11	NMOD
13	the	the	DT	_	17	NMOD
14	Plg	plg	NN	_	15	NMOD
15	network	network	NN	_	16	AMOD
16	targeted	target	VBN	_	17	NMOD
17	mice	mouse	NNS	_	12	PMOD
18	.	.	.	_	6	P

1	Matsuno	matsuno	NNP	_	7	SBJ
2	et	et	FW	_	3	AMOD
3	al	al	FW	_	1	NMOD
4	[	[	-LRB-	_	5	P
5	32	0	CD	_	1	PRN
6	]	]	-RRB-	_	5	P
7	reported	report	VBD	_	0	ROOT
8	no	no	DT	_	9	NMOD
9	difference	difference	NN	_	7	OBJ
10	in	in	IN	_	9	NMOD
11	bleeding	bleeding	NN	_	12	NMOD
12	time	time	NN	_	10	PMOD
13	for	for	IN	_	9	NMOD
14	tPA	tpa	NN	_	24	NMOD
15	-	-	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	-	-	SYM	_	14	P
18	,	,	,	_	24	P
19	uPA	upa	NN	_	24	NMOD
20	-	-	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	-	-	SYM	_	19	P
23	,	,	,	_	24	P
24	PAI	pai	NN	_	30	NMOD
25	-	-	HYPH	_	24	P
26	1	0	CD	_	24	NMOD
27	-	-	SYM	_	24	P
28	/	/	HYPH	_	24	P
29	-	-	SYM	_	24	P
30	mice	mouse	NNS	_	13	PMOD
31	compared	compare	VBN	_	30	NMOD
32	to	to	IN	_	31	PMOD
33	WT	wt	NN	_	34	NMOD
34	mice	mouse	NNS	_	32	PMOD
35	,	,	,	_	7	P
36	and	and	CC	_	7	COORD
37	the	the	DT	_	38	NMOD
38	assay	assay	NN	_	39	SBJ
39	was	be	VBD	_	36	CONJ
40	similar	similar	JJ	_	39	PRD
41	,	,	,	_	7	P
42	but	but	CC	_	7	COORD
43	the	the	DT	_	46	NMOD
44	tail	tail	NN	_	45	NMOD
45	clip	clip	NN	_	46	NMOD
46	segment	segment	NN	_	47	SBJ
47	was	be	VBD	_	42	CONJ
48	considerably	considerably	RB	_	49	AMOD
49	shorter	short	JJR	_	47	PRD
50	and	and	CC	_	47	COORD
51	bleeding	bleeding	NN	_	52	NMOD
52	times	time	NNS	_	50	GAP-SBJ
53	reduced	reduced	JJ	_	52	OPRD
54	compared	compare	VBN	_	52	ADV
55	to	to	IN	_	54	PMOD
56	the	the	DT	_	57	NMOD
57	times	time	NNS	_	55	PMOD
58	reported	report	VBN	_	57	NMOD
59	in	in	IN	_	58	ADV
60	our	our	PRP$	_	61	NMOD
61	study	study	NN	_	59	PMOD
62	.	.	.	_	7	P

1	Bleeding	bleeding	NN	_	2	NMOD
2	time	time	NN	_	3	SBJ
3	has	have	VBZ	_	0	ROOT
4	not	not	RB	_	3	ADV
5	been	be	VBN	_	3	VC
6	previously	previously	RB	_	5	TMP
7	reported	report	VBN	_	5	VC
8	for	for	IN	_	7	ADV
9	Plg	plg	NN	_	13	NMOD
10	-	-	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	-	-	SYM	_	9	P
13	mice	mouse	NNS	_	8	PMOD
14	.	.	.	_	3	P

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	found	find	VBN	_	2	VC
4	similar	similar	JJ	_	5	NMOD
5	values	value	NNS	_	3	OBJ
6	for	for	IN	_	5	NMOD
7	Plg	plg	NN	_	11	NMOD
8	-	-	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	-	-	SYM	_	7	P
11	mice	mouse	NNS	_	6	PMOD
12	in	in	IN	_	11	LOC
13	a	a	DT	_	21	NMOD
14	50	0	CD	_	15	NMOD
15	%	%	NN	_	16	NMOD
16	B6	b0	NN	_	19	NMOD
17	:	:	:	_	19	P
18	50	0	CD	_	19	NMOD
19	%	%	NN	_	21	NMOD
20	129	0	CD	_	19	NMOD
21	background	background	NN	_	12	PMOD
22	(	(	-LRB-	_	23	P
23	J.	j.	NNP	_	3	CIT
24	Hoover	hoover	NNP	_	23	DEP
25	-	-	HYPH	_	24	P
26	Plow	plow	NNP	_	23	DEP
27	,	,	,	_	26	P
28	A.	a.	NNP	_	26	CONJ
29	Shchurin	shchurin	NNP	_	23	DEP
30	,	,	,	_	29	P
31	and	and	CC	_	29	COORD
32	E.	e.	NNP	_	31	CONJ
33	Hart	hart	NNP	_	23	DEP
34	,	,	,	_	23	P
35	unpublished	unpublished	JJ	_	23	DEP
36	results	result	NNS	_	23	DEP
37	)	)	-RRB-	_	23	P
38	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	results	result	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	5	NMOD
5	study	study	NN	_	3	PMOD
6	suggest	suggest	VBP	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	not	not	RB	_	7	COORD
9	only	only	RB	_	8	ADV
10	is	be	VBZ	_	8	CONJ
11	bleeding	bleeding	NN	_	12	NMOD
12	time	time	NN	_	10	SBJ
13	genetically	genetically	RB	_	10	ADV
14	determined	determine	VBN	_	10	VC
15	by	by	IN	_	14	LGS
16	background	background	NN	_	15	PMOD
17	,	,	,	_	7	P
18	but	but	CC	_	7	COORD
19	also	also	RB	_	18	ADV
20	that	that	IN	_	18	CONJ
21	tail	tail	NN	_	22	NMOD
22	rebleeding	rebleeding	NN	_	23	NMOD
23	time	time	NN	_	24	SBJ
24	is	be	VBZ	_	20	SUB
25	genetically	genetically	RB	_	24	MNR
26	determined	determine	VBN	_	24	VC
27	.	.	.	_	6	P

1	While	while	IN	_	18	TMP
2	blood	blood	NN	_	3	NMOD
3	pressure	pressure	NN	_	4	SBJ
4	could	could	MD	_	1	SUB
5	conceivably	conceivably	RB	_	4	ADV
6	be	be	VB	_	4	VC
7	higher	high	JJR	_	6	PRD
8	in	in	IN	_	6	LOC
9	mice	mouse	NNS	_	8	PMOD
10	with	with	IN	_	9	NMOD
11	elevated	elevate	VBN	_	14	NMOD
12	tail	tail	NN	_	13	NMOD
13	bleeding	bleeding	NN	_	14	NMOD
14	time	time	NN	_	10	PMOD
15	,	,	,	_	18	P
16	several	several	JJ	_	17	NMOD
17	studies	study	NNS	_	18	SBJ
18	suggest	suggest	VBP	_	0	ROOT
19	that	that	IN	_	18	OBJ
20	this	this	DT	_	21	SBJ
21	is	be	VBZ	_	19	SUB
22	not	not	RB	_	21	ADV
23	the	the	DT	_	24	NMOD
24	case	case	NN	_	21	PRD
25	.	.	.	_	18	P

1	Studies	study	NNS	_	12	SBJ
2	of	of	IN	_	1	NMOD
3	A	a	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	J	j	NN	_	11	NMOD
6	[	[	-LRB-	_	7	P
7	33	0	CD	_	5	PRN
8	-	-	SYM	_	9	P
9	36	0	CD	_	7	NMOD
10	]	]	-RRB-	_	7	P
11	mice	mouse	NNS	_	2	PMOD
12	have	have	VBP	_	0	ROOT
13	reported	report	VBN	_	12	VC
14	either	either	CC	_	17	COORD
15	decreased	decrease	VBN	_	17	NMOD
16	blood	blood	NN	_	17	NMOD
17	pressure	pressure	NN	_	13	OBJ
18	or	or	CC	_	17	COORD
19	no	no	DT	_	20	NMOD
20	difference	difference	NN	_	18	CONJ
21	compared	compare	VBN	_	17	NMOD
22	to	to	IN	_	21	PMOD
23	the	the	DT	_	25	NMOD
24	B6	b0	NN	_	25	NMOD
25	mice	mouse	NNS	_	22	PMOD
26	.	.	.	_	12	P

1	Blood	blood	NN	_	2	NMOD
2	pressure	pressure	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	measured	measure	VBN	_	3	VC
5	in	in	IN	_	4	LOC
6	the	the	DT	_	11	NMOD
7	Plg	plg	NN	_	11	NMOD
8	-	-	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	-	-	SYM	_	7	P
11	mice	mouse	NNS	_	5	PMOD
12	(	(	-LRB-	_	13	P
13	D.	d.	NNP	_	4	CIT
14	Hellard	hellard	NNP	_	13	DEP
15	,	,	,	_	14	P
16	J.	j.	NNP	_	14	CONJ
17	Hoover	hoover	NNP	_	13	DEP
18	-	-	HYPH	_	17	P
19	Plow	plow	NNP	_	13	DEP
20	,	,	,	_	19	P
21	and	and	CC	_	19	COORD
22	E.	e.	NNP	_	21	CONJ
23	Plow	plow	NNP	_	13	DEP
24	,	,	,	_	13	P
25	unpublished	unpublished	JJ	_	13	DEP
26	results	result	NNS	_	13	DEP
27	)	)	-RRB-	_	13	P
28	,	,	,	_	3	P
29	and	and	CC	_	3	COORD
30	these	these	DT	_	31	NMOD
31	mice	mouse	NNS	_	32	SBJ
32	have	have	VBP	_	29	CONJ
33	reduced	reduce	VBN	_	35	NMOD
34	blood	blood	NN	_	35	NMOD
35	pressure	pressure	NN	_	32	OBJ
36	when	when	WRB	_	37	TMP
37	compared	compare	VBN	_	32	TMP
38	to	to	IN	_	37	ADV
39	WT	wt	JJ	_	40	NMOD
40	littermates	littermates	NNS	_	38	PMOD
41	,	,	,	_	32	P
42	and	and	CC	_	32	COORD
43	uPA	upa	NN	_	57	NMOD
44	-	-	SYM	_	43	P
45	/	/	HYPH	_	43	P
46	-	-	SYM	_	43	P
47	[	[	-LRB-	_	48	P
48	37	0	CD	_	43	PRN
49	]	]	-RRB-	_	48	P
50	and	and	CC	_	43	COORD
51	Lepob	lepob	NN	_	50	CONJ
52	[	[	-LRB-	_	55	P
53	38	0	CD	_	55	NMOD
54	,	,	,	_	55	P
55	39	0	CD	_	51	PRN
56	]	]	-RRB-	_	55	P
57	mice	mouse	NNS	_	59	SBJ
58	also	also	RB	_	59	ADV
59	have	have	VBP	_	42	CONJ
60	reduced	reduce	VBN	_	62	NMOD
61	blood	blood	NN	_	62	NMOD
62	pressure	pressure	NN	_	59	OBJ
63	,	,	,	_	3	P
64	but	but	CC	_	3	COORD
65	there	there	EX	_	66	SBJ
66	is	be	VBZ	_	64	CONJ
67	no	no	DT	_	68	NMOD
68	correspondence	correspondence	NN	_	66	PRD
69	between	between	IN	_	68	NMOD
70	blood	blood	NN	_	71	NMOD
71	pressure	pressure	NN	_	69	PMOD
72	and	and	CC	_	71	COORD
73	tail	tail	NN	_	77	NMOD
74	bleeding	bleeding	NN	_	77	NMOD
75	or	or	CC	_	74	COORD
76	rebleeding	rebleeding	NN	_	75	CONJ
77	times	time	NNS	_	72	CONJ
78	.	.	.	_	3	P

1	Morphometric	morphometric	JJ	_	2	NMOD
2	analysis	analysis	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	tail	tail	NN	_	3	PMOD
6	indicated	indicate	VBD	_	0	ROOT
7	a	a	DT	_	8	NMOD
8	difference	difference	NN	_	6	OBJ
9	in	in	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	collagen	collagen	NN	_	12	NMOD
12	content	content	NN	_	9	PMOD
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	15	NMOD
15	tail	tail	NN	_	13	PMOD
16	in	in	IN	_	8	LOC
17	the	the	DT	_	21	NMOD
18	A	a	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	J	j	NN	_	21	NMOD
21	mice	mouse	NNS	_	16	PMOD
22	.	.	.	_	6	P

1	Differences	difference	NNS	_	15	SBJ
2	in	in	IN	_	1	NMOD
3	the	the	DT	_	4	NMOD
4	structure	structure	NN	_	2	PMOD
5	and	and	CC	_	4	COORD
6	/	/	HYPH	_	5	P
7	or	or	CC	_	5	COORD
8	metabolism	metabolism	NN	_	5	CONJ
9	of	of	IN	_	4	NMOD
10	collagen	collagen	NN	_	9	PMOD
11	or	or	CC	_	10	COORD
12	extracellular	extracellular	JJ	_	14	NMOD
13	matrix	matrix	NN	_	14	NMOD
14	proteins	protein	NNS	_	11	CONJ
15	may	may	MD	_	0	ROOT
16	contribute	contribute	VB	_	15	VC
17	to	to	IN	_	16	ADV
18	the	the	DT	_	24	NMOD
19	increased	increase	VBN	_	20	NMOD
20	rebleeding	rebleeding	NN	_	24	NMOD
21	and	and	CC	_	20	COORD
22	reduced	reduce	VBD	_	23	NMOD
23	occlusion	occlusion	NN	_	21	CONJ
24	time	time	NN	_	17	PMOD
25	in	in	IN	_	16	LOC
26	the	the	DT	_	30	NMOD
27	A	a	NN	_	29	NMOD
28	/	/	HYPH	_	27	P
29	J	j	NN	_	30	NMOD
30	mice	mouse	NNS	_	25	PMOD
31	and	and	CC	_	16	COORD
32	warrant	warrant	VB	_	31	CONJ
33	further	further	JJ	_	34	NMOD
34	investigation	investigation	NN	_	32	OBJ
35	.	.	.	_	15	P

1	The	the	DT	_	2	NMOD
2	genes	gene	NNS	_	14	SBJ
3	for	for	IN	_	2	NMOD
4	Plg	plg	NN	_	3	PMOD
5	,	,	,	_	4	P
6	PAI	pai	NN	_	4	CONJ
7	-	-	HYPH	_	6	P
8	1	0	CD	_	6	NMOD
9	,	,	,	_	6	P
10	and	and	CC	_	6	COORD
11	α2	α0	NN	_	13	NMOD
12	-	-	HYPH	_	11	P
13	antiplasmin	antiplasmin	NN	_	10	CONJ
14	reside	reside	VBP	_	0	ROOT
15	on	on	IN	_	14	ADV
16	the	the	DT	_	18	NMOD
17	three	three	CD	_	18	NMOD
18	chromosomes	chromosome	NNS	_	15	PMOD
19	identified	identify	VBN	_	18	NMOD
20	for	for	IN	_	19	ADV
21	QTL	qtl	NN	_	20	PMOD
22	for	for	IN	_	21	NMOD
23	rebleeding	rebleeding	NN	_	24	NMOD
24	time	time	NN	_	22	PMOD
25	and	and	CC	_	14	COORD
26	may	may	MD	_	25	CONJ
27	or	or	CC	_	26	COORD
28	may	may	MD	_	27	CONJ
29	not	not	RB	_	28	ADV
30	be	be	VB	_	28	DEP
31	coincidental	coincidental	JJ	_	30	PRD
32	to	to	IN	_	31	AMOD
33	the	the	DT	_	35	NMOD
34	observed	observe	VBN	_	35	NMOD
35	phenotypes	phenotype	NNS	_	32	PMOD
36	found	find	VBN	_	35	NMOD
37	in	in	IN	_	36	LOC
38	the	the	DT	_	42	NMOD
39	A	a	NN	_	41	NMOD
40	/	/	HYPH	_	39	P
41	J	j	NN	_	42	NMOD
42	mice	mouse	NNS	_	37	PMOD
43	and	and	CC	_	42	COORD
44	CSS	cs	NNS	_	43	CONJ
45	.	.	.	_	14	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	not	not	RB	_	2	ADV
4	likely	likely	JJ	_	2	PRD
5	that	that	IN	_	2	OBJ
6	merely	merely	RB	_	8	NMOD
7	the	the	DT	_	8	NMOD
8	concentration	concentration	NN	_	12	SBJ
9	of	of	IN	_	8	NMOD
10	these	these	DT	_	11	NMOD
11	components	component	NNS	_	9	PMOD
12	explains	explain	VBZ	_	5	SUB
13	the	the	DT	_	16	NMOD
14	increased	increase	VBN	_	16	NMOD
15	rebleeding	rebleeding	NN	_	16	NMOD
16	time	time	NN	_	12	OBJ
17	and	and	CC	_	16	COORD
18	reduced	reduce	VBN	_	21	NMOD
19	arterial	arterial	JJ	_	20	NMOD
20	occlusion	occlusion	NN	_	21	NMOD
21	time	time	NN	_	17	CONJ
22	in	in	IN	_	16	LOC
23	the	the	DT	_	27	NMOD
24	A	a	NN	_	26	NMOD
25	/	/	HYPH	_	24	P
26	J	j	NN	_	27	NMOD
27	mice	mouse	NNS	_	22	PMOD
28	.	.	.	_	2	P

1	When	when	WRB	_	2	TMP
2	compared	compare	VBN	_	21	TMP
3	to	to	IN	_	2	ADV
4	the	the	DT	_	6	NMOD
5	B6	b0	NN	_	6	NMOD
6	mice	mouse	NNS	_	3	PMOD
7	,	,	,	_	21	P
8	the	the	DT	_	12	NMOD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	12	NMOD
12	mice	mouse	NNS	_	21	SBJ
13	and	and	CC	_	12	COORD
14	the	the	DT	_	16	NMOD
15	three	three	CD	_	16	NMOD
16	strains	strain	NNS	_	13	CONJ
17	with	with	IN	_	12	NMOD
18	elevated	elevated	JJ	_	20	NMOD
19	rebleeding	rebleeding	NN	_	20	NMOD
20	time	time	NN	_	17	PMOD
21	had	have	VBD	_	0	ROOT
22	variable	variable	JJ	_	23	NMOD
23	Plg	plg	NN	_	21	OBJ
24	,	,	,	_	23	P
25	PAI	pai	NN	_	23	CONJ
26	-	-	HYPH	_	25	P
27	1	0	CD	_	25	NMOD
28	,	,	,	_	25	P
29	and	and	CC	_	25	COORD
30	α2	α0	NN	_	32	NMOD
31	-	-	HYPH	_	30	P
32	antiplasmin	antiplasmin	NN	_	29	CONJ
33	.	.	.	_	21	P

1	Two	two	CD	_	3	NMOD
2	allelic	allelic	JJ	_	3	NMOD
3	forms	form	NNS	_	9	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	8	NMOD
6	mouse	mouse	NN	_	8	NMOD
7	Plg	plg	NN	_	8	NMOD
8	gene	gene	NN	_	4	PMOD
9	have	have	VBP	_	0	ROOT
10	been	be	VBN	_	9	VC
11	reported	report	VBN	_	10	VC
12	for	for	IN	_	11	ADV
13	B6	b0	NN	_	18	NMOD
14	and	and	CC	_	13	COORD
15	A	a	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	J	j	NN	_	14	CONJ
18	mice	mouse	NNS	_	12	PMOD
19	[	[	-LRB-	_	20	P
20	40	0	CD	_	11	PRN
21	]	]	-RRB-	_	20	P
22	.	.	.	_	9	P

1	Plg	plg	NN	_	2	NMOD
2	concentration	concentration	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	increased	increase	VBN	_	3	VC
5	in	in	IN	_	4	LOC
6	A	a	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	J	j	NN	_	9	NMOD
9	mice	mouse	NNS	_	5	PMOD
10	compared	compare	VBN	_	4	ADV
11	to	to	IN	_	10	PMOD
12	B6	b0	NN	_	13	NMOD
13	mice	mouse	NNS	_	11	PMOD
14	.	.	.	_	3	P

1	Although	although	IN	_	12	ADV
2	we	we	PRP	_	3	SBJ
3	did	do	VBD	_	1	SUB
4	not	not	RB	_	3	ADV
5	detect	detect	VB	_	3	VC
6	differences	difference	NNS	_	5	OBJ
7	in	in	IN	_	6	NMOD
8	Plg	plg	NN	_	9	NMOD
9	structure	structure	NN	_	7	PMOD
10	,	,	,	_	12	P
11	this	this	DT	_	12	SBJ
12	would	would	MD	_	0	ROOT
13	not	not	RB	_	12	ADV
14	exclude	exclude	VB	_	12	VC
15	possible	possible	JJ	_	17	NMOD
16	functional	functional	JJ	_	17	NMOD
17	differences	difference	NNS	_	14	OBJ
18	.	.	.	_	12	P

1	A	a	DT	_	3	NMOD
2	congenic	congenic	JJ	_	3	NMOD
3	strain	strain	NN	_	36	SBJ
4	(	(	-LRB-	_	3	P
5	specific	specific	JJ	_	3	NMOD
6	for	for	IN	_	5	AMOD
7	a	a	DT	_	9	NMOD
8	homosomic	homosomic	JJ	_	9	NMOD
9	region	region	NN	_	6	PMOD
10	from	from	IN	_	9	NMOD
11	A	a	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	J	j	NN	_	10	PMOD
14	and	and	CC	_	13	COORD
15	the	the	DT	_	17	NMOD
16	remaining	remain	VBG	_	17	NMOD
17	Chr	chr	NN	_	14	CONJ
18	and	and	CC	_	20	COORD
19	background	background	NN	_	20	SBJ
20	is	be	VBZ	_	9	PRN
21	from	from	IN	_	20	PRD
22	B6	b0	NN	_	23	NMOD
23	mice	mouse	NNS	_	21	PMOD
24	)	)	-RRB-	_	20	P
25	of	of	IN	_	3	NMOD
26	A	a	NN	_	28	NMOD
27	/	/	HYPH	_	26	P
28	J	j	NN	_	29	NMOD
29	chromosome	chromosome	NN	_	25	PMOD
30	17	0	CD	_	29	NMOD
31	that	that	WDT	_	32	SBJ
32	includes	include	VBZ	_	3	NMOD
33	the	the	DT	_	35	NMOD
34	Plg	plg	NN	_	35	NMOD
35	gene	gene	NN	_	32	OBJ
36	was	be	VBD	_	0	ROOT
37	tested	test	VBN	_	36	VC
38	in	in	IN	_	37	ADV
39	the	the	DT	_	41	NMOD
40	bleeding	bleeding	NN	_	41	NMOD
41	assay	assay	NN	_	38	PMOD
42	.	.	.	_	36	P

1	Values	value	NNS	_	10	SBJ
2	for	for	IN	_	1	NMOD
3	bleeding	bleeding	NN	_	2	PMOD
4	and	and	CC	_	3	COORD
5	rebleeding	rebleeding	NN	_	4	CONJ
6	in	in	IN	_	1	LOC
7	this	this	DT	_	9	NMOD
8	congenic	congenic	JJ	_	9	NMOD
9	strain	strain	NN	_	6	PMOD
10	were	be	VBD	_	0	ROOT
11	similar	similar	JJ	_	10	PRD
12	to	to	IN	_	11	AMOD
13	values	value	NNS	_	12	PMOD
14	from	from	IN	_	13	NMOD
15	B6	b0	NN	_	16	NMOD
16	mice	mouse	NNS	_	14	PMOD
17	,	,	,	_	10	P
18	indicating	indicate	VBG	_	10	ADV
19	that	that	IN	_	18	OBJ
20	the	the	DT	_	21	NMOD
21	QTL	qtl	NN	_	22	SBJ
22	is	be	VBZ	_	19	SUB
23	not	not	RB	_	22	ADV
24	Plg	plg	NN	_	22	PRD
25	.	.	.	_	10	P

1	There	there	EX	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	genes	gene	NNS	_	2	PRD
4	for	for	IN	_	3	NMOD
5	other	other	JJ	_	6	NMOD
6	proteases	protease	NNS	_	4	PMOD
7	and	and	CC	_	6	COORD
8	matrix	matrix	NN	_	9	NMOD
9	proteins	protein	NNS	_	7	CONJ
10	that	that	WDT	_	11	SBJ
11	reside	reside	VBP	_	6	NMOD
12	on	on	IN	_	11	ADV
13	chromosome	chromosome	NN	_	12	PMOD
14	17	0	CD	_	13	NMOD
15	in	in	IN	_	2	ADV
16	addition	addition	NN	_	15	PMOD
17	to	to	IN	_	16	NMOD
18	unknown	unknown	JJ	_	19	NMOD
19	genes	gene	NNS	_	17	PMOD
20	.	.	.	_	2	P

1	DNA	dna	NN	_	5	NMOD
2	base	base	NN	_	4	NMOD
3	pair	pair	NN	_	4	NMOD
4	sequence	sequence	NN	_	5	NMOD
5	data	datum	NNS	_	25	SBJ
6	for	for	IN	_	5	NMOD
7	the	the	DT	_	11	NMOD
8	PAI	pai	NN	_	11	NMOD
9	-	-	HYPH	_	8	P
10	1	0	CD	_	8	NMOD
11	gene	gene	NN	_	6	PMOD
12	or	or	CC	_	11	COORD
13	the	the	DT	_	17	NMOD
14	α2	α0	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	antiplasmin	antiplasmin	NN	_	17	NMOD
17	gene	gene	NN	_	12	CONJ
18	in	in	IN	_	5	LOC
19	B6	b0	NN	_	24	NMOD
20	and	and	CC	_	19	COORD
21	A	a	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	J	j	NN	_	20	CONJ
24	mice	mouse	NNS	_	18	PMOD
25	have	have	VBP	_	0	ROOT
26	reported	report	VBN	_	25	VC
27	no	no	DT	_	28	NMOD
28	differences	difference	NNS	_	26	OBJ
29	[	[	-LRB-	_	30	P
30	51	0	CD	_	26	PRN
31	]	]	-RRB-	_	30	P
32	,	,	,	_	25	P
33	but	but	CC	_	25	COORD
34	regulatory	regulatory	JJ	_	35	NMOD
35	genes	gene	NNS	_	41	SBJ
36	upstream	upstream	RB	_	35	LOC
37	of	of	IN	_	36	AMOD
38	the	the	DT	_	40	NMOD
39	coding	code	VBG	_	40	NMOD
40	region	region	NN	_	37	PMOD
41	may	may	MD	_	33	CONJ
42	be	be	VB	_	41	VC
43	important	important	JJ	_	42	PRD
44	.	.	.	_	25	P

1	Our	our	PRP$	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	novel	novel	JJ	_	8	NMOD
6	or	or	CC	_	5	COORD
7	unknown	unknown	JJ	_	6	CONJ
8	genes	gene	NNS	_	9	SBJ
9	may	may	MD	_	4	SUB
10	interact	interact	VB	_	9	VC
11	with	with	IN	_	10	ADV
12	the	the	DT	_	15	NMOD
13	Plg	plg	NN	_	14	NMOD
14	system	system	NN	_	15	NMOD
15	components	component	NNS	_	11	PMOD
16	to	to	TO	_	10	PRP
17	modify	modify	VB	_	16	IM
18	their	their	PRP$	_	19	NMOD
19	function	function	NN	_	17	OBJ
20	.	.	.	_	3	P

1	In	in	IN	_	6	ADV
2	summary	summary	NN	_	1	PMOD
3	,	,	,	_	6	P
4	this	this	DT	_	5	NMOD
5	study	study	NN	_	6	SBJ
6	reports	report	VBZ	_	0	ROOT
7	marked	marked	JJ	_	8	NMOD
8	differences	difference	NNS	_	6	OBJ
9	in	in	IN	_	8	LOC
10	two	two	CD	_	12	NMOD
11	inbred	inbred	JJ	_	12	NMOD
12	strains	strain	NNS	_	9	PMOD
13	of	of	IN	_	12	NMOD
14	mice	mouse	NNS	_	13	PMOD
15	,	,	,	_	12	P
16	B6	b0	NN	_	12	APPO
17	and	and	CC	_	16	COORD
18	A	a	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	J	j	NN	_	17	CONJ
21	,	,	,	_	8	P
22	in	in	IN	_	8	NMOD
23	arterial	arterial	JJ	_	24	NMOD
24	thrombosis	thrombosis	NN	_	25	NMOD
25	formation	formation	NN	_	22	PMOD
26	in	in	IN	_	25	NMOD
27	a	a	DT	_	31	NMOD
28	FeCl3	fecl0	NN	_	31	NMOD
29	vascular	vascular	JJ	_	30	NMOD
30	injury	injury	NN	_	31	NMOD
31	model	model	NN	_	26	PMOD
32	,	,	,	_	25	P
33	rebleeding	rebleeding	NN	_	34	NMOD
34	time	time	NN	_	25	CONJ
35	in	in	IN	_	34	NMOD
36	a	a	DT	_	39	NMOD
37	tail	tail	NN	_	38	NMOD
38	bleeding	bleeding	NN	_	39	NMOD
39	assay	assay	NN	_	35	PMOD
40	,	,	,	_	34	P
41	plasminogen	plasminogen	NN	_	42	NMOD
42	function	function	NN	_	34	CONJ
43	,	,	,	_	42	P
44	and	and	CC	_	42	COORD
45	tissue	tissue	NN	_	49	NMOD
46	and	and	CC	_	45	COORD
47	vessel	vessel	NN	_	46	CONJ
48	collagen	collagen	NN	_	49	NMOD
49	deposition	deposition	NN	_	44	CONJ
50	.	.	.	_	6	P

1	Three	three	CD	_	2	NMOD
2	chromosomes	chromosome	NNS	_	8	SBJ
3	from	from	IN	_	2	NMOD
4	A	a	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	J	j	NN	_	7	NMOD
7	mice	mouse	NNS	_	3	PMOD
8	were	be	VBD	_	0	ROOT
9	identified	identify	VBN	_	8	VC
10	that	that	WDT	_	11	SBJ
11	had	have	VBD	_	2	NMOD
12	QTL	qtl	NN	_	11	OBJ
13	for	for	IN	_	12	NMOD
14	rebleeding	rebleeding	NN	_	15	NMOD
15	time	time	NN	_	13	PMOD
16	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	genes	gene	NNS	_	3	SBJ
3	may	may	MD	_	0	ROOT
4	interact	interact	VB	_	3	VC
5	with	with	IN	_	4	ADV
6	components	component	NNS	_	5	PMOD
7	in	in	IN	_	6	NMOD
8	the	the	DT	_	10	NMOD
9	Plg	plg	NN	_	10	NMOD
10	network	network	NN	_	7	PMOD
11	and	and	CC	_	4	COORD
12	modulate	modulate	VB	_	11	CONJ
13	arterial	arterial	JJ	_	14	NMOD
14	occlusion	occlusion	NN	_	15	NMOD
15	time	time	NN	_	12	OBJ
16	.	.	.	_	3	P

1	Conclusion	conclusion	NN	_	0	ROOT

1	The	the	DT	_	4	NMOD
2	marked	marked	JJ	_	4	NMOD
3	independent	independent	JJ	_	4	NMOD
4	differences	difference	NNS	_	14	SBJ
5	demonstrated	demonstrate	VBN	_	4	NMOD
6	in	in	IN	_	5	LOC
7	the	the	DT	_	13	NMOD
8	B6	b0	NN	_	13	NMOD
9	and	and	CC	_	8	COORD
10	A	a	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	J	j	NN	_	9	CONJ
13	mice	mouse	NNS	_	6	PMOD
14	can	can	MD	_	0	ROOT
15	be	be	VB	_	14	VC
16	exploited	exploit	VBN	_	15	VC
17	to	to	TO	_	16	PRP
18	identify	identify	VB	_	17	IM
19	genetic	genetic	JJ	_	20	NMOD
20	determinants	determinant	NNS	_	18	OBJ
21	of	of	IN	_	20	NMOD
22	thrombosis	thrombosis	NN	_	21	PMOD
23	and	and	CC	_	22	COORD
24	haemostasis	haemostasis	NN	_	23	CONJ
25	.	.	.	_	14	P

1	Our	our	PRP$	_	2	NMOD
2	results	result	NNS	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	CSS	cs	NN	_	6	NMOD
6	screening	screening	NN	_	3	PMOD
7	suggest	suggest	VBP	_	0	ROOT
8	that	that	IN	_	7	OBJ
9	novel	novel	JJ	_	12	NMOD
10	or	or	CC	_	9	COORD
11	unknown	unknown	JJ	_	10	CONJ
12	genes	gene	NNS	_	13	SBJ
13	can	can	MD	_	8	SUB
14	be	be	VB	_	13	VC
15	used	use	VBN	_	14	VC
16	to	to	TO	_	15	PRP
17	identify	identify	VB	_	16	IM
18	the	the	DT	_	19	NMOD
19	genes	gene	NNS	_	17	OBJ
20	responsible	responsible	JJ	_	19	NMOD
21	for	for	IN	_	20	AMOD
22	the	the	DT	_	23	NMOD
23	traits	trait	NNS	_	21	PMOD
24	related	relate	VBN	_	23	NMOD
25	to	to	IN	_	24	AMOD
26	arterial	arterial	JJ	_	27	NMOD
27	thrombosis	thrombosis	NN	_	25	PMOD
28	,	,	,	_	23	P
29	tail	tail	NN	_	32	NMOD
30	bleeding	bleeding	NN	_	32	NMOD
31	/	/	HYPH	_	30	P
32	rebleeding	rebleeding	NN	_	23	APPO
33	and	and	CC	_	32	COORD
34	vessel	vessel	NN	_	36	NMOD
35	extracellular	extracellular	JJ	_	36	NMOD
36	matrix	matrix	NN	_	33	CONJ
37	.	.	.	_	7	P

1	Identification	identification	NN	_	22	SBJ
2	of	of	IN	_	1	NMOD
3	differences	difference	NNS	_	2	PMOD
4	in	in	IN	_	3	LOC
5	the	the	DT	_	7	NMOD
6	parent	parent	NN	_	7	NMOD
7	strains	strain	NNS	_	4	PMOD
8	,	,	,	_	3	P
9	such	such	JJ	_	10	PMOD
10	as	as	IN	_	3	NMOD
11	those	those	DT	_	10	PMOD
12	described	describe	VBN	_	11	NMOD
13	in	in	IN	_	12	ADV
14	this	this	DT	_	15	NMOD
15	study	study	NN	_	13	PMOD
16	,	,	,	_	1	P
17	and	and	CC	_	1	COORD
18	screening	screening	NN	_	17	CONJ
19	of	of	IN	_	18	NMOD
20	the	the	DT	_	21	NMOD
21	CSS	cs	NN	_	19	PMOD
22	is	be	VBZ	_	0	ROOT
23	a	a	DT	_	26	NMOD
24	first	$#ORD#$	JJ	_	26	NMOD
25	-	-	HYPH	_	24	P
26	step	step	NN	_	22	PRD
27	in	in	IN	_	26	NMOD
28	the	the	DT	_	29	NMOD
29	discovery	discovery	NN	_	27	PMOD
30	of	of	IN	_	29	NMOD
31	new	new	JJ	_	33	NMOD
32	genetic	genetic	JJ	_	33	NMOD
33	determinants	determinant	NNS	_	30	PMOD
34	of	of	IN	_	33	NMOD
35	thrombotic	thrombotic	JJ	_	36	NMOD
36	risk	risk	NN	_	34	PMOD
37	.	.	.	_	22	P

1	Abbreviations	abbreviation	NNS	_	0	ROOT

1	B6	b0	NN	_	5	SBJ
2	=	=	SYM	_	5	P
3	C57BL	c0bl	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	6J	0j	NN	_	0	ROOT

1	CSS	cs	NNS	_	5	SBJ
2	=	=	SYM	_	5	P
3	chromosome	chromosome	NN	_	5	NMOD
4	substitution	substitution	NN	_	5	NMOD
5	strains	strain	NNS	_	0	ROOT

1	CSS	cs	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	#	#	NN	_	11	SBJ
4	=	=	SYM	_	11	P
5	B6	b0	NN	_	7	NMOD
6	-	-	HYPH	_	5	P
7	Chr	chr	NN	_	11	NMOD
8	#	#	NN	_	11	NMOD
9	A	a	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	J	j	NN	_	0	ROOT

1	CSS	cs	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	#	#	NN	_	4	NMOD
4	F1	f0	NN	_	13	SBJ
5	=	=	SYM	_	13	P
6	(	(	-LRB-	_	13	P
7	B6	b0	NN	_	9	NMOD
8	×	×	SYM	_	9	P
9	CSS	cs	NN	_	13	NMOD
10	-	-	HYPH	_	9	P
11	#	#	NN	_	13	NMOD
12	)	)	-RRB-	_	13	P
13	F1	f0	NN	_	0	ROOT

1	WT	wt	NN	_	5	SBJ
2	=	=	SYM	_	5	P
3	wild	wild	JJ	_	5	NMOD
4	-	-	HYPH	_	3	P
5	type	type	NN	_	0	ROOT

1	-	-	SYM	_	3	P
2	/	/	HYPH	_	3	P
3	-	-	SYM	_	5	SBJ
4	=	=	SYM	_	5	P
5	deficient	deficient	JJ	_	0	ROOT

1	Plg	plg	NN	_	3	SBJ
2	=	=	SYM	_	3	P
3	plasminogen	plasminogen	NN	_	0	ROOT

1	PAI	pai	NN	_	7	SBJ
2	-	-	HYPH	_	1	P
3	1	0	CD	_	1	NMOD
4	=	=	SYM	_	7	P
5	plasminogen	plasminogen	NN	_	6	NMOD
6	activator	activator	NN	_	7	NMOD
7	inhibitor	inhibitor	NN	_	0	ROOT
8	-	-	HYPH	_	7	P
9	1	0	CD	_	7	NMOD

1	tPA	tpa	NN	_	5	SBJ
2	=	=	SYM	_	5	P
3	tissue	tissue	NN	_	4	NMOD
4	plasminogen	plasminogen	NN	_	5	NMOD
5	activator	activator	NN	_	0	ROOT

1	uPA	upa	NN	_	5	SBJ
2	=	=	SYM	_	5	P
3	urokinase	urokinase	NN	_	4	NMOD
4	plasminogen	plasminogen	NN	_	5	NMOD
5	activator	activator	NN	_	0	ROOT

1	SEM	sem	NN	_	4	SBJ
2	=	=	SYM	_	4	P
3	standard	standard	JJ	_	4	NMOD
4	error	error	NN	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	mean	mean	NN	_	5	PMOD

1	QTL	qtl	NN	_	5	SBJ
2	=	=	SYM	_	5	P
3	quantitative	quantitative	JJ	_	4	NMOD
4	trait	trait	NN	_	5	NMOD
5	locus	locus	NN	_	0	ROOT

1	Competing	compete	VBG	_	2	NMOD
2	interests	interest	NNS	_	0	ROOT

1	The	the	DT	_	2	NMOD
2	author	author	NN	_	6	SBJ
3	(	(	-LRB-	_	2	P
4	s	s	AFX	_	2	NMOD
5	)	)	-RRB-	_	2	P
6	declare	declare	VBP	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	they	they	PRP	_	9	SBJ
9	have	have	VBP	_	7	SUB
10	no	no	DT	_	12	NMOD
11	competing	compete	VBG	_	12	NMOD
12	interests	interest	NNS	_	9	OBJ
13	.	.	.	_	6	P

1	Authors	author	NNS	_	3	NMOD
2	'	'	POS	_	1	NMOD
3	contributions	contribution	NNS	_	0	ROOT

1	JHP	jhp	NNP	_	2	SBJ
2	conceived	conceive	VBD	_	0	ROOT
3	and	and	CC	_	2	COORD
4	designed	design	VBD	_	3	CONJ
5	the	the	DT	_	6	NMOD
6	study	study	NN	_	2	OBJ
7	,	,	,	_	2	P
8	coordinated	coordinate	VBD	_	2	CONJ
9	the	the	DT	_	10	NMOD
10	experiments	experiment	NNS	_	8	OBJ
11	and	and	CC	_	8	COORD
12	drafted	draft	VBD	_	11	CONJ
13	the	the	DT	_	14	NMOD
14	manuscript	manuscript	NN	_	12	OBJ
15	.	.	.	_	2	P

1	AS	a	NNP	_	2	SBJ
2	developed	develop	VBD	_	0	ROOT
3	and	and	CC	_	2	COORD
4	performed	perform	VBD	_	3	CONJ
5	the	the	DT	_	8	NMOD
6	tail	tail	NN	_	7	NMOD
7	bleeding	bleeding	NN	_	8	NMOD
8	assay	assay	NN	_	2	OBJ
9	and	and	CC	_	2	COORD
10	participated	participate	VBD	_	9	CONJ
11	in	in	IN	_	10	ADV
12	drafting	draft	VBG	_	11	PMOD
13	the	the	DT	_	14	NMOD
14	manuscript	manuscript	NN	_	12	OBJ
15	.	.	.	_	2	P

1	EH	eh	NNP	_	2	SBJ
2	carried	carry	VBD	_	0	ROOT
3	out	out	RP	_	2	PRT
4	the	the	DT	_	7	NMOD
5	vascular	vascular	JJ	_	6	NMOD
6	injury	injury	NN	_	7	NMOD
7	model	model	NN	_	2	OBJ
8	and	and	CC	_	7	COORD
9	analyses	analysis	NNS	_	8	CONJ
10	and	and	CC	_	9	COORD
11	the	the	DT	_	14	NMOD
12	tail	tail	NN	_	13	NMOD
13	bleeding	bleeding	NN	_	14	NMOD
14	assay	assay	NN	_	10	CONJ
15	,	,	,	_	2	P
16	participated	participate	VBD	_	2	VC
17	in	in	IN	_	16	ADV
18	the	the	DT	_	21	NMOD
19	tail	tail	NN	_	20	NMOD
20	collagen	collagen	NN	_	21	NMOD
21	analyses	analysis	NNS	_	17	PMOD
22	,	,	,	_	21	P
23	and	and	CC	_	21	COORD
24	coordination	coordination	NN	_	23	CONJ
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	28	NMOD
27	mouse	mouse	NN	_	28	NMOD
28	breeding	breeding	NN	_	25	PMOD
29	.	.	.	_	2	P

1	JS	j	NNP	_	2	SBJ
2	participated	participate	VBD	_	0	ROOT
3	in	in	IN	_	2	ADV
4	the	the	DT	_	5	NMOD
5	analysis	analysis	NN	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	11	NMOD
8	vascular	vascular	JJ	_	9	NMOD
9	injury	injury	NN	_	10	NMOD
10	model	model	NN	_	11	NMOD
11	results	result	NNS	_	6	PMOD
12	and	and	CC	_	5	COORD
13	collagen	collagen	NN	_	14	NMOD
14	analyses	analysis	NNS	_	12	CONJ
15	.	.	.	_	2	P

1	JHN	jhn	NNP	_	4	SBJ
2	and	and	CC	_	1	COORD
3	AHE	ahe	NNP	_	2	CONJ
4	provided	provide	VBD	_	0	ROOT
5	the	the	DT	_	8	NMOD
6	CSS	cs	NN	_	8	NMOD
7	breeding	breeding	NN	_	8	NMOD
8	pairs	pair	NNS	_	4	OBJ
9	,	,	,	_	4	P
10	JHN	jhn	NNP	_	11	SBJ
11	participated	participate	VBD	_	4	CONJ
12	in	in	IN	_	11	ADV
13	discussions	discussion	NNS	_	12	PMOD
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	16	NMOD
16	results	result	NNS	_	14	PMOD
17	,	,	,	_	11	P
18	and	and	CC	_	11	COORD
19	JBS	jbs	NNP	_	22	SBJ
20	and	and	CC	_	19	COORD
21	JHN	jhn	NNP	_	20	CONJ
22	developed	develop	VBD	_	18	CONJ
23	the	the	DT	_	24	NMOD
24	CSS	cs	NN	_	22	OBJ
25	.	.	.	_	4	P

1	All	all	PDT	_	3	NMOD
2	the	the	DT	_	3	NMOD
3	authors	author	NNS	_	4	SBJ
4	have	have	VBP	_	0	ROOT
5	read	read	VBN	_	4	VC
6	and	and	CC	_	5	COORD
7	approved	approve	VBN	_	6	CONJ
8	the	the	DT	_	10	NMOD
9	final	final	JJ	_	10	NMOD
10	manuscript	manuscript	NN	_	5	OBJ
11	.	.	.	_	4	P

1	Pre-publication	pre-publication	JJ	_	2	NMOD
2	history	history	NN	_	0	ROOT

1	The	the	DT	_	3	NMOD
2	pre-publication	pre-publication	JJ	_	3	NMOD
3	history	history	NN	_	7	SBJ
4	for	for	IN	_	3	NMOD
5	this	this	DT	_	6	NMOD
6	paper	paper	NN	_	4	PMOD
7	can	can	MD	_	0	ROOT
8	be	be	VB	_	7	VC
9	accessed	access	VBN	_	8	VC
10	here	here	RB	_	9	ADV
11	:	:	:	_	7	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	The	the	DT	_	2	NMOD
2	authors	author	NNS	_	3	SBJ
3	thank	thank	VBD	_	0	ROOT
4	Dr.	dr.	NNP	_	6	NMOD
5	A.	a.	NNP	_	6	NMOD
6	Vasanji	vasanji	NNP	_	3	OBJ
7	,	,	,	_	6	P
8	Shiyang	shiyang	NNP	_	9	NMOD
9	Wang	wang	NNP	_	6	CONJ
10	,	,	,	_	9	P
11	and	and	CC	_	9	COORD
12	Jenna	jenna	NNP	_	13	NMOD
13	Saraniti	saraniti	NNP	_	11	CONJ
14	for	for	IN	_	3	PRP
15	assistance	assistance	NN	_	14	PMOD
16	with	with	IN	_	15	NMOD
17	image	image	NN	_	18	NMOD
18	analyses	analysis	NNS	_	16	PMOD
19	,	,	,	_	3	P
20	David	david	NNP	_	21	NMOD
21	Hellard	hellard	NNP	_	3	GAP
22	for	for	IN	_	21	PRP
23	performing	perform	VBG	_	22	PMOD
24	the	the	DT	_	27	NMOD
25	blood	blood	NN	_	26	NMOD
26	pressure	pressure	NN	_	27	NMOD
27	measurements	measurement	NNS	_	23	OBJ
28	,	,	,	_	21	P
29	Dr.	dr.	NNP	_	30	NMOD
30	Y.Shchurina	y.shchurina	NNP	_	21	GAP
31	for	for	IN	_	30	PRP
32	the	the	DT	_	34	NMOD
33	plasminogen	plasminogen	NN	_	34	NMOD
34	analyses	analysis	NNS	_	31	PMOD
35	,	,	,	_	30	P
36	Drs.	drs.	NNPS	_	38	NMOD
37	Lindsey	lindsey	NNP	_	38	NMOD
38	Burrage	burrage	NNP	_	30	GAP
39	and	and	CC	_	38	COORD
40	Jonathan	jonathan	NNP	_	41	NMOD
41	Smith	smith	NNP	_	39	CONJ
42	for	for	IN	_	38	PRP
43	helpful	helpful	JJ	_	44	NMOD
44	discussions	discussion	NNS	_	42	PMOD
45	,	,	,	_	38	P
46	and	and	CC	_	38	COORD
47	Robin	robin	NNP	_	48	NMOD
48	Lewis	lewis	NNP	_	46	GAP
49	for	for	IN	_	48	PRP
50	assistance	assistance	NN	_	49	PMOD
51	with	with	IN	_	50	NMOD
52	manuscript	manuscript	NN	_	53	NMOD
53	preparation	preparation	NN	_	51	PMOD
54	.	.	.	_	3	P

1	This	this	DT	_	2	NMOD
2	study	study	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	supported	support	VBN	_	3	VC
5	by	by	IN	_	4	LGS
6	grants	grant	NNS	_	5	PMOD
7	from	from	IN	_	6	NMOD
8	NIH	nih	NNP	_	7	PMOD
9	,	,	,	_	6	P
10	HL17964	hl0	NN	_	14	NMOD
11	,	,	,	_	14	P
12	HL65204	hl0	NN	_	14	NMOD
13	,	,	,	_	14	P
14	HL078701	hl0	NN	_	6	APPO
15	(	(	-LRB-	_	16	P
16	JHP	jhp	NNP	_	14	PRN
17	)	)	-RRB-	_	16	P
18	,	,	,	_	14	P
19	T32	t0	NN	_	20	NMOD
20	HL07914	hl0	NN	_	14	CONJ
21	(	(	-LRB-	_	22	P
22	AS	a	NNP	_	20	PRN
23	)	)	-RRB-	_	22	P
24	,	,	,	_	20	P
25	and	and	CC	_	20	COORD
26	RR12305	rr0	NN	_	25	CONJ
27	(	(	-LRB-	_	28	P
28	JHN	jhn	NNP	_	26	PRN
29	)	)	-RRB-	_	28	P
30	.	.	.	_	3	P

